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ABSTRACT 
  
Medical policies, practices, and definitions do not exist solely in the clinical 
realm; they show up in the lived experiences of patients. This research examines how 
people with the chronic illness called myalgic encephalomyelitis (ME) define their own 
illness experiences. They have situated knowledge about their illness onset, search for 
care, and clinical encounters. Their knowledge complicates and challenges the existing 
norms in clinical practice and medical discourse, as the experience of searching for care 
with ME reveals weaknesses in a system that is focused on acute care. Patient narratives 
reveal institutional patterns that obstruct access to medical care, such as disbelief from 
clinicians and lack of training in chronic illness protocols. They also reveal patterns in 
physician behavior that indicate the likelihood of receiving effective care. These patient 
narratives serve as a basis for continued examination of ME as well as further 
reconstruction of medical practice and procedure. 
 
 
  
 ii 
 
DEDICATION 
  
To Michelle and Pamela Cutler, for being my constant motivation and for making 
my own diagnosis possible. It is their work that led me to medical care and being well 
enough to enter graduate school in the first place.  
To David Cramer, for maintaining this vision and seeing it through with me, day 
by day. And also, for planning our wedding while I did these interviews. I am daily 
grateful for you, love. 
 
 
 
  
 iii 
 
ACKNOWLEDGMENTS 
I would like to express my heartfelt gratitude to those whose guidance made this 
thesis possible: Dr. Olga Idriss Davis, for her generous time, knowledge, and direction; 
Rebecca Townsley, for believing in my ability and showing the way; Carolyn Anh Dang, 
for her continuous insights into the medical community and for her support while I chose 
this subject to study; Nanette Schuster, for organizing a campus screening of Unrest, 
which unleashed a ripple effect of connections and mentors that made this thesis possible; 
to my committee, Drs. Oliverio, Mann, and Behl, for their support and generosity of 
spirit; and most importantly, to Ashanti, Lena, Elizabeth, Karen, Kelli, Cheryl, and 
Adaline—this is your story.    
 
  
 iv 
 
TABLE OF CONTENTS 
       Page 
LIST OF TABLES ............................................................................................................. vi 
1 INTRODUCTION ........................................................................................................... 1 
Overview ................................................................................................................. 1 
Literature Review.................................................................................................... 7 
Theory & Methods ................................................................................................ 37 
2 THE LIVED EXPERIENCE OF ME ............................................................................ 55 
“It Was a Lifesaver …”......................................................................................... 55 
Exertion, Payback, & Rest: The Balancing Act .................................................... 58 
Day-to-Day Life .................................................................................................... 64 
Changes ................................................................................................................. 74 
3 NAVIGATING HEALTHCARE................................................................................... 90 
“All I Wanted Was to Figure Out What Was Wrong with Me”  .......................... 90 
Concepts & Diagnostic Terms .............................................................................. 93 
Experiences with Institutions .............................................................................. 101 
Experiences with Individual Physicians ............................................................. 122 
4 RECOMMENDATIONS ............................................................................................. 136 
Recommendations for Institutions ...................................................................... 137 
 v 
 
Page 
Recommendations for Physicians ....................................................................... 143 
Recommendations for Patients ........................................................................... 146 
Recommendations for Future Research .............................................................. 149 
REFERENCES ............................................................................................................... 152 
APPENDIX  .................................................................................................................... 160 
A TL;DR ............................................................................................................. 160 
B INTERNATIONAL CONSENSUS CRITERIA (ICC) .................................. 166 
C NAMING MULTI-SYSTEM CONDITIONS ................................................ 170 
D SUICIDE IN CHRONIC ILLNESS COMMUNITIES .................................. 174 
E IRB APPROVAL DOCUMENTS .................................................................. 180 
BIOGRAPHICAL SKETCH .......................................................................................... 183 
 
 
 
  
 vi 
 
LIST OF TABLES 
Table                   Page 
1.    Participant Demographics ………………………………………………….  45 
2.    Diagnostic Terms Within the Participant Interviews ………………............. 96 
3.    Recommendations for Overcoming Barriers to Effective Care …………… 136 
 
 
 
  
 1 
 
CHAPTER 1  
INTRODUCTION 
Overview1 
“Sickness doesn’t terrify me. Death doesn’t terrify me.  
What terrifies me is that you can disappear because  
someone is telling the wrong story about you.” 
Jennifer Brea (2017) 
  
The social construction of illness crosses boundaries. It is constructed in and 
through history, politics, medicine, family relationships, education, and social 
movements. Collectively, language and institutions impact the experience of those with 
chronic illness, through the meanings that literature, popular media, and medical journals 
create about illness. This can provide common ground and common understanding. 
However, when misinformed definitions and narratives about illness dominate these 
institutions, in medical journals and in board meetings, it becomes a barrier to actual 
treatment, care, and quality of life. This is why Jennifer Brea (2017) and others with 
myalgic encephalomyelitis (ME)2, a chronic neuroimmune condition, find it crucial to tell 
                                                 
1
 Look for tl;dr footnotes. I have provided a short summary of each section, listed as a footnote connected 
to the section heading. The acronym tl;dr stands for “too long; didn’t read”. It is used on social media 
platforms as a way to present information succinctly, and indicates the person is providing a short 
summary. Providing my own version of this facilitates communication with key communities outside 
academia. Including the tl;dr footnotes will also allow interview participants from this study to more 
readily scan, analyze, and provide feedback on this thesis. Their feedback has been vital to this thesis and 
continues to be is vital for future research. Refer to Appendix A, which contains all the tl;dr summaries 
in one place. 
 
tl;dr - Overview - Beliefs and ideas about illness are created socially. This makes advocacy and patient 
narratives necessary in order to challenge harmful beliefs about illness held by dominant medical 
institutions. Disability studies offers analytical tools to reconstruct medical norms. 
 
2
 For additional information on the diagnostic criteria for ME, see Appendix B. 
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their stories about how this chronic illness affects them. When her debilitating symptoms 
were classified by doctors as hysterical (a trend in medical institutions documented 
elsewhere by Hoffmann & Tarzian, 2001; Werner, Isaksen, & Malterud, 2004; Jäntti, 
2010), Brea launched MEAction.net, a platform for advocacy and the #MillionsMissing3 
social media campaign. This website highlights the lives and needs of millions of 
Americans who are homebound due to chronic untreatable illness, who have disappeared 
from society, and who are often told by medical practitioners to go home and wait for a 
cure (Brea, 2017). Her work with this community-based advocacy continues to gather 
support in cities across the globe, as people with ME demand to be seen and heard by 
physicians and funding agencies. They work to change harmful language and framing 
used by centers of medical power such as the CDC. They demand institutional attention 
through increased funding of clinical research that will lead to more effective diagnosis, 
stronger patient-physician collaboration, and the development of treatments for ME. 
This fight for visibility and equal access to care mirrors similar conversations 
happening within the field of disability studies, where normative structures are critiqued 
and dismantled to create inclusive and accessible societies for people who do not match 
the ‘able-bodied’ societal norm. However, this field also marks clear boundaries that 
differentiate illness from disability, in order to keep disability conceptually distinct from 
illness (Couser, 2015), because of the history of harm on disability communities by 
medicalization and marginalization (Riessman, 1983; Dusenbery, 2018). Illness and 
disability are related, since chronic illness can lead to disability. However, disability is 
                                                 
3
 For addition information about #MillionsMissing, see www.MEAction.net and 
my.meaction.net/calendars/MillionsMissing.  
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often impacted by the visible, and chronic illness is impacted by the invisible, which 
plays out in various ways across different communities at the intersections of ability, 
class, race, and gender. Feminist disability studies grew out of theories dedicated to 
centering the needs of those marginalized by these same domains of class, race, and 
gender (Garland-Thomson, 2014). The theoretical foundations within disability studies 
provide a workable framework that can accommodate two opposing demands: 
1. Disability communities maintain that physical, mental, emotional, or behavioral 
differences do not need to be ‘cured’; insisting that all bodies meet the same 
standard of ability is erasure. 
2. People living with ME, dysautonomia, and other complex chronic illnesses need 
options for medical treatment and are actively seeking them; insisting that people 
continue to live with debilitating symptoms while doing nothing about it is 
erasure.  
Because of its commitment to exposing patterns of erasure, disability studies is uniquely 
equipped to handle these contradictory demands. The work of critiquing and dismantling 
the medical model can coincide with advocacy for medical research. By challenging the 
medical model’s dominance, this field can meet the needs of people demanding medical 
treatment as well as the needs of people seeking demedicalization. The parts of the 
medical model that concern this thesis are medical legitimacy (what type of knowledge is 
valid) and authority (whose knowledge is valid). 
Definitions and diagnoses within the medical model are also embedded in 
contradiction, as people seek care as patients, yet are disadvantaged because they remain 
at the mercy of professed experts with preconceived standards of behavior. In this paper, 
I use the term ‘patient’ to refer to a person who is engaged in the role of seeking medical 
care. In the specific context of a doctor’s appointment, the patient and the physician both 
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engage in their respective roles as they interact with each other. The patient’s role or 
responsibility is to communicate their symptoms, when feasible, and to receive care. The 
role of ‘patient’ can also extend further into a person’s lived experience as people with 
chronic physical symptoms (such as debilitating fatigue, pain, motor/cognitive 
dysfunction, seizures, or organ system failure) lead them and their caregivers to operate 
day-to-day within the context of medical care, contacting physicians, and navigating 
hospitals, insurance codes, and treatment plans. This ongoing participation places them in 
the continuous role of ‘patient’, consuming their time and resources. 
The term patient also appears in another context. Many people with 
misunderstood chronic illness feel immense pressure to be ‘the ideal patient’ (Edwards, 
2008). One woman described her tenuous relationship with doctors in this way: “I have to 
be emotionally perfect in order to get help” (M. Cutler, personal communication, March 
7, 2018). These standards of behavior come from social constructions of “normal 
behavior”, “the ideal body”, and who holds authority. It locates patients alongside 
disability studies scholars to the degree that they both recognize the harm done by these 
unrealistic standards and seek to deconstruct/reconstruct accepted norms surrounding 
behavior and the body. 
I realize that using the medicalized term ‘patient’ is complicated within a 
disability studies framework that views the medical model as a source of oppression 
(Couser, 2015). Discussing dysfunctions of the body can be problematic as scholars 
within the field seek to dismantle the ideology of the atypical body as ‘defective’ or 
‘impaired’ (Siebers, 2008). I use it strategically, because as long as the medical model 
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remains the dominant narrative, individuals are thrown into the medical industrial 
complex when they seek care as well as interpreting their lived experience from a 
medical perspective. People become lifelong patients within the medical industrial 
complex (Clare, 2017; Illich, 1976). Keeping these considerations in mind, I strive 
throughout my work to write in a way that recognizes the nonnegotiable, irrevocable 
personhood of everyone impacted by chronic illness while also recognizing the 
community of people their individual stories represent. I use the term patient to indicate 
the medical context the person is in and what actions are expected of them, just as the 
terms nurse or physician denote a medical context and set of responsibilities. Everywhere 
else, I will use the term ‘person with ME.’ This terminology highlights the value of each 
person’s experience while also turning attention to the expectations and norms of medical 
care. 
Through my research, I seek to reveal contextualized aspects of the lived 
experience of ME. This project asserts that analysis of patient narratives will strengthen 
our understanding of lived ME experiences and can be used to challenge medical 
discourse regarding different aspects of chronic illness generally, such as patient-
physician relationships, more effective collaboration techniques, removing barriers, and 
innovating clinical practices that meet patient needs. Hugo Campos, a Medicine X 
ePatient Advisor, captured the contribution of patient narratives to medical education 
curriculum in this way: “Patient stories will help us create a new generation of doctors 
who have more empathy and have a lot more joy for the profession of being a doctor” 
(Chu & Price, 2019, p. 8). This indicates that the knowledge chronic illness communities 
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already possess is key to addressing persistent inequities. As shown by Behl (2017), 
“knowledge itself is a product and productive of power” (p. 581). One of the key 
outcomes from examining patient narratives is the transformative influence they can have 
as medical practices and norms are reevaluated and recreated. 
This paper explores and contextualizes the lived experience of ME in four 
sections. The first chapter is a combination of the literature review and methodology, 
which provides background on the history of ME, medical practices, and the theoretical 
framework employed in this thesis. The second chapter documents and explores the daily 
lives of people with ME as self-reported. The third chapter examines the experiences of 
people with ME as they navigate healthcare systems. These experiences shed light on 
some of the limitations of the healthcare system and possibly suggest ways the system 
needs to be transformed. The fourth chapter provides recommendations based on patient 
perspectives in order to guide medical and social constructions about ME toward 
effective and humane outcomes. 
 These patient narratives are located within current social and medical contexts 
maintained by institutions, processes, and systems. They provide perspectives that can 
contribute to the body of knowledge regrading invisible disabilities and chronic illness, 
while also pointing the way to important, practical changes. 
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Literature Review 
Myalgic Encephalomyelitis 
Myalgic encephalomyelitis (ME) is currently defined as a neuroimmune disease 
characterized by physical and cognitive exhaustion not improved by sleep, with an 
ongoing occurrence of symptoms over months and years. Although this disease has been 
on the books since 1956, research on this disease is still in its infancy. There are still no 
FDA approved treatments (Centers for Disease Control and Prevention, 2018B) and a 
continued lack of coverage in medical curriculum (Jason, et al, 2010). For this thesis and 
its accompanying research, I utilize the International Consensus Criteria (ICC) for ME4. 
These diagnostic criteria are outlined in Appendix B. Note the four symptom categories 
in the ICC that comprise the main elements of ME: post-exertional neuroimmune 
exhaustion (PENE); neurological impairments; immune, gastro‐intestinal, and 
genitourinary impairments; and energy production/transportation impairments5. One of 
the key symptoms that differentiates ME from other chronic illnesses is PENE, which 
causes a drastic reduction in physical and cognitive activity. People with ME navigate 
                                                 
4
 Why I use the term ME instead of ME/CFS or CFS: The name Chronic Fatigue Syndrome (CFS) is often 
confused with the symptom “chronic fatigue” (CF). CF as a symptom is present in many diseases, but CFS 
is a specific syndrome with neurologic and immunity components. The vague language and lack of 
understanding surrounding the term ‘fatigue’ has contributed to misinformation about the seriousness of the 
CFS and has led to patients being labeled chronic complainers or malingerers. ME and CFS are often used 
interchangeably, amplifying existing confusion. The term ME/CFS arose from patient-community requests 
to refer to ME first, to draw increased attention to the term myalgic encephalomyelitis; however, it still 
contains the reference to ‘fatigue’ as an overshadowing component of this disease, which can perpetuate 
misinformation. In this text, I use the term ME to refer to this illness, unless I am matching specific 
language used in cited publications, in which case I may use the terms CFS or ME/CFS (Dimmock & 
Lazell-Fairman, 2015, p. 4). 
 
5
 Appendix B provides specific examples of each of these. 
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these physical symptoms while simultaneously seeking medical care through a complex 
healthcare system.  
History of ME6 
The names used to describe ME reveal a lot about the views of the medical 
establishment and its influence on the general public. Tracing myalgic encephalomyelitis 
back through the last several decades shows the influence of the social conditions that 
surround this illness: 
‘Chronic fatigue syndrome’. In 1984, there was an outbreak of viral infections 
in the resort town of Incline Village, Nevada. At the insistence of two local physicians, 
the Centers for Disease Control and Prevention (CDC) investigated the outbreak. Relying 
on an all-white, mostly female sample, the CDC determined that the Epstein-Barr virus 
could not be reliably linked to the outbreak; it was in this report that they used the term 
“syndrome of chronic fatigue” (Centers for Disease Control and Prevention, 1986). 
Beyond this, the men sent from the CDC to Incline Village did little more than encourage 
the two physicians to focus their energy on patients with conditions that are already 
medically understood (Newsweek, 1990). Many of the phrases from an article in 
Newsweek Magazine that reported on chronic fatigue syndrome still ring true to the 
current situation: “We're desperate for care “, “treatment proceeds by trial and error”, “no 
one would take them seriously” (Newsweek, 1990). The cause of the outbreak remained 
largely a mystery, but the association of ‘fatigue’ with women was beginning to be 
established. 
                                                 
6
 tl;dr - ME has gone by various names over the years. These names reflect social attitudes of the time 
period toward the disease, by their emphasis on fatigue/burnout OR on specific biological processes. 
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 ‘Yuppie flu’7. Time Magazine ran a piece in 1987 that listed many names for this 
condition, including epidemic neuromyasthenia, myalgic encephalitis, Iceland disease, 
Royal Free disease, postviral fatigue syndrome, chronic Epstein-Barr virus infection, 
chronic mononucleosis, and chronic fatigue syndrome (Boffey, 1987). The label that 
appealed the most at this time with mainstream information was the Yuppie flu. Yuppie 
was the derogatory term for middle-class women in the 1980’s who entered professions 
that had previously been overwhelmingly male. Using the term yuppie flu pulled on the 
misogynistic heartstrings of a changing society; the logic used at the time was that 
women had violated social norms by pursuing professional status and yuppie flu was the 
natural consequence. This terminology centered the issues and concerns of white, middle-
class communities. The social perception of the disease supported the move toward 
predominantly psycho-social methods of treatment, including psychotherapy to remove 
patients’ beliefs about their illness, as the common trope from the medical establishment 
was that the disease was rooted in an innate desire to be sick (Dimmock & Lazell-
Fairman, 2015). 
‘Myalgic encephalomyelitis, International Consensus Criteria’. While the 
term myalgic encephalomyelitis appeared far back as 19568, the name did not gain 
                                                 
7
 In the cultural context of this time period, the ‘yuppies’ of the 1980s were the ‘hippies’ from the 1970s—
whose belief system transformed from ostensibly anti-establishment to embracing the establishment and 
striving for greater economic, upward mobility. Thus, they were given the moniker, ‘yuppies'. This increase 
in socio-economic status caused a good deal of anxiety. While both men and women were in the ‘yuppie’ 
group, women were specifically targeted as more and more women entered the workforce in jobs that were 
traditionally male dominated. 
 
8
 Published in The Lancet; in an editorial in 1956, and in an article by Ramsey on the outbreak at Royal 
Free hospital in London in 1957. The term was subsequently overtaken by psychiatric terms throughout the 
1970s. 
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traction until relatively recently. In 2011, a collaborative panel of clinicians, medical 
school faculty, researchers, and one patient advocate published the International 
Consensus Criteria (ICC)9, designed for the purpose of providing an accurate diagnostic 
tool for patients and clinicians. This criteria sets a higher bar for diagnosis with multiple 
symptom categories. The ICC purposefully removed language about ‘fatigue’ from the 
diagnosis, noting that other diseases that cause fatigue, such as cancer or multiple 
sclerosis, don’t have ‘fatigue’ as part of their name, and therefore, neither should CFS 
(Carruthers, et al., 2011). They promoted the use of myalgic encephalomyelitis over CFS, 
with particular care taken with each of the descriptive symptoms to remove or change 
language that diminished the seriousness or credibility of the disease. For example, they 
replaced post-exertional malaise (PEM) with post-exertional neuroimmune exhaustion 
(PENE). ‘Malaise’ suggests malingering or indistinct discomfort. This report changed the 
language so that it centered the impact of the neuroimmune system (Carruthers et al., 
2011). The ICC definition and symptomatology are the criteria used for my thesis 
research. 
ME/CFS. The official language from the Centers for Disease Control and 
Prevention (CDC) currently utilizes the term ‘ME/CFS’ and makes an effort to highlight 
that the disease is biological, not psychological (Centers for Disease Control and 
Prevention, 2018A). This term is widely used in academic and medical literature since it 
includes both ME and CFS. 
                                                 
9
 See Appendix B.  
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Systemic Exertion Intolerance Disorder. In 2015, the National Academy of 
Sciences (NAS) released a report based on the input of ME specialists, patient advisors, 
and others. They examined the various criteria for ME and CFS, including areas of 
overlap as well as limitations of each criteria. They created a new diagnostic criterion10 
and suggested a new term, Systemic Exertion Intolerance Disorder (SEID), to replace 
ME/CFS. One of their main goals was to give primary care providers practical tools for 
learning about, diagnosing, and treating people who meet the diagnostic criteria for 
SEID. This term has not yet taken hold in academic, medical, and conversational areas, 
and NAS recommends that this criterion be re-examined in 2020 (NAS, 2015).  
ME in Context11  
In the United States, ME has a disease burden slightly higher than HIV/AIDS and 
multiple sclerosis (MS). However, in terms of funding for research and treatments, 
ME/CFS receives approximately $5 per patient from the National Institutes of Health 
                                                 
10 “Proposed Diagnostic Criteria for ME/CFS. Diagnosis requires that the patient have the following three 
symptoms: 
1) A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, 
educational, social, or personal activities that persists for more than 6 months and is accompanied by 
fatigue, which is often profound, is of new or definite onset (not lifelong), is not the result of ongoing 
excessive exertion, and is not substantially alleviated by rest, 
2) Post-exertional malaise,* and Unrefreshing sleep* 
3) At least one of the two following manifestations is also required: Cognitive impairment* or Orthostatic 
intolerance. 
* Frequency and severity of symptoms should be assessed. The diagnosis of ME/CFS should be questioned 
if patients do not have these symptoms at least half of the time with moderate, substantial, or severe 
intensity” (NAS, 2015, p. 6). 
 
11
 tl;dr - Funding - In the United States, the NIH does not fund ME research at a level appropriate to the 
disease burden.  
 
 tl;dr - Medical Model - The medical model claims that all life events are under the jurisdiction of medical 
institutions. Under this model, symptoms and illnesses are counted as ‘real’ when they are visible and 
thereby granted medical legitimacy by the institution. 
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(NIH), compared to $2,482 for HIV/AIDS and $255 for MS, according to data from 2014 
(Dimmock, Mirin, & Jason, 2016). Both HIV/AIDS and MS as disease categories have 
gone through significant periods of patient activism and institutional change to get where 
they are now in terms of funding, public understanding, and professional understanding12. 
Government agencies have known about ME for decades, but unlike the needed growth 
of research provided for HIV/AIDS and MS, the NIH has kept ME funding persistently 
low. This process of funding does not take only medical factors into consideration. Social 
beliefs and behaviors factor in to decisions about medical care. When examining the 
reasons for underfunding, Dimmock, Mirin, & Jason reported, “we tend to underfund 
things where we blame the victim” (2016, pp. 2). Issues of funding first require a shift in 
social perceptions, followed by a shift in legislative and bureaucratic prioritization of 
funds. To comprehend this issue of funding, we must explore the broader issues.  
Decisions about medical funding occur within the broader framework of accepted 
beliefs about illness. Scholars in disability theory refer to our western dominant narrative 
as the medical model 13. The medical model is a system of ideas and practices that bring 
all life events under the authority of medicine and healthcare, positioning physicians’ 
offices as sites of power (DasGupta, 2015). The term medicalization also refers to 
subsuming human behaviors into a medical context and using the medical field as a tool 
for controlling deviant behavior (Riessman, 1983). Because this model is the dominant 
                                                 
12
 Refer to the section on psychogenesis for further discussion of the history of MS.  
13
 For additional context about the academic critique of the medical model, refer to section of this literature 
review on Critical Disability Theory, which, in contrast to the medical model, views disability “as the 
product of social injustice” (Siebers, 2008, p. 3) as opposed to the bodily failings of an individual. 
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narrative in western cultures, conversations about illness14 and mainstream 
understandings of ME (plus other similar diagnoses15) center around medicalized ideas 
and practices. This is also referred to as the medical industrial complex (Clare, 2017), an 
assemblage of corporations that profit off medical systems, particularly the 
pharmaceutical industry, which is the direct beneficiary of creating higher demand for an 
increasing range of treatments. Pharmaceutical companies continue to fabricate medical 
needs and then provide the drugs. This plan has worked quite successfully, since “the 
public finds medicalization attractive because the notion of simple but scientific solutions 
fits in with a general cultural overinvestment in biological explanations and 
interventions” (Tiefer, 2006). In this way, the dominant model is self-sustaining. 
People enter the medical industrial complex through their primary care provider 
and from there they run the course from clinician to clinician who specializes in one 
small area, not in whole-body understanding or interconnectedness. Because modern 
medical protocols largely developed from wartime needs and emergency-related medical 
care, focus on transportation and acute injury care remain in force (Rostker, 2013). The 
systems developed around this type of acute care prioritize focusing in on one aspect, 
such as the lungs or a leg injury, instead of considering how systems work together. 
Acute care results in more and more specialized areas of medical practice. However, not 
                                                 
14
 Conversations about illness occur through dialogues in medical journals, medical school curriculum and 
training, disability accommodations, and they also happen person-to-person. 
 
15
 For clarity, diagnoses is the plural form of diagnosis. The last syllable of diagnosis is pronounced “sis” 
like “sister”. The last syllable of diagnoses is pronounced “es” like “ease”. I use both the singular form and 
the plural form throughout this paper. 
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every condition can be addressed in that way, particularly chronic illness, which requires 
a robust knowledge of how organ systems relate to each other. Because of this, western 
medicine16 has fallen short17 regarding chronic illness care.  
Within this model, empirical data and observable proof are highly valued which 
creates an over-emphasis on that which is visible and easily measured (Brea, 2017). The 
prevailing belief is that conditions that matter can be seen concretely in lab results, which 
disadvantages the experiential knowledge held by patients (Spandler & Allen, 2018). 
Medical institutions decide what is real, what is urgent, and what is not; those decisions 
are largely based on what the eye can see. The authority rests with medical professionals, 
who further codify beliefs about illness into the DSM, ICD-10, and other lists of official 
clinical diagnoses. When Brea (2017) says that the wrong story is being told about people 
with ME18, she is referring to this fraught history of the medical model. 
 The accepted narrative of the medical model says, you don’t look sick.  
It says, if doctors don’t know what’s wrong, the patient is the problem.  
It says, if science cannot explain your symptoms, your symptoms are not real.  
This results in erasure and harm. Health advocates and community organizations 
for health equality imagine an alternative narrative, in a system built around reciprocity 
instead of erasure, where this phrase could be flipped on its head: if science cannot 
                                                 
16 A deeper look into Eastern modalities of medicine is beyond the scope of this paper; however chronic 
illness patients may seek out this kind of care because of the limitations of Western medicine. 
 
17 In addition, the medical model places responsibility on the individual through stigma (Oliver, 2008) but 
does not individualize the approach to meeting patient needs, which include the nuances of managing 
chronic illness, which cannot be met by examining discrete parts disconnected from the whole. 
 
18
 See quote at the beginning of the Overview section. 
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explain your symptoms, then it needs to be interrogated, not the patient (Adams, Reiss, & 
Serlin, 2015; Brea, 2017). 
The medical field is not a neutral environment. The development of medicine as a 
distinct profession was rife with biopolitical struggles, as upper-class male physicians 
pushed out lower-class female healers in the ongoing struggle for authority and 
credibility (Ehrenreich & English, 1973). In her work, Riessman (1983) explains that 
“medical practice becomes a vehicle for eliminating or controlling problematic 
experiences that are defined as deviant, for the purpose of securing adherence to social 
norms” (p.48). This idea is supported Conrad and Schneider (1992) and also by 
Ehrenreich and English (1973) who investigate the centuries old tradition of erasing 
women from professional medical practice, and warn that “the stakes are even higher 
today, when total control of medicine means potential power to determine who will live 
and who will die, who is fertile and who is sterile, who is ‘mad’ and who is sane” (p. 28). 
Additionally, medical advancement has been borne on the backs of communities of color 
through unethical medical trials such as Tuskegee, profiting off the contribution of 
Henrietta Lacks, and testing on nonconsenting emergency room patients (Washington, 
2006). Recognizing this violent history behind current medical practices is key to 
understanding their formation and the ways in which they operate today. Specifically, 
Riessman (1983) argued that women as a group have negotiated the risks involved in 
both rejecting and accepting the medicalization of human life for a long time. Rejecting 
the system distances women from potential life-saving advances, but accepting the 
system puts women in jeopardy of being (mis)treated for illnesses that were constructed 
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for the purpose of control (such as conversion disorder, the modern equivalent of 
hysteria, or treating pregnancy and menstruation as disease). Women have navigated 
these risks for generations, and people of all genders are susceptible to the negative 
impacts of living in a system built around these risks. 
The relationship between women and chronic illness19. As an umbrella 
category, people who self-identify as women in the United States are more likely to 
experience chronic illness than fatal illness. Case and Paxson (2005) found that women 
are more likely to experience non-fatal-chronic illnesses that affect their quality of life 
and are also more likely to report and seek treatment for those conditions, compared to 
men who are more likely to experience fatal medical events. This phenomena of higher 
levels of morbidity (illness) in women contrasted with higher levels of mortality (death) 
in men is referred to as the sex health paradox. Case and Paxson (2005) conclude that the 
health risks associated with smoking contribute to a higher mortality rate in men (p. 209) 
even when the rate of hospitalization and self-reporting of symptoms is the same among 
women and men. The main takeaway here is women as a whole are more likely to 
experience, report, and seek treatment for chronic illnesses that affect their day to day 
quality of life. 
These differences in the likelihood of chronic illness between women and men 
reveal the need for healthcare systems at an institutional level to be able to provide 
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 tl;dr - Women are more likely to have chronic conditions. Men are more likely to have fatal conditions. 
An estimated 75% of people with ME are women. 
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adequate care for chronic illness20. The lack of institutional attention to these issues 
allows the dominant norms (fixation on acute, fatal events) to remain in force. Dusenbery 
(2018) refers to this as a systemic emphasis “on preventing death over improving health” 
(p. 163). 
Since ME is one of the chronic illnesses that is more likely to be found in women, 
with an estimated 75% of people with ME identifying as women (National Academy of 
Sciences, 2015), the question remains: how has our healthcare system traditionally 
handled issues relevant to women’s health? One prime example is the reaction of the 
medical establishment to the shifts that occurred during the last part of the twentieth 
century. 
The changing position of women’s health within medical institutions21. The 
decade spanning from the mid-1990s to the early-2000s saw unprecedented scrutiny of 
medical norms, due to the action and scholarship stemming from feminist researchers 
(Dresser, 1992; Fourcroy, 1994; Riessman, 1983). During this time period, women made 
                                                 
20
 Jennifer Brea’s work in film and community advocacy addresses the harm of gender bias: “Our immune 
systems are just as much a battleground for equality as the rest of our bodies … Bias against women in 
medicine operates at every stage from lab research to diagnosis to treatment. Women are significantly more 
likely than men to suffer from ME and autoimmune disorders. Yet, many of these diseases are significantly 
underfunded relative to their impact on human well-being and cost to the economy. Human males and male 
animals are still used more frequently as test subjects. At the diagnostic level, women’s symptoms are more 
likely to be perceived as exaggerated or psychosomatic, meaning women are often misdiagnosed, 
underdiagnosed, or, worse, blamed for their symptoms with invalidating diagnoses like ‘it’s all in your 
head.’ It wasn’t long ago that doctors were diagnosing women with “hysteria” for diseases they didn’t 
understand. The medical profession has moved on from the name but the bias lives on” (Brea, n.d). 
 
21
 tl;dr - Limited gains have been made in integrating women’s health concerns into medical curriculum 
and clinical practice. The FDA banned women from participating in drug trials from 1977 to 1993. Despite 
attempts to reverse this practice, drug companies still test drugs primarily on male samples, resulting in 
consumer risk for the broader public. 
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bold reclamations of autonomy over their bodies (Davis, 2007). Ineffective medical 
practices were called out like never before, particularly when it came to treating female 
bodies as a subset of male bodies: “Many of the problems associated with women today 
can be considered signs of mental illness only in comparison with a male standard of 
what is healthy and normal” (Tavris, 1994, p.101). Scholars and public citizens 
demanded recognition of the medical field’s failure to address women’s health from start 
to finish, in research and training and diagnosis (Dresser, 1992; Fourcroy, 1994; Tavris, 
1994; Herz, 1997).  
One area of particular importance is the exclusion of women from drug trials. 
Women have historically been barred from participation in medical research and clinical 
drug trials (Ibarra, et al., 2017; Uhl, Parekh, & Kweder, 2007; Herz, 1997; Mastroianni, 
Faden, & Federman, 1994; Fourcroy, 1994), resulting in little attention to the role of 
female biology on the usage and metabolization of prescription medication. Drugs were 
tested for safety and dosage on male laboratory rats (Dresser, 1992; Goodman, 1994). 
Subsequent testing on human populations followed patterns of erasure and violence: an 
overemphasis on sample populations comprised of white, single, middle-class men 
(Dresser, 1992); or unethical, nonconsensual experiments on minority groups 
(Washington, 2006). Marked with the FDA’s stamp of approval, these medications were 
then put on the market for consumption by all patients.  
Centuries of social and political ideology were codified in the FDA’s 1977 policy 
that all women capable of reproduction must be excluded from drug trials (Carey, et al., 
2017; Josefson, 1997) but by 1993 the persistent backlash over that decision prompted a 
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reversal by the FDA (Cotton, 1993, p. 2067). An FDA report on the ongoing inequalities 
in medical research listed reasons why male bodies were/are used as the model while 
female bodies were prohibited: “simplicity”, “homogeneity”, “lower costs”, 
“paternalism”, “fear of liability” and “concern about confounding effects of hormonal 
and reproductive issues” (Uhl, Parekh, & Kweder, 2007, p. 600). This had and continues 
to have consequences for women who take medication. 
Because of this scholarship and activism, the tacit acceptance of male biological 
data as general human data fell into disrepute. A well-known study of aspirin at the time 
claimed the drug was successful in preventing migraines and reducing the chance of heart 
attack, but their data were collected from all male subjects22. One study went so far as to 
analyze the effects of obesity on breast cancer, which they “conducted—you guessed it—
solely on men” (Dresser, 1992, p. 21). These two reports were not well met in the public. 
Researchers were attempting to carry out business as usual, which in their field meant 
male lab rats and male subjects; however, this institutional norm, long ignored, was 
repeatedly brought to light in an effort to replace it with an equitable standard. 
These demands for procedural change, and the subsequent changes in policy by 
the FDA, represent an important step forward, but it was not sufficient to make lasting 
changes on the medical industrial complex. Pharmaceutical corporations continued to test 
drugs on male populations and then sell those medications to both women and men. 
Female patients continue to be misdiagnosed or mis-medicated because male norms are 
still universalized. A recent study shows that medications are metabolized in women 
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 It also ignored the data that showed women experience 66% more migraines than men and also 
experience high rates of heart disease (Dresser, 1992).  
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differently than in men (Ibarra, et al., 2017), but clinical trials are still functioning under a 
rationale that claims the results found in men can be applied to female populations. A 
2017 analysis of generic prescription drugs found that the results of clinical trials did not 
maintain their validity when tested in female populations23. Drug companies do not want 
significant numbers of women included in clinical trials because it leads to “higher 
intrasubject variability” (Ibarra, et al., 2017, p. 31). Recommendations from the study 
urge pharmaceutical companies to redo the trials with specific attention given to sex 
differences in order to reduce consumer risk, but there is no indication that companies 
will do so voluntarily.  
The scholarship and medical activism of the 1990s was an attempt to solve a 
twentieth century problem. In the two decades since, the problem has evolved but our 
healthcare institutions are no better equipped to solve it. Changes in law and policy have 
resulted in limited gains. In 1994, the US Congress pressed for an analysis of the 
curriculum used in medical schools, and over the next decade, from 1994 to 2004, even 
under pressure from Congress, medical schools in the United States have shown 0% 
growth in the number of courses and student rotations that focus specifically on women’s 
health, though they have incorporated more information into their existing courses 
(Henrich, 2004, p. 283). A study involving male professors in medical courses found that 
they consistently described gender-related issues as relevant, “but of low status” and 
exhibited reluctance to incorporate issues predominantly affecting women into their 
                                                 
23 This also applies to male-centered theories in human and moral development. Theories generated through 
data gathered from women resulted in markedly different insights into moral development. 
cf. Gilligan, In a Different Voice, 1982 
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syllabus (Risberg, Johansson, & Hamberg, 2011, p. 613). This medical and cultural norm 
persists into the twenty-first century and continues to impact new generations of 
clinicians and patients—particularly patients with chronic illness. 
Naming chronic conditions24. While modern medicine has brought about 
significant advancements, there remain glaring omissions in medical understandings of 
the causes of certain diseases25 such as ME, dysautonomia, lupus, and others with 
autoimmune and neurological components. These diagnoses are particularly chaotic for 
patients because the medical community has limited answers about causes or treatments. 
These chronic illnesses consist of multiple symptoms across multiple organ systems. 
Because of the war-time emergence of medical protocols, modern western medicine does 
not view the body holistically, thus missing the ways in which systems interact and affect 
each other, and also fixating on managing acute symptoms rather than understanding the 
underlying causes. Refer to Appendix C for a list of diagnoses that pose particular 
problems in medical categorization and understanding. The three main categories shown 
in Appendix C are: 1) diagnoses related to the immune system, 2) diagnoses related to the 
autonomic nervous system, and 3) conditions where diagnosis is currently elusive. These 
umbrella categories represent large groups of similar conditions, each of which contains 
its own body of research, debate, hegemonic understandings, resistance, and 
transformation. In addition, the specific diagnostic terms within the umbrella categories 
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 tl;dr - Conditions that fall in the neuroimmune and autoimmune category have similarities in patient 
experiences of stigma, dismissal, and lack of specialists. 
 
25
 Appendix C shows an overview of definitions and distinctions between these chronic illness categories: 
diagnoses for the immune system, diagnoses for the autonomic nervous system (ANS), and terms for 
undiagnosed conditions.  
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often have multiple iterations. For example, there are eight different sets of diagnostic 
criteria for ME alone. There are also over seventy sub-types of dysautonomia. These 
categories and terms overlap, intersect, disrupt, and complicate each other. 
It is important to note that the immune system (IS) and the autonomic nervous 
system (ANS) are connected to many other organ systems (for example, the circulatory 
system or the digestive system). Therefore, when the IS or ANS are not functioning, it 
can impact any number of different organs. This results in a difficult path for people 
seeking medical care. For example, if a person's ANS isn't running well and symptoms 
arise such as gastrointestinal dysfunction, a person might seek out care from a 
gastroenterologist. But the problem isn't rooted in the digestive system—it arises from 
problems in the ANS. Due to the current nature of medical education, and the symptom-
specific approach of medicine, it is unlikely that a gastroenterologist will have 
specialized training about the ANS. The next logical step would be to seek care from 
someone who is accredited as an autonomic specialist. However, as of this year there are 
only 48 certified autonomic specialists in the United States (United Council for 
Neurologic Subspecialties, 2019). Due to lack of specialists, lack of research, and limited 
clinician time, patients with diagnosis listed in Appendix C present healthcare needs that 
are incompatible with the current healthcare system. Patients with these types of chronic 
illness face decreased access to treatment in addition to increased stigma and invalidation 
(Agency for Healthcare Research and Quality, 2014, p. ES-4). These experiences of 
erasure forge a sense of community around these illnesses. The terminology in Appendix 
C shows how far the medical field has come in understanding biophysical processes; each 
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diagnosis represents a condition that medical institutions recognize and treat. However, it 
also highlights vital areas where medical knowledge is lacking. 
The processes involved in naming and categorizing chronic, multi-system 
illnesses have been influenced by two medical concepts worth discussing here: medically 
unexplained symptoms and psychogenesis26. Both of these concepts are problematic and 
directly harmful for people with ME and other chronic illnesses. Many of the terms for 
undiagnosed illnesses highlight the absence of physical evidence that the medical model 
requires. The ‘unexplained’ part of medically unexplained symptoms (MUS) does not 
refer, as it should, to the limitations of our current scientific knowledge, but instead 
places the blame on the individual patient.  
The physical symptoms of the chronic illnesses in Appendix C are often explained 
or dismissed using psychogenic terms. Language and assumptions from the field of 
psychiatry have caused particular harm to people with chronic illness. This field uses 
categories such as ‘functional’ and ‘somatoform’ disorders to indicate physical symptoms 
that cannot be medically explained, such as the psychiatric diagnosis conversion disorder, 
which claims that pain in the absence of biophysical markers originates from the brain 
converting emotions into physical complaints.  
The historical assumption has been that symptoms with no physical explanation 
are psychologically based. Patients with chronic, multi-system illnesses navigate a 
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 psycho = of the mind 
  genesis = origin or cause 
  psychogenesis = the idea that a disease comes from the mind instead of from physical factors 
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minefield of medical attitudes and assumptions, as has been shown in studies of patients 
with ME/CFS:  
“Seeking and receiving a diagnosis can be a frustrating process for several 
reasons, including skepticism of health care providers about the serious nature of 
ME/CFS and the misconception that it is a psychogenic illness or even a figment 
of the patient’s imagination” (National Academy of Sciences, 2015, p. 1). 
People who deal with ME and people who deal with mental health issues are both 
underserved by the concept of psychogenesis (Spandler, 2018). When illness is framed in 
a psychiatric context, patients often bear the burden of unmet physical disorders. This 
issue has permeated psychiatric care for decades. Hoffman (1982) found that 63% of 
patients admitted to psychiatric in-patient centers for dementia were found to have 
treatable physical conditions which were ignored, and that 41% of patients admitted to 
one psychiatric hospital had neurological/physical disorders rather than psychiatric ones. 
For these patients, no one was looking for possible biological underlying causes until 
Hoffman’s team arrived. Even after these revelations, the passage of time did not yield 
systemic improvement. Fifteen years later, Klonoff and Landrine (1997) reported on the 
same issue: 
“Many physical disorders suffered by women have psychiatric symptoms. For 
example, hyperthyroidism can result in depression and anxiety, and temporal lobe 
epilepsy can have the same symptoms as bipolar disorder. As a result, women are 
in danger of being misdiagnosed as having psychiatric problems and receiving 
completely inappropriate treatment” (p. xxii). 
The process required to reach accurate diagnoses can contain high levels of uncertainty. 
Instead of dealing with that uncertainty, healthcare institutions fall into patterns of 
stereotyping, often gendered, that lead to quick and uninformed medical decisions. These 
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practices are unacceptable in a field that has sufficient technical and scientific resources 
to address this issue. 
The leap from clinical uncertainty to psychogenesis can happen immediately, due 
to the formation and frequent use of psychogenic language in clinical settings—for 
example, one of the medical terms used synonymously with MUS is somatization (Smith 
& Dwamena, 2007). This language gives clinicians license to categorize puzzling 
symptoms as psychosis. This is the story told in medical journals and medical schools, a 
dominant narrative that ignores the profession’s own ugly history of erasure. For 
example, clinicians historically used the diagnosis ‘hysterical paralysis’—this diagnosis 
is no longer used because we are now able to administer CAT scans—the ‘hysterical 
paralysis’ patients showed physical evidence on their CAT scans of demyelination in the 
brain. We now refer to that same condition as multiple sclerosis (Brea, 2017). Now that 
clinicians have the technology to see the physical evidence that was always there, the 
condition is officially recognized and no longer labeled ‘hysterical’. This disease gained 
clout the moment it became visible on a CAT scan. A side-by-side comparison of funding 
from the National Institutes of Health shows the discrepancy between visible and 
invisible diseases. In 2016, the reported government spending on multiple sclerosis was 
$97 million compared to $8 million for ME/CFS (NIH Research Portfolio Online 
Reporting Tools [RePORT], 2017). This points to the ongoing pattern of medical funding 
for conditions with visible evidence.  
 The failure to medically explain ME symptoms is rooted in a collective 
misunderstanding of the human body due to gendered, racialized, ableist, sexualized gaps 
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in knowledge and the types of conditions that our medical institutions have refused to 
investigate.  
The role of institutional betrayal27. Institutional betrayal is the trauma 
experienced by an individual when an institution28 they trust or depend on is a source of 
harm. This type of trauma emerges in varied ways—isolated or systemic, caused by 
direct action or omission, or a complex combination of all of these descriptors (Smith & 
Freyd, 2014). Patients with chronic illness depend on healthcare services for their 
continued well-being, while also experiencing the trauma of repeated dismissal, disbelief, 
and dehumanization from those same healthcare services. This is reflected in Smith’s 
(2017) findings: participants reported that healthcare professionals did not respond to 
their concerns and denied the accuracy of their negative reports. Smith and Freyd (2017) 
found that institutional betrayal came up as a barrier to healthcare services, since the 
participants who experienced institutional betrayal in healthcare settings were less likely 
to invest their trust in the medical institutions that were the source of both harm and care. 
There remains a paradox that systemic change often requires patients to first demand 
change but advocating within such a broken system destroys the trust that is fundamental 
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 tl;dr - When people are harmed by institutions they depend on for their well-being, this is called 
institutional betrayal. In healthcare, this occurs when patients’ reports of their conditions are dismissed and 
their reports of negative experiences are not believed. 
 
28
 The institutions that are most frequently perpetrators of systemic trauma (such as higher education, the 
military, and healthcare) possess common characteristics, listed here with specific ways the healthcare 
system meets each description:  
1) rigid standards for membership (medical certification and board exams), 
2) prestige (valuing empirical data over contextualized experience; social capital of clinicians),  
3) priorities (valuing reputation over individual member health, as in the treatment of medical students),  
4) and institutional denial (continuous refusal to research certain conditions, shifting blame to patients).  
(Smith & Freyd, 2014) 
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to effective healthcare relationships. Smith (2017) delineates the concept of trust—
specifically in the context of betrayal in healthcare institutions—into fiduciary trust 
(which can be expressed as “They will help me”), confidence (expressed as “They are 
able to and qualified to help me”), and satisfaction (“They helped me”) (p. 134). Smith 
notes that fostering an environment of trust is self-serving for healthcare organizations, as 
it is linked to higher rates of recovery and lower cost (p.133). However, this study 
showed that 66% of participants reported institutional betrayal in their healthcare 
experiences (p. 138). These results provide empirical backing for populations who 
experience unalleviated betrayal in healthcare settings.  
Drawing on the work of Smith and Freyd (2014), Tamaian, Klest, and Mutschler 
(2017) conducted a study to assess negative experiences patients with chronic illness 
experienced in the Canadian medical system. While this study had only 14 participants, 
making it difficult to generalize the findings, it was conducted outside the US healthcare 
system and remains relevant because it builds on and raises questions about Smith and 
Freyd’s original research regarding institutional betrayal. Most importantly, this study 
creates a link between betrayal trauma theory (usually reserved for victims of direct 
violence) and chronic illness, applying the framework of institutional betrayal to the 
experiences of patients with ongoing medical needs. The barriers to care that Tamaian, 
Klest, and Mutschler (2017) reported include shortages of doctors, no accountability for 
doctors who are perpetrators of trauma, and the regularity of negative experiences. They 
suggest changing institutional factors to create accountability for doctors and ensure that 
providers will report medical errors when they occur. As it stands currently, healthcare as 
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an institution continues to evade accountability. In 1999 and again in 2015 the Institute of 
Medicine found systemic errors in diagnosis (Smith, 2017, p. 135) that had not been 
addressed despite public attention. Smith and Freyd (2014) identify the barriers to 
addressing this continued betrayal, including a “lack of language around the issues” 
(p.581), as well as a pattern of knowing an issue exists but creating taboos about 
discussing it. Advocates can begin by using repeated language to frame the problem and 
make that language widely accessible. Repairing the damage of institutional betrayal 
requires institutional leaders to actively practice transparency and protect members at the 
expense of the institution; this practice of repair remains rare and elusive. 
Feminisms and Disability Theories 
The ongoing dismissal of people with ME and other chronic illnesses is a feminist 
issue because of the work feminism does in taking apart the ideas of positivism and how 
these operate to dominate the medical model’s approach to scientific research.  
Multiple Feminisms.29 Feminist movements are concerned with the lived 
experience of women and dismantling patriarchal structures (Murfin, 2016). In the 
academy, feminist theory has critiqued longstanding norms of Western philosophical 
tradition because of that tradition’s role in the marginalization of women and their work 
(Dhamoon, 2013; Mies, Bennholdt-Thomsen, & Von Werlhof, 1988). In Western 
tradition, positivist theory claims to create ‘neutral’ data because it is empirically based; 
the assumption that empirical observations are objective and neutral (and thereby 
                                                 
29 tl;dr – Feminist theory encompasses the lived knowledge of multiple groups (queer theory, disability 
theory, Latinx theory, womanist theory) and makes ample room for the contradictions within and between 
these groups. Feminist research acknowledges that the scientific method and ‘objective’ research are 
impacted by human biases. It seeks to reveal hidden power imbalances. 
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meaningful) has long stood as the standard for creating the false dichotomy between 
legitimate (objective) and illegitimate (subjective) knowledge (Hawkesworth, 2006; 
Schwartz-Shea & Yanow, 2012). For example, in clinical encounters experiential reports 
of pain are taken less seriously than reports generated through medical imagery 
technology (Brea, 2017). This practice marginalizes patients, particularly women, and 
undermines the process of care. Understanding knowledge inequities such as this requires 
situated knowledge (Nagar & Geiger, 2007); feminist methodology provides the tools to 
excavate the deeply contextualized nuances and experiences that constitute relationships 
within medical care. The deployment of this experiential knowledge as opposed to the 
exclusive use of empirical knowledge (Hawkesworth, 2005) works within feminist 
methodology to make visible these power structures.  
In a medical context, one form of oppression occurs in the hierarchical 
relationship between physicians and patients, where the subjectivity of the physician 
(their own implicit or learned biases) is hidden behind a facade of neutrality (Spandler, 
2018). Feminist theory seeks to expose that subjectivity and feminist research 
methodology sits in tension with positivism as it “seeks to reveal concealed power 
dynamics” (Ackerly & True, 2013, p. 135). Positivist theory may also present categories 
as fixed points; categories that include binaries such as male/female, sick/healthy, and 
good patient/bad patient. These categories ignore the chaos, context, and fluidity of 
material realities (Dhamoon, 2013). Deploying meanings as fixed points is an effective 
way to hide the dynamic relationships and oppressions that underpin those definitions 
(Hawkesworth, 2006).  
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Feminist methodology replaces positivist assumptions with the context-rich norms 
of interpretivism; this creates a fluid construction of meaning that is constantly critiqued 
and simultaneously built and unbuilt (Behl, 2017). This process continues as ever-
changing relationships and power dynamics unfold new social constructions. Feminist 
methodology claims plurality as a strength, in this way destabilizing the normative 
meanings found in positivist theory (Dhamoon, 2013). This plurality is also layered with 
additional tensions between multiple feminisms, drawing on scholarship that places a 
particular marginalized group at the center (queer theory, disability theory, Latinx theory, 
womanist theory). Dhamoon (2013) threads a single question through multiple feminisms 
by asking: how does this form of feminism disrupt conventional meanings and contribute 
to their continual reconstruction? For example, the field of poststructural feminism claims 
that “systems of meaning-making that produce and organize sex must also be 
deconstructed” (p. 99). No category or definition is taken for granted; all are questioned 
and examined.  
In this way, the category of ‘woman’ serves as a departure point, not an end point. 
Categories of gender are socially and culturally negotiated; they do not arise from static 
categories of sameness. Notice the word choice in Dhamoon’s (2013) interpretation of 
the debate over the meaning of woman: “Ultimately this gender trouble is a challenge to 
the naturalized coherency of sex, gender, sexual desires, and woman—categories often 
presumed to be stable among feminists” (p. 102, emphasis added). This is further 
complicated by the backlash from those in power when the power structures they stand 
on are made clear. Feminist methodology matters because power is at stake. Conducting 
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feminist scholarship that utilizes fluid definitions and constant critique brings the benefit 
of being able to create meanings that reflect lived experience, as Dhamoon (2013) 
explains:  
“Rather than posing a problem for feminism, continuous critical questioning of 
concepts and categories that seem foundational (such as woman) opens up the 
possibilities of imagining and reimagining differences in alternative and new 
kinds of ways” (p. 104).  
Using research that explores gender differences in no way implies that all people 
navigating the medical system fall into binary categories of sex or gender. Instead, these 
studies shed light on the ways in which society constructs expectations around 
masculinity/femininity or generates knowledge about male/female bodies, which have 
direct bearing on medical experiences for all patients.  
Disability Theories.  
Feminist Disability Theory.30 A key component within feminist methodology is 
the critique of relationships of power. For Dhamoon (2013) power is at the center of 
feminist critique as “an organizing device” and a “site of transformation” (p. 89). 
Feminist scholars recognize health, and women’s health in particular, as not only a 
personal concern but as a political concern (Ackerly & True, 2010, p. 465), because any 
field that deals in life and death must reckon with the concept of power.  
Patients face a number of inequities as they seek access to healthcare. Navigating 
the US healthcare system is an embodied experience that is materially constructed by 
                                                 
30 tl;dr – Feminist disability theory uses the tools within feminism and critical race theory in order to 
address the social inequalities experienced by people disabled by that society’s norms. 
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race, gender, sexual orientation, and class (Charlton, 1998). The experience of illness is 
affected by social, environmental, and biological factors; therefore, solutions, treatments, 
and diagnostic criteria cannot be developed in a vacuum that ignores these domains. 
Feminist disability studies is an intersectional framework that grew out of decades of 
work in queer studies, critical race theory, and feminist theory (Garland-Thomson, 2014).  
It focuses on ability/disability as a positionality that crosses over social positions of class, 
race, and gender. Addressing marginalization based on ability enhances and supports 
scholarship that addresses these other forms of marginalization. 
Critical Disability Theory.31 This theory views disability as a function of power, 
instead of a function of health or medicine (Siebers, 2008). As a field of study, Critical 
Disability Theory (CDT) interrogates ableist norms with its methodological focus on 
fluid definitions, embodied experience, the human right to life, and local knowledge 
(Siebers, 2008). Approaching the issue of #MillionsMissing32 from this methodology 
uncovers the critical issue of whose knowledge matters and whose presence in society is 
valued. The current erasure of millions of people with under-researched chronic illness 
points to major problems with the social and medical models, both of which are key 
concepts that CDT interrogates (Adams, Reiss, & Serlin, 2015). As a field, disability 
studies provides an analytical path for interrogating these issues, particularly through 
CDT, which focuses on critique of the medical and social models of disability. The 
                                                 
31 tl;dr – Critical Disability Theory (CDT) examines medical and social systems that create disabling 
circumstances. 
 
32
 For more context on the #MillionsMissing campaign, refer to the Overview. 
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medical model, as described previously33, is a way of thinking that revolves around 
granting medical institutions power over life and death. On the other hand, the social 
model is a way of thinking that reveals the role of society in health and well-being, 
because “disease is always generated, experienced, defined, and ameliorated within a 
social world” (Jones, Podolsky, & Greene, 2012, p. 2333). The social model was 
described in part by Wendell (1996), as the “social conditions that straightforwardly 
create illness, injuries, and poor physical functioning” in addition to the “subtle cultural 
factors that determine standards of normality and exclude those who do not meet them 
from full participation in their societies” (p. 36). This is also implied in Siebers’ (2008) 
commentary on the limits the medical model places on human capacity. Identifying the 
social constructs that exist within the medical profession can cast light on what needs to 
change. Women in particular stand as stakeholders in raising the general consciousness 
that medicine is a social business and not a purely scientific endeavor. 
Even if the medical model claimed to have absolute clinical knowledge of the 
human body, it would not solve the power imbalance between physicians (perceived as 
educated, healthy, contributing members of society) and patients (perceived as unreliable, 
weak, burdens on society) (Adams, Reiss, & Serlin, 2015). Disability activism often 
centers on this shift in cultural values and perceptions (Charlton, 1998). In disability 
studies, the social model’s mission to depathologize the body is vital, even in the context 
of chronic illness, because patients are more than a body and live out their experiences in 
a social environment. Wendell (1996) defines the social model in terms of how social 
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 The medical model is discussed in depth later in this chapter. 
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factors damage bodies: lack of access to basic resources; injuries from assault or war; 
medical malpractice; increasing the standard expectations of pace and productivity; the 
ubiquitous assumption “everyone is healthy” (p. 39); the physical design of buildings 
made for strong bodies to navigate; and some forms of dependence being invisibilized for 
the able-bodied. Each of these considerations point to social systems of erasure and the 
marginalizing impact of patients striving to maintain a hectic pace of life based on social 
expectations of performance that are invisible to the non-disabled. Wendell (1996) notes 
that “any increase in the pace of work will decrease the energy available for other life 
activities” (p. 37); this concept is referred to in the chronic illness community as the 
spoon theory (BBC, 2013). Many of the conditions delineated in Appendix C are 
described as ‘invisible illnesses’ because they easily go unnoticed: some patients ‘pass’ 
as able-bodied, while others are homebound and out of sight.  
 Wendell (1996) also acknowledges the limits of the social model, in that not every 
disability arises from social factors alone (p. 42). For patients grappling with poorly 
understood chronic conditions, social and cultural issues are one part of their illness 
experience, added to their experience with physical pain. Viewing illness from a social 
standpoint alone does not address the underlying physical nature of the conditions these 
patients face. 
 Where the social model thrives is its capacity to take into consideration the 
personal and social costs of prolonged illness and its effect on the material conditions of 
life. For patients, every exertion is mediated through the filter of chronic illness; all 
decisions pass first through its hands. This impacts everything from employment to 
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relationships. In addition, there is a social cost that impacts our society at a national level. 
The economic burden of ME alone from lost income and medical expenses is between 
$17 and $24 billion annually in the United States (National Academy of Sciences, 2015, 
p. 2). Medical practice would benefit from incorporating the work of scholars in the 
social deconstruction of disability (Wendell, 1996, p. 45), which promotes addressing 
human needs with social solutions, because healthcare is both a human need and a social 
solution. 
Multiple strategies.34 Relying solely on the medical or the social model results in 
dead ends for those with complex chronic illnesses and their advocates. For example, 
adrenaline release (a physical response common in dysautonomia patients) can be 
connected to high stress environments (a social consideration). Looking at this symptom 
with purely medical eyes or purely social eyes does not address the experience 
holistically. Neither model offers the patient a complete solution.  
When it comes to creating viable solutions for patients with chronic illness, 
disability studies is uniquely positioned to offer a methodological framework that 
incorporates both social and medical strategies in innovative ways, as well as offering 
modes of analysis from which activists can create a variety of strategies. Using the 
theoretical scholarship in this field, patient activists continue to pursue multiple modes of 
action, in securing funding for medical research as well as reconstructing social norms in 
ways that promote health equality. Even though the biological nature of chronic illness 
often places it in contrast to the groups that founded disability studies, the scholarship 
                                                 
34 tl;dr – Solutions to health inequality require simultaneous work in both medical and social systems. 
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generated in this field can both support this set of patients as well as reciprocally benefit 
from their shared goals of social and medical change. The very complexity created by the 
urgent need for better medical understanding alongside the call to dismantle the medical 
model altogether positions disability studies as an appropriate field from which to analyze 
the treatment and erasure of complex illnesses. 
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  Theory & Methods 
Theoretical Framework & Methodology35 
This research engages qualitative feminist inquiry36 in order to “render visible” 
(Ackerly & True, 2010) people with myalgic encephalomyelitis (ME) and the meanings 
they create in terms of their lived illness experiences and healthcare barriers. It values co-
generated understandings of authority, credibility, access, and navigating complex 
relationships (mis)diagnosis and various clinician interactions. Feminist theory in relation 
to medicine operates as a critique of bias shown against women when they report pain. It 
operates as a rebuttal of the overreach of medicalization. It offers a method to reconstruct 
medical norms, practices, and expectations in effective and humane ways.  
Using feminist methodology in the examination of data and knowledge 
production adds value to the construction of meaning from the patient’s point of view and 
increases the applicability of academic work to lived experience. This situated knowledge 
(Nagar & Geiger, 2007) from each participant reveals the material implications of 
healthcare policy and practice. While macro-level quantitative and statistical data are 
important, these methods are critically enriched by contextual knowledge, and they 
maintain meaning as they are supported by qualitative data containing rich descriptions 
and situated knowledge through lived experiences.  
                                                 
35
 For tl;dr summaries, refer to the footnotes throughout this section.  
 
36
 tl;dr - Qualitative feminist inquiry - A method of study that critiques bias and power imbalances. 
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Throughout this thesis, I incorporate theoretical elements that support the 
production of knowledge with patients at the center. I draw on Feminist Disability 
Theory37 to frame and challenge existing medical terminology with experience-near data, 
since terms like ‘treatment’ and ‘recovery’ cannot be abstracted for patients. They are 
lived in concrete ways. This type of knowledge production can push back on dominant 
claims from the medical model. I center patient narratives as a vital source of context-rich 
knowledge (Shwartz-Shea & Yanow, 2012).  
The institutional, systemic power structures within medicine are materially 
significant because they dictate viable modes of knowledge production, select the 
beneficiaries of the work, and impact the agency and authority of vulnerable groups 
(Nagar & the Sangtin Writers, 2006). Viable modes of knowledge production rely on 
social validation, often from our institutions. When an institution values one form of 
knowledge over another, this is called epistemic injustice38 (Spandler & Allen, 2018). For 
example, the medical institution values empirical knowledge over experiential 
knowledge, and visible evidence over lived experience. Scholars of epistemic injustice 
ask the question: how do you know what you know? How does society know what they 
collectively know? When considering medical practice, this idea leads us to ask: how do 
clinicians know when a person has an illness? With all the complexities that people with 
ME face, it is not that myalgic encephalomyelitis is so complex—the complexity arises 
                                                 
37
 tl;dr - Feminist Disability Theory - Used here to center the stories and perspectives of people with ME, 
in keeping with the disability rights motto ‘Nothing About Us Without Us’. 
 
38
 tl;dr - Epistemic injustice - Certain types of knowledge (empirical) are privileged over others 
(experiential). 
 
 39 
 
from the medical world that houses diagnoses like ME. The illness is not the source of 
confusion, nor is the patient. It emerges from the hierarchy of ways of knowing. 
In keeping with my commitment of trustworthiness to the communities I research, 
I utilize techniques from the plain language movement39, which seeks to address the 
outsized load put on marginalized communities by recognizing specific communication 
needs (Cheung, 2017). This is usually applied to legal documents about rights, policies, 
contracts, and consent; however, the same ideas apply to creating academic products that 
are accessible to the communities that made the production possible. Using tl;dr 
summaries (see Appendix A) is one way I incorporate plain language into this thesis. 
My procedures are grounded in interpretivist processes40 (Schwartz-Shea & 
Yanow, 2012) with epistemological commitment to local knowledge, awareness of 
speaking with rather than speaking for, member-checking, and prioritizing 
interconnectedness and empathy (Khan, 2005; Nagar & Geiger, 2007). When considering 
how power dynamics impact specific groups, Schatz (2009) highlights the value of 
“close, person-to-person contact that is attuned to the worldviews of the people we study” 
(p. 4). The tendency to hold conversations about disability without incorporating the 
input of the people who are most affected underscores the need for the disability rights 
movement’s slogan: nothing about us without us (Charlton, 1998; Carey, 2015). This is 
why I center the experiences and discourse of people with ME in this thesis.  
                                                 
39 tl;dr -Plain language movement - Language and documents should be accessible to the people they are 
made for. 
 
40
 tl;dr - Interpretivist processes - This method of research uses ethnography (close up study of 
communities) and awareness of positionality (intersections of social privileges and oppressions). 
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Starting from an ethnographic sensibility (Schatz, 2009) that recognizes the 
importance of context and co-generation of meaning, I approach my interview 
participants as co-equal members of the research team rather than subjects of study. As a 
researcher, I am also an active agent, visible in the work; not as an unattached ‘neutral’ 
observer, but as an invested participant. Within the context of his work on ethnography, 
Schatz (2009) introduces empathy as methodology, since ethnography “is an approach 
that cares—with the possible emotional engagement that implies—to glean the meanings 
that the people under study attribute to their social and political reality” (p. 5). 
Embeddedness produces situated knowledge. Designing research around an ethnographic 
sensibility involves emotional entanglements; it claims these without apology as a source 
of strength because they provide a richer, more complete picture of the social landscape. 
It is important to note that “for the interpretivist, we can only discern what is ‘real’ by 
taking people's worldviews seriously; after all, such worldviews lie at the core of the 
social construction of reality” (Schatz, 2009, p. 13). This is empathy. The skills necessary 
for practicing empathy (such as listening, attending to the emotional state of others, and 
thinking through the impact of your actions on others) lend themselves to ethnographers 
as ways to understand relationships, power dynamics, and community experiences. 
The positionality of both the researcher and the participants impacts the 
development and formation of knowledge in this thesis (Behl, 2017). In their work, Nagar 
and Geiger (2007) combine the concepts of identity and plurality in order to emphasize 
the fluid quality of identities which constantly shift as perceptions are formed, 
questioned, discarded, and reformed. My positionality as a patient, though part of a 
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somewhat different community, means that I have been embedded in patient communities 
for more than a decade and have formed relationships over time. Working with patients is 
an area where I can leverage my lived experience with chronic illness to speak to core 
concepts with authenticity, as well as have access to participants through my 
embeddedness in patient support communities. However, maintaining critical reflexivity 
(Behl, 2017) throughout the research process continuously revealed to me the ways in 
which my own experiences diverge from people with ME due to the differences in our 
physical symptoms. My understanding of the chronic illness experience on a general 
level does not provide insight into specific experiences of post-exertional neuroimmune 
exhaustion for each participant. I was mindful of this as I listened to participant narratives 
and endeavored to lead with their specific definitions rather than my own. 
It is important to note the two salient categories that are crucial to my own 
positionality in relation to the medical field: standing at the axis of being female and 
having years of experience with chronic illness. My medical experiences include a series 
of disbelieving doctors (“You don’t look sick”) and twelve years of misdiagnosis. I saw a 
fundamental refusal within medical institutions to believe patients. I am also situated in 
various locations of privilege as a white, educated, cis, middle-class woman. My 
privileges provided a support system to fall back on while I navigated misdiagnosis and 
provided a network through which I found a doctor who would eventually listen with 
sensitivity and curiosity. This exploration required time, money, energy, and social 
connections. Chronic illnesses are further complicated for many patients by their 
embodied experiences of race, class, and sexual identity. Neither my personal 
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experiences nor this thesis have shed sufficient light onto racial and economic 
considerations, pointing me toward further opportunities to study and uncover the 
intersection of these categories with health equality. 
As a researcher, I have to negotiate my own lived experience in the medical 
industrial complex, including medical professionals crossing boundaries of 
dehumanization. I have to manage anger toward individual doctors who categorized 
physical symptoms as psychological ones. I have to reckon with the systemic misogyny 
that operates at every level of medical practice, from lab research to diagnosis. These 
experiences continuously shape my perceptions when dealing with medical personnel. 
While I strive to mediate the effects my own anger, I also value the information it yields. 
It gives me a keener view to identify possible sites of inequality and inequity. It has the 
power to provide insight into patient perceptions that may differ from their provider’s 
perceptions. It allows me to ask questions and explore responses that others may not 
bring to the situation. Scholars with more research experience have already marked a 
path, recognizing that “anger is loaded with information and energy” (Lorde, 1981, p. 8) 
and that love, guilt, and anger can motivate and underpin my writing so that it becomes a 
manifestation of the real in contrast to the abstract (Behl, 2019). Following their lead, I 
seek to harness that energy into qualitative, embedded methods and feminist theoretical 
orientations that have the potential to make visible the power struggles and structures 
within healthcare. 
Methods41 
                                                 
41 tl;dr – In conducting this study, I used semi-structured interviews with seven participants with ME. 
 43 
 
For this study, I recruited seven people with ME to participate in semi-structured 
interviews. To be eligible for this study, each participant needed to be over the age of 18, 
meet the diagnostic criteria outlined in the ICC (see Appendix B) via self-reporting, and 
be currently or formerly housebound. Approval for this study was granted by the 
Institutional Review Board at Arizona State University. 
During recruitment, I communicated with existing contacts in patient support 
groups. These relationships with community gatekeepers were an important resource in 
locating individuals to interview. I used purposeful sampling42 to create interview 
environments that are most relevant to the research question at hand. Interviewing 
participants who are homebound or have previously been homebound offers a perspective 
of the lived experience of ME that is not often reflected in the medical literature. Current 
college students, clinic patient lists, or those who respond to a survey are often the main 
population utilized for patient studies. These populations tend to reflect the experiences 
of the healthier segment of patients, not the more afflicted group. Conducting in-home 
interviews that take a participant’s physical endurance into account is one way to balance 
this oversight. Digging into theory-based considerations contributed to the way I 
approached participant recruitment. Home visits, personal interaction, and reflexivity are 
key considerations due to the lack of mobility many patients face. Interviewing 
participants from absent groups (for example, those who are housebound) has the 
potential to reveal dynamics of erasure, while participants from groups that are regularly 
represented have the potential to problematize and refine those representations through 
                                                 
42
 Refer to Table 1 for participant demographics.  
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their own specific narratives. For these reasons, I focused on recruiting people with ME 
who are homebound and, whenever possible43, from underrepresented cultural 
ethnoracial groups44. These are the patients whose stories are most often erased and are 
therefore at the center of my work. Through the gatekeepers, members of the ME 
community who met these criteria were put in contact with me if they were able to 
participate. 
I chose semi-structured interviews as a means of data collection in order to best 
meet the needs of the participants. I knew that “close, person-to-person contact” (Schatz, 
2009), attuned to their individual needs for rest, would provide a beneficial environment 
for communication of patient narratives. This knowledge comes from my experiences 
being embedded in ME patient support communities through community work, an 
internship, and advocacy with them. The interviews lasted approximately one and a half 
hours and consisted of open-ended questions designed to explore context-specific 
meanings of ‘access’, ‘diagnosis’, and ‘recovery’. Each person's medical history contains 
insight into the way social constructions of illness, institutional narratives, and patterns of 
dismissal impact people every day.  
 
 
                                                 
43
 The demographics of the participants in this research still reflect a heavily European-descended female 
sample, despite efforts to mitigate this pattern.  
 
44
 Jason, et al. (1999) indicate in their findings that, despite a common misperception that CFS occurs 
primarily in white populations, higher rates of CFS occur within Latino and African American populations. 
Jason, et al. use the diagnostic criteria for CFS here, instead of ME, because of the historical time period of 
their research. 
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Table 1      
Participant Demographics     
 Mobility1  Gender Age Ethnoracial Group Marital Status 
Adaline  Housebound 
Semi-bedbound 
W 47 European-descended 
American 
Married 
Ashanti  Housebound 
Bedbound 
W 38 African American Single 
Cheryl Semi-housebound W 53 Mixed race2 Married 
Elizabeth Semi-housebound 
Semi-bedbound 
W 41 European-descended 
American 
Single 
Karen Employed, 
fulltime 
Semi-housebound 
 
W 52 European-descended 
American 
Divorced 
Kelli Semi-housebound W 56 European-descended 
American 
Married 
Lena Housebound 
Mostly bedbound 
W 46 European-descended 
American 
Divorced 
1 Mobility terms and definitions 
Definitions of Housebound— 
Fully-housebound: Due to symptoms, spends essentially all their time within their home, 
leaving only for the most necessary activities, such as medical appointments. 
 
Housebound: Due to symptoms, spends a clear majority of their time within their home. 
Leaves their home rarely (a couple times a month), for medical appointments, errands, or 
special occasions. 
 
Semi-housebound: Able to spend part of the day out and about, while still having substantial 
periods of time within their home. 
 
Definitions of Bedbound— 
Fully-bedbound: Due to symptoms, spends all their time laying down. 
 
Bedbound: Due to symptoms, spends most of their day-time hours laying down, leaving only 
for necessities. 
 
Semi-bedbound: Able to spend part of the day upright within their home. 
 
2 Latina/Sub-Saharan African/European-descended American 
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Each participant in this study is referred to by a self-selected pseudonym, as 
shown in Table 1. Each of the seven participants identify as women, therefore that is the 
term I use when describing them. The average age of this sample is 47, with the youngest 
being 38-years-old and the oldest being 56-years-old. The average age of onset nationally 
is 33 (NAS, 2015), indicating that this sample encompasses the experiences of people 
with ME who are older than the average time of onset and have more years of experience 
dealing with the illness. 
The term ‘ethnoracial groups’ recognizes that race and ethnicity are socially 
constructed categories with material implications that affect everyday life. European-
descended American is my term of choice over white or caucasian because of the latter 
terms’ rampant misuse in medical literature, which normalizes the categories of race as 
biologically determined, rather than socially constructed. This misuse also occurs in the 
form of categorizing populations as either white or non-white, a practice that centers and 
normalizes whiteness, and collapses all other distinctions.45  
 
Throughout the writing and revision process, I engage in ‘member-checking’ 
(Shwartz-Shea & Yanow, 2012). Each person I interview is a co-collaborator in the 
generation on the final thesis product (Galleta, 2013). Primarily via email, and less 
frequently via videoconference and phone calls, I brought my analysis and writing to the 
participant, listened to their feedback, asked clarifying or deepening questions, and 
                                                 
45
 I came to these conclusions about the use of ethnoracial terms after conducting a review of each article in 
volumes 3 - 5 (2016 - 2018) in Lupus Science and Medicine, a peer-reviewed medical journal, identifying 
how each published article handled ethnoracial terms and considerations. 
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incorporated all this into the formation of each chapter. This process of member-checking 
brings their own voice more fully to the project and insures that their situated viewpoint 
is reflected in the writing by using their nuances of understanding which may differ from 
my own. This reciprocity between researcher and participant is foundational to the 
construction of meaning in this thesis. 
The stories46 that these participants shared about their personal experiences 
contain key insights into what goes astray in medical policies, beliefs, and systems; they 
also contain insights that can lead to transformative actions to make medical encounters 
more of a partnership between patient and medical provider, and thus more effective and 
humane rather than condescending, dismissive and oppressive.  
                                                 
46 A note on edits made to the original transcripts of each interview: When quoting participant interviews in 
the text, I removed the following extraneous phrases in order to maintain clarity: "I mean", "you know", 
"um", and "like". When "like" was used the same way as "for example", I kept it. When "like" was used in 
the same way as "um", I deleted it. 
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CHAPTER 2 
THE LIVED EXPERIENCE OF ME 
“It was a lifesaver just to have somebody understand what I was going through”47 
Throughout this chapter I will explore the lived experiences of seven women with 
ME in order to understand their day-to-day lives, the changes ME brought to their lives, 
and the ways they balance rest and exertion. Knowledge about the lived experience of 
people with myalgic encephalomyelitis is key to creating more informed healthcare 
practices. People with ME already hold valuable knowledge about this disease. A crucial 
element of building from an interpretivist framework is centering the voices of the seven 
people with ME who participated in this project. Each participant shared the details of 
their day-to-day lives, which reveal both broad themes and subtle nuances integral to 
understanding the reality of living with this disease.  
What does it mean to live with myalgic encephalomyelitis? Elizabeth, a 
biochemist, describes her symptoms in this way: “It's sort of that feeling that you have 
when you have a fever or the flu or something and your body just aches. That's how I feel 
most of the time.” 
  Adaline, a 47-year-old college instructor and marketing professional, categorizes 
her days in this way: “On a bad day, I'm pretty much in bed... no noise, no stimulation. 
On a decent day, I can do stuff at my desk. If I have a really, really good day, which is 
                                                 
47
 Quoted from Kelli’s interview.  
 
tl;dr - Direct quotes from each interview participant give an overview of life with ME 
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where we might actually go out and have dinner, that's maybe once a month, if I'm 
lucky.” 
Ashanti, a 38-year-old registered nurse, shares what it's like to communicate with 
the people in her life about her illness: 
I actually tell them that I know what I experience is incomprehensible to them and 
that it's incomprehensible to anyone who has never experienced uncontrollable 
body failure. Healthy people really struggle to wrap their brain around chronic 
illness and how it affects us … they think, oh I'm tired today, and that that's the 
same as what I feel on the day-to-day. 
Kelli, a 56-year-old journalist and grandmother, finds it similarly difficult to get 
others to understand what her experience is really like: “People don't realize that I'm in 
bed eleven hours a night generally, and another nine or ten hours either lying down, 
reclining, or sleeping. Takes a lot out of your day. I just don't have the kind of time that I 
used to, even when I'm awake.” In Kelli’s search for medical treatment she encountered 
physicians, nurses, family members, and others who had no knowledge of myalgic 
encephalomyelitis. Her symptoms became more and more disabling as her search for care 
continued to yield ineffective responses from her doctors. By chance her daughter heard a 
segment on NPR about ME; she called Kelli and said, “Mom, I think this is what you 
have.” That kernel of information helped Kelli find a doctor who was knowledgeable 
about ME. “It was a lifesaver just to have somebody understand what I was going 
through and not feel like a strange—a person with a bunch of strange symptoms.” 
Many people with chronic illness experience isolation after the traumatic life 
event of illness onset, both of which are common risk factors for suicide. Suicide among 
chronic illness patients is an important discussion that was beyond the scope of this 
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study; however, research on this topic is urgently needed. Currently, recorded data about 
the rate of suicide in populations with ME is limited48. The topic itself is fraught due to 
decades of work to destigmatize ME and distance it from being viewed as psychosomatic 
(Gilman, 2015; Spandler; 2018). Self-described observations by the ME community 
members indicate that patient support groups often deal with suicidal ideation, with 
limited resources at hand49. Further research is needed; specific interventions need to be 
developed and implemented as part of chronic illness care. See Appendix D Suicide in 
Chronic Illness Communities for participant commentary on the topic of suicide. 
The experience of living with ME changes over time, with periods of intense 
and/or debilitating symptoms (often referred to as ‘crashes50’) and periods of less intense 
symptoms. Cheryl, a registered nurse who specialized in psychiatry, summarizes her life 
during particularly difficult crashes:  
At my worst, I was homebound and nearly bed bound. I had only about four hours 
a day of being upright—sitting or standing—and could not shower daily, help 
with chores or cooking, or go out for anything but medical appointments. If I 
exceeded my limits, I could crash for two weeks and up to a month at a time. 
 
For Lena, a 46-year-old health advocate and mother of three, the onset of ME was 
sudden and extreme: “I couldn’t even speak. I couldn’t do anything. I was basically in a 
                                                 
48 See Devendorf, McManimen, & Jason, 2018 for some of the available data. 
 
49
 In Adaline’s experience, “patient support groups have NO resources. The only resource we have is each 
other.” 
 
50 Elizabeth adds nuance to the usage of ‘crash’, extending the meaning to day-by-day highs and lows, not 
just the “longer-term low points in a person’s disease experience.” She further notes, “for me, a ‘crash’ can 
be what happens after I do too much in day or week … I’d say I ‘crash' regularly, sometimes even daily, 
whereas my worst [period of] disease was in the first year and perhaps a few periods of a few months each 
since then.” 
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coma, except I was alive and suffering enormously. I was just praying to get through hour 
to hour physically because I couldn't speak, I couldn't move, I couldn't do anything.” 
Karen, a 52-year-old educational director, says that life with ME means being 
“always sick, always tired.” The pervasiveness of ME in their lives showed up in 
unexpected ways as well; not just in the stories shared with me, but imbedded in the 
conversations as we talked together: 
… [clears throat, coughs] excuse me—yeah, my voice struggles with ME; 
this is a part of life with ME, so you'll hear me clearing my voice and my voice 
will weaken and teeter…  
… Now I lost my train of thought because—that's the brain fog… 
… sorry, my brain is failing me again …51  
These types of brain fog symptoms are just one facet of the daily experience of living 
with ME. Because of the physical symptoms these participants deal with, they have each 
developed ways to balance the demands of their illness with the demands of everyday 
life. 
Exertion, Payback, & Rest: The Balancing Act52 
Kelli: I was already figuring parts of it out. I figured out that if I did anything on 
one day then I was useless the next. Not just the next, maybe for three weeks. I 
could already make a correlation between any activity or stress or anything and 
some sort of payback. 
                                                 
51
 Quoted from Ashanti’s interview. 
 
52
 tl;dr - Exertion, Payback, & Rest: The Balancing Act - People with ME are careful about overexertion 
in order to minimize crashes. Rest serves the purpose of counterbalancing physical or cognitive activity, to 
the degree it is possible. Restorative, scheduled, and pre-emptive rest are some of the types of rest that 
participants utilize. 
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Cheryl: If I exceeded my limits, I could crash for two weeks and up to a month at 
a time. 
Elizabeth: I would say most days I had spent about 50, at least 50% of my day 
lying down, of my waking hours, lying down. And then the rest of it will be 
mostly just kind of getting basic stuff done around the house.  
Part of the illness experience that ‘healthy’ people in the participants’ lives 
struggle to understand are the consequences of engaging in physical or cognitive 
exertion. The consequence for over-exerting is a ‘crash’: a state of neuroimmune 
exhaustion with a flare up of symptoms, often resulting in being bed-bound for stretches 
of time. 
Woven through every decision about exertion is the unremitting need for rest. To 
be very clear, rest does not result in renewed strength and it does not neutralize post-
exertional neuroimmune exhaustion. Rest serves solely to avoid overexertion. Once 
neuroimmune exhaustion kicks in it is a different story. 
Kelli: Rest does not help me feel better. I don't rest and regroup, then rise with 
more energy, as I used to. Instead, ‘resting’ is what I'm doing when I'm not 
utilizing the tiny amount of energy I have. During a crash, there is less energy, so 
there is more ‘resting'. In other words, I rest because I can't do anything else, and 
because if I am foolish enough to push through my energy envelope, I'll need 
even more rest in the days and weeks that follow. 
People with ME and other chronic illnesses utilize different modes of rest. Often, they 
will have routine-based scheduled rest at the same time each day no matter what else is 
going on. They may prepare for an activity beforehand by doing pre-emptive rest or they 
may compensate after a strenuous activity with restorative rest, as Cheryl describes: 
I can also do restorative rest after an activity. If I have my hour rest this morning 
and then we do this interview and then I decide okay, I'm going to grab a walk 
before it gets dark, and I take a walk and then I come back and I'm like, wow, I 
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feel a little symptomatic, like have a little pain or feeling really tired or my brain 
feels a little foggy; I will rest. 
Some periods of rest focus on limiting physical and/or cognitive activity; this may or may 
not include sleep. Other forms of rest focus on reducing or eliminating sensory stimuli.  
Figuring out how to rest, and how important it is, plays a large role in the 
transition from pre-illness:  
Cheryl: I realized every day—and it would happen usually by noon—I was hitting 
a wall … If I got up and took a shower, which normally when I was healthy I 
could take two or three showers a day and it didn't bother me, but if I got up and 
took a shower I would have to lay back down. 
Because of physical and cognitive exertion limitations, people with ME are mindful 
about the activities they give their energy to. They carefully choose which tasks are the 
most important.  
Among the seven interviewees, everyone had different responses when it came to 
what types of activities they prioritized, revealing the diverse lives of people with ME. 
Some of the top priorities that emerged are (not listed in order of importance): 
● Physical activity, such as taking a walk every day 
● Cognitive activity, such as reading and community advocacy 
● Maintaining relationships with family and friends 
● Career and continuing education 
● Art and concerts 
● Taking care of their children 
Making space for things that specifically bring them joy, and supplementing with rest 
before and after, guides each person as they plan their days. While the specific priorities 
vary from person to person, the necessity of consciously planning for those activities 
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remains constant. Planning ahead often includes reserving an entire day, several days, or 
weeks in order to make their priorities achievable. 
In addition to holding different priorities, each of the seven women have their 
own methods for balancing exertion with rest in order to avoid the most severe 
consequences of over-exertion. Scheduling in large chunks of time to rest is a major 
factor, but people with ME also use other techniques to make it through the tasks of the 
day.  
Many people with chronic illness, including the interview participants in this 
study, use activity-shifting. This is a pacing strategy which consists of alternating short 
bursts of exertion with rest and also “switching between different activities that require 
different types of energy”; for example, “do a cognitive task, then do a physical task, 
rather than two physical tasks in a row.”53 This requires the person to have an accurate 
awareness of their own crash patterns in order to calibrate this successfully.  
Adaline: It took a while to find people like me who could teach me about pacing 
and planning. Because that's not something that is really shared or taught in 
disability world in general. 
Participants reported using activity-shifting in two ways: short-term and long-term. 
Short-term activity-shifting is used hourly; a few minutes of exertion followed by rest; or 
switching between varying levels of cognitive and physical exertion. Long-term activity-
shifting is used at the daily or weekly level; an intensive day preceded or followed by a 
day of minimum exertion. Kelli describes her long-term use of activity shifting with this 
example: 
                                                 
53 Quoted from Elizabeth. 
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Interviewer: On the days when you do things with your daughter do you take 
other activities out? 
Kelli: Yes, I do balance it. I will have big rest spaces between ... I'm going to take 
my four-year-old granddaughter, pick her up from preschool, and do something 
with her and feed her lunch and take her back to her mom … I will rest as much 
as I can before something like that. And then I will know I'm probably not going 
to get anything else done that day. I'll still pay, but I'm trying to get some life in. 
On a short-term scale, Karen alternates work with “a 15-to-20-minute rest period; lights 
out, covered eyes, earplugs.” This pattern of alternating rest and exertion is key to these 
women’s management of ME symptoms. 
Other techniques used to compensate for symptoms include: 
● Making lists on their phone 
● Taking notes to process small chunks of information 
● Calling to get information about insurance instead of reading long descriptions 
● Outsourcing household tasks like cleaning and cooking54 
● Documenting symptoms and events to make up for poor memory 
● Using assistive devices: wheelchair, shower chair, walker, or spinal/wrist brace 
● Resting in areas where their family members are near, for social engagement 
● Laying down (rest) while talking (exertion) 
● Scheduling showers 
 
Even with a pattern of activity shifting, conserving energy is needed as well. This means 
refraining from certain activities or tasks, going slow, laying down while talking, and 
avoiding/missing social events. As Karen puts it: “I do those things to conserve energy.” 
In addition to individualized techniques, all seven interviewees talked about their 
family support structure as a key element to their survival. Close family members stepped 
in to fulfil the tasks that ME made impossible for the participants to continue to do. One 
                                                 
54
 Hiring out household tasks requires a level of financial security that is not available to all people with 
ME. Systemic social issues of class and wealth inequality impact a person’s ability to utilize many of these 
compensating measures. 
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participant organizes her life so that she is able to take care of her own household tasks. 
The others shared how their family members they live with contribute by taking on the 
cooking, laundry, shopping, and cleaning. For this group of women, husbands and 
mothers were the ones who most often stepped into that caretaker role. They express 
gratitude to be fortunate enough to have these support systems already in place. 
Support not only occurs through direct assistance with physical needs, but also 
through emotional support and understanding. Having family members who know about 
and truly see their lived reality is important. 
Karen: My family sees about 75% of my life, now. They used to only see about 
50%. But I've told my mom and dad recently, my brother recently, my son. So, in 
the last nine to twelve months, slowly, I've been explaining to people and they're 
getting it and they're supportive. Thank god they're supportive. 
Sometimes it is involved family members who know the details of this illness who are 
able to open the door to getting a diagnosis: 
Ashanti: My sisters actually had separately—they hadn't even spoken to each 
other about it—found information about ME and texted it to me. So, I ended up 
reading and I'm like, oh wow, these symptoms do sound like me.  
Kelli: ...the Institute of Medicine's 2015 report on chronic fatigue syndrome came 
out. My daughter heard about it on NPR. And she called me and she said, "I think 
that's what you have."  
Lack of family and community networks can result in increased stress and worry about 
meeting the basic necessities of life. After a divorce and a move to a new neighborhood, 
Lena wondered about what would happen: “I was kind of worried I would have nobody 
to take care of me.” That worry extends to others they know through online communities. 
Both Adaline and Kelli expressed concern as they considered what might happen to 
people who don’t have family members to fight for them. 
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Day-to-Day Life 
Ashanti: A typical day, I would say, is primarily spent in my bed, the way you see 
me right now. I'm in my bed, I'm in my pajamas. That is pretty much a typical day 
for me. If I have a doctor's appointment then I have to get myself together for that, 
but the majority of my time is spent in my bed. 
Early in the interviews, I asked participants to describe a typical day, including what 
kinds of activities they are able to do and what types of limitations arise. Their responses 
detailed what might occur in a usual day, what kinds of activities they do, and methods 
they’ve developed to balance basic life tasks with their symptoms and physical ability 
that day.  
Routines55 
While some trends were fairly consistent across the interviews, there are two 
circumstances of note that only apply to a couple of the participants. First, Karen is the 
only participant who is currently employed, so many of her routines center on managing 
her energy on the job, including making time for rest in her office. Second, Ashanti and 
Lena have young/teenage children at home, so their experiences are impacted by daily 
tasks that relate to child care. 
Two participants offered the exact same caveat before describing the day-to-day 
conditions of their lives: “every day is different”.  
Interviewer: "Will you walk me through a typical day for you?”  
Adaline: “Quite honestly, there is no typical day for me. Every day is different. I 
never know how I'm going to feel.” 
  
Interviewer: "Would you walk me through a typical day for you?  
                                                 
55
 tl;dr - Routines - While day-to-day routines differ between each person with ME, common concerns 
include managing energy output and symptoms. Large portions of the day are dedicated to rest. 
 
 65 
 
Elizabeth: “Oh gosh … every day is different.” 
 Morning routines. A typical morning consists of waking up, taking pills56 and 
supplements, eating a light breakfast, resting, brief online activity, child care, and light 
exercise or stretching. The wake-up times among the participants varies widely. While 
their wake-up times differ, many report that they wake unrefreshed, in pain, and stiff. 
Unrefreshing and inconsistent sleep patterns are one of the hallmarks of ME57 
(Carruthers, et al., 2011) and this is reflected in the interviews, as participants note that 
falling and staying asleep can be a difficult aspect of their lives. 
 On better days, this morning routine could also include small chores (i.e. laundry, 
vacuum, dishes, pet care) and hygiene activities (i.e. showering, getting dressed). For the 
two participants with children at home, child care tasks were the focus and priority of the 
day. These activities are often done in brief chunks, such as fifteen minutes of work at a 
time, with rest between each chunk. Every participant brought up resting in some form 
(in bed or on a sofa, sitting quietly, reclining, meditating) especially after describing their 
engagement in household chores. Physical activity in the mornings is particularly gentle, 
with an emphasis on stretching and yoga. 
 The topic of rest came up in every interview as participants talked about their 
morning routines. Participants shared how difficult it was to adjust to the need for this 
level of physical and cognitive rest. 
                                                 
56
 One healthcare routine that impacts the entire day is taking medications at certain times. This requires 
physical and mental effort and may determine eating patterns too if the medication needs to be taken with 
food. This results in the day revolving around when medications need to be taken. [Noted by Adaline.] 
 
57
 See Appendix B International Consensus Criteria. 
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Lena: So, in the meantime I go back to bed, because I need as much rest as 
possible. Sometimes I’ll sleep, sometimes I won’t, it depends, and I’ll just lay in 
bed for a while, until probably 10 o’clock, sometimes later, sometimes 11, 
sometimes 12, depending on how sick I am that day. 
Kelli: I head back to either my sofa or my bed and I lay on top of it reclining with 
my computer with very little getting up. 
 
Karen: I always go back and lay in my bed. 
 
Elizabeth: At that point, I'm generally pretty exhausted and I need to get back in 
bed or on the couch and just rest for a bit. 
 
Adaline: On a bad day, I'm pretty much in bed . . . no noise, no stimulation. Being 
in bed or reclined on a sofa often created frustration at first, followed by a process 
of understanding that rest allows them to do everything else throughout the rest of 
the day.  
 Daytime routines. From approximately late morning to dinner time, daily 
activities frequently center on rest, basic chores, managing medical logistics, and limited 
online activity. Doctor’s appointments and clinic visits also take up a significant amount 
of daytime energy, which participants plan for throughout the week. Again, rest plays the 
largest role throughout the day and most particularly during daytime routines, as will be 
discussed later. Any physical activity is counterbalanced with laying down on a bed, a 
yoga mat, or a sofa.  
 Basic chores done throughout the afternoon include changing laundry from the 
washer to the dryer (folding the clothes too, if it is a particularly good day), feeding pets, 
washing dishes, and general chores around the house. These are accomplished in short 
spurts with rest in between, as described by Cheryl: 
… if I know I'm going to be home for the day, I might do some chores around the 
house. I typically will break things up into small chunks and maybe spend 15 to 
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30 minutes doing some kind of chore. Could be a load of laundry, could be clean 
one bathroom, or vacuum one area, or sweep the kitchen floor, you know, small 
tasks. 
 Cognitive activities were often brought up in the context of daytime priorities. 
Some participants indicated involvement in volunteer work with patient advocacy groups 
or other online activity during the afternoons. They may play word games or other 
cognitive exercises, make phone calls, answer emails, or manage medical appointments 
and insurance issues. This work requires cognitive exertion which, like physical exertion, 
must be counterbalanced with rest.  
Evening routines. When talking about their end-of-day routines, participants 
brought up dinner, going out (or not going out), low-key activities, and bedtime. 
Dinnertime looks different for all of the participants, depending on who is in their 
household. Some eat with their families, some have a very light dinner before bed, some 
use their allotted energy on meal prep, and some do not, but dinner remains a daily 
activity that requires some degree of attention.  
Participants commented on their ability to go out in the evenings with friends or 
family once a week, once a month, or almost never, depending on their symptoms. 
Elizabeth, who leaves the house approximately two - five times a week, reserves energy 
for restorative service and exercise: "One night a week I often go to [do volunteer 
work].” Ashanti shared that being “sick and trapped in your house, it's hard to get out. I'm 
not saying I'm never able to leave my house besides doctor appointments but it's very 
rare.” For these participants, evenings commonly consist of a little food, a little 
television, and settling into bed by 8 or 9pm, although actual sleep may occur much later. 
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These morning, daytime, and evening routines reveal a group of people doing 
what they can with what they have. This requires razor-sharp attention to their current 
energy levels to calibrate an appropriate balance of exertion and rest. They are likely to 
overdo it, push themselves further than their bodies allow, and pay for it with symptom 
flares. Over time their expertise about their own bodies has become a well-honed craft. 
These routines also hold undercurrents of grief and joy, frustration and 
satisfaction, over the difficulty of tasks that used to be mundane and the accomplishment 
of small victories. Cheryl described it this way: 
I've got[ten] a little bit better about that, like now it sort of gives me a sense of 
accomplishment when I—when I mopped all the floors the other day I was like, 
oh the floors look really nice! And I feel like I've done something productive. So, 
it's helpful to sort of reframe stuff that you used to not enjoy to be more enjoyable 
now, just like, oh my gosh, remember three years ago I could never mop a floor. I 
had to—I remember having to sit down to fold laundry, like sit down next to the 
dryer and pull the clothes out and put them on hangers and fold them right there. I 
couldn't stand and do laundry. 
Many participants communicated the importance of recognizing their own 
progress within the context of learning to live with their illness. 
Boundaries Around Exertion58 
Cheryl: The most benign activity is taxing to your energy. 
Lena: In terms of like physical activity and stuff, I can't really do anything. You 
know, the only thing I can really do is talk a little bit to people sometimes but 
even that really wears me out. I can't do it too much.  
                                                 
58
 tl;dr - Boundaries Around Exertion - Living with Post-exertional Neuroimmune Exhaustion (PENE) 
means that physical and cognitive activities (such as hygiene, online tasks, advocacy, emotional labor, and 
sensory input) take a serious toll and must be accounted for. 
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Kelli: … everything used to be easy, you know, like cleaning the bathroom. 
Everything was easy … Now I'm generally lying down twenty hours or more a 
day. 
For people with ME, exertion of any type requires careful planning and awareness 
because of the consequences of overdoing it. This is the reality of living with post-
exertional neuroimmune exhaustion. Even basic fine motor skills, like lifting light 
objects, can be affected. As Adaline notes: “I have trouble with my grip and I drop 
things. We like antique stuff and I've broken our vintage glasses because it's just fallen 
out of my hand.” Any exertion (physical, cognitive, emotional, sensory) must be 
accounted for. 
Pain. Interrelated with exertion is physical pain. In one of the interviews the word 
‘pain’ did not come up at all, and in another it was used twenty-three times. In one, the 
word ‘pain’ was used solely to describe chest pain, and in another it only came up when 
the participant described the pain of swallowing. Pain often came up in descriptions of 
symptom flares, such as: 
Adaline: I'm generally too weak to stand at a stove or it just causes such a pain 
flare that it's really impossible. 
Elizabeth: I don't know if I have brain fog. All I know is sometimes I'm so tired 
that that kind of activity causes my pain and other symptoms to get worse. 
Seeing doctors for pain often pre-dated their ME diagnosis. They sought out pain-specific 
treatments, often with no success, as their symptoms worsened. 
 Hygiene. One of the most commented-on physical activities throughout the 
interviews was the topic of showering. The physical energy required to take a shower 
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makes this hygiene task an important topic of conversation that reveals the boundaries of 
physical exertion that each participant lives with. 
Adaline: Showers. I really only shower every once—once every week or two. It's 
just, it's one of those activities that is so exhausting. And I have to plan for it. I 
have to go, okay, so on this day, I'm going to see a doctor, so I probably don't 
want to be completely stinky, so let's keep the day before clear so that I can 
shower … and that's my day, is showering.   
Interviewer: Just the one thing.  
Adaline: Yeah. Which sucks, but that's, you know, kind of the way it is.  
The topic of showering came up over and over again. It is a task that most took for 
granted and it now looms as a major activity. Showering becomes a gauge or a 
benchmark of well-being, as Cheryl expressed in her sum up about her most difficult 
crashes, by including the inability to shower regularly as the indicator of her mobility 
level. The inability to perform this personal act of bodily care sat heavily on the minds 
and hearts of many of the participants. Even during periods of physical improvement 
Cheryl found that, “one of the issues that was really clear to me was any time I took a 
shower it wiped me out.” She turned to her online community of people with ME and 
drew on their shared knowledge. (“It’s POTS59!). They told her lovingly, “... get a shower 
stool dum-dum. I was like, oh you can get one on Amazon for 20 bucks. I got a shower 
stool and that really made a huge difference.” Sitting often helps people with ME to 
complete hygiene tasks. Ashanti sits on her walker at her vanity to do her hair and also 
                                                 
59
 Postural Orthostatic Tachycardia Syndrome (POTS) is commonly co-morbid with ME. People with 
POTS have trouble standing because the nervous system fails to send the appropriate signals to the 
cardiovascular system to counteract gravity, causing blood to pool in the legs instead of carrying needed 
oxygen to the rest of the body including the brain. 
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uses a chair for showering, as she notes here: “Occasionally I am able to shower. I do use 
a shower chair, and even with the shower chair, while sitting, my heart rate is usually in 
the 140s to the 150s.” 
 Karen manages getting ready in the morning “basically through stages, through 
my makeup and dressing. Some days, I wear more makeup than others, some days I don't 
wash my hair, I'll use a dry shampoo, you know, I do those things to conserve energy”. 
And alternating activity with rest is key. Karen has had to adapt to this and notes that 
after showering, “I always go back and lay in my bed”. Planning ahead and putting 
showers on the calendar helps too. For Elizabeth, “to shower and wash my hair is a big 
twice weekly event that I kind of plan into my schedule.” 
Cognition. The ability to remember, the ability to read, and the ability to retrieve 
words are issues that arise daily for these seven women. Cognitive tasks, like physical 
activity, must be planned for. 
Elizabeth: … cognitive work, particularly anything that I'm doing with my 
activism with MEAction and anything related to ME, puts me into … reading the 
literature or thinking about the science in some way. And that will definitely 
crash me way faster than any other effort. And I think it's a combination of ... 
just being on a screen … it's just the cognitive effort of doing science or reading 
science and thinking about science is harder. And I've had a few times in the last 
few months where I didn't think I did that much, I was lying down, just reading a 
science paper, but then it took me a week to recover from it. So I had a really bad 
crash and then took a week or two to get back to baseline and—and just realize, 
oh! And then after that happened a few times, it was like, right, I need to be really 
careful about cognitive because I think that I'm just lying down but it turns out 
that I really am—yeah—exerting! 
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Throughout their daily routines, most participants included descriptions of their cognitive 
tasks, such as online activity, processing the sensory input from television or music, 
calling doctor’s offices, and communicating with others by email or phone. 
Rationing cognitive activities helps to mitigate the negative effects of overdoing 
it, but there are some aspects of cognition that participants have lost and often grieve that 
loss. 
Cheryl: I don't have creativity. I can't generate ideas about what to get for 
people—what my nieces and nephew might want for Christmas … it's probably 
going to be gift cards for everyone and that makes me sad. I used to have a brain 
that I could think of something and I just—I don't have it anymore. It's gone. 
Not only is the loss of creativity and memory an issue, so is the ability to negotiate 
healthcare decisions, as highlighted in this conversation with Ashanti: 
Interviewer: How has that been, navigating that whole web of decisions and 
signing on and paperwork [for insurance plans], while also navigating your 
physical symptoms? 
Ashanti: Very difficult. Extremely difficult. Sometimes I just don't have the brain 
capacity to even absorb … like, okay this plan does this, and this one does this, 
this, and this. Like what? What are you saying? It's too much. I can't … The thing 
is this, I was very smart before I became sick. Although to those people who don't 
know me, I still appear smart, I know that my brain is not functioning anywhere 
near the level of function that it was pre-illness. Nowhere near ... I used to have a 
photographic memory. That's all gone. My ability to focus, concentrate, my 
ability to read—I used to love to read. Literally, I cannot read anymore. I cannot 
absorb what's on the paper. Like, I can say the words. The words I can actually 
read, if I have to read out loud. If you ask me what I just read, I don't know.  
Elizabeth also notes: “I would say emotional effort also counts as exertion … life 
is challenging for all humans and doubly so for having cognitive—for having chronic 
illness … and stigmatized misunderstood chronic illness.” People with chronic illness 
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have to deal with the physical symptoms of the disease but there is also an emotional 
element of grief and loss when things that were once easy become huge obstacles. 
Lena: Yes. Yeah, even just the other day I had my one of my friends who has ME 
message me about how tough of a time she's having and she's dealing with other 
things too, like everybody does, and it's a really hard time for her—but also the 
disease compounds everything. 
 
Elizabeth shares how stressful the process of applying for disability status and 
social services is; just thinking about that process represents an emotional load. She tries 
not to let it take too much of her energy.  
Elizabeth: For me—it's always about just figuring out how to fill those most 
important niches. And I think, yeah, having a cognitive life—I'm very grateful 
that I'm able to. There have been times … when I'm particularly unwell, where 
word-finding is a little bit of a problem or short-term memory. Like I'll open a 
web browser and then literally from the second that I was like, oh I should look up 
X, and then I open the browser, and I'm literally on my computer, so it's a second 
that I've clicked a button and the browser comes up and I can't remember what it 
was I was going to look up. And then it'll take me five or ten minutes to come 
back and realize, oh it was X … that never happened to me before … I would say 
I don't always have that problem, I think it's more when I'm particularly unwell or 
pushing myself or—I don't know. I mean, there's so many variables. 
The terminology around these symptoms is used differently among people with 
ME, who may gravitate toward some terms and reject others. 
Elizabeth: I don't know what this term brain fog means—still means nothing to 
me. I don't know if I have brain fog. All I know is sometimes I'm so tired that that 
kind of activity causes my pain and other symptoms to get worse. And sometimes 
I just can't do it. I can't make myself do it, because I'm so tired. But it feels more 
like the pain and the fatigue are what limit me cognitively, both in terms of 
reading or listening to music or those kinds of things, … it was hard for me to 
kind of relate my symptoms to what I was hearing from other people. Just because 
of the way that it looks so different in different people.  
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Cognitive exhaustion effects each person differently, and so do environmental sensory 
factors. 
Sensory Stimuli. Some have found that limiting stimuli from light, noise, and 
scents helps to maintain their well-being. Too much stimuli from any of those sources 
can exacerbate symptoms. For example, Cheryl related an experience of encountering 
strong scents and perfumes at work that made her pain worse. She also notes that playing 
music in the background makes it difficult to have a conversation because it means doing 
two cognitive activities at once (processing the musical sound and attending to the 
conversation). She’s learned to do just one thing at a time. The same can be true for light 
and visual stimulation, as Cheryl wears blue blockers when using devices with screens to 
cut out the extra sensory stimuli. However, not all experiences around light and sound are 
consistent. During periods of post-exertional neuroimmune exhaustion, light sensitivity is 
particularly problematic for Elizabeth. She says “… if I'm doing well then sound and 
light don't bother me” and in regard to stimuli from sound, “it's mostly just the effort that 
it takes to process the sound, like somehow that's actually the problem ...it's like it's 
asking energy of me that I just don't have.” The process of taking in sensory stimuli is 
often thought of (or not thought of) as unconscious, but it does require exertion and 
therefore becomes a topic of importance for people with ME. 
Changes 
 When the women I interviewed described their lives before their illness began, 
they talked about being active, busy, hard-working, and fit. They worked as nurses 
pulling 12-hour overnight shifts, as entrepreneurs keeping their small businesses running, 
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as university faculty and staff mentoring students and researching. A high-activity 
lifestyle60 functioned as part of their self-formation. And then everything changed. 
Onset61 
‘Onset’ refers to the period of time that marks the transition from pre-illness to 
illness. Some people with ME experience sudden onset and some experience gradual 
onset. Some have adolescent onset and some develop symptoms later in life. Of the seven 
participants in this study, six commented on viral infections at the time of onset or just 
previous. 
Six women who participated in this research talked about the onset of their illness 
in the context of work. They spoke about their employment, their experiences on the job, 
the tasks they suddenly struggled to complete, and the logistics of remaining at work 
versus leaving. Here are three of their onset stories in their own words. 
Ashanti. "Some people I know get sick gradually. For me, it was like an instant 
… My last night shift was August 10th, 2016 and my symptoms began a few days after 
that … Interviewer: And you weren't able to return to work after that? Ashanti: Yup. 
That's why I say, for me it was like getting run over by a train, because once I was hit, 
that was it. I never recovered. I never went back to work for one day, for one hour, 
nothing. That was it. That was my last night shift ever.” 
                                                 
60
 When reports of viral outbreaks and chronic fatigue syndrome hit the news in the 1980s (see ‘Yuppie 
flu’ in the Literature Review), the rebuttal from medical institutions was: this is what you get for upending 
social norms and gender roles in order to pursue careers; you wanted it all and you burned out; that’s 
what you get (see Dusenbery, 2018, pp. 259-262). This response, while sounding wildly out of place today, 
continues to have harmful implications and continues to reverberate through clinician beliefs. One 
participant in this study indicated that she still encounters this idea. 
 
61
 tl;dr - Onset - Participants share their personal stories about when their symptoms started. 
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Elizabeth. "I had a gradual onset … at that time I was a postdoctoral fellow [in 
biochemistry] … I took five days right after I finished my postdoc and I rested … I just 
rested for five days straight. I slept a lot of the day. I didn't even read that much. I was 
just so, so tired. But I got better and went back to my very active life ... I would every 
once and awhile dip into this deep tiredness. But I would rest and I would come back out 
and be able to be totally physically active. So, it wasn't until 2014 that rest didn't seem to 
make a difference anymore … I started thinking, I need to do another deep resting, 
because I'm feeling really tired. And I did that over … the summer after I started as a 
tenure-track faculty member ... I was at a small undergraduate institution, so—but they 
had very high standards for research and publications and all that. So, yes, I had students 
in my lab but I wasn't teaching and that was a huge shift … so then I try to rest over the 
summer. I felt like I had rested a bit but I started the fall feeling tired. And then I started 
getting lots of infections … I knew something was wrong ... feeling just so exhausted all 
the time. And in a way that felt different from just normal tired, like everybody's tired 
and everybody's overworked but this just felt like a whole other dimension of tired. 
And then I started prepping … and I was trying to help a friend, a colleague friend 
who—we were going to co-teach a class together—and I was trying to—he was the main 
one and I was assisting—and I just kept finding I … physically couldn't move. And I 
realized I was just dropping the ball so badly and I was like, I can't do this, I'm barely 
able to get out of bed. So, I went on medical leave. And I ended up being on medical 
leave for a year … I had a lot of friends who were junior faculty with me ... I had some 
people bring me food, mostly because they offered, but some because I asked, I think. So 
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that was the main thing, was just people bringing me food. And I had a friend who took 
me to at least one doctor's appointment that was kind of far away and that was most of it 
... I was somehow getting by. I don't really know how … the whole time is sort of a blur.” 
Cheryl. “One of the problems I had was just chronic pain and I was having 
terrible pain in my tailbone and my hips and both my arms. I had tennis elbow in both 
arms. And I worked in a psychiatric emergency room, which was a very busy place 
anyway, and a lot of what I did was running around, but I also sat a lot for documentation 
purposes and to interview patients. And so, I decided that standing would be better for 
my pain. So I ... asked for a stand-up desk. They actually installed one that folded out 
from the wall where I could stand and do my charting … so I tried just standing through 
my shift thinking that was better for me. And then I literally became disabled at work 
during a shift where cognitively I could not function. I could not fax a document and 
that's something that I would do hundreds of times during a shift, it was so second nature. 
And I tried like ten times to fax this document and finally the clerk that was sitting in 
front of me turned around and she's like, ‘Cheryl what's—what's going on? What's the 
problem?’ She's hearing the fax machine make these rejection noises or whatever. She's 
like, ‘What's going on with you?’ 
And I'm like, ‘I'm not—you know—call the supervisor, I'm not doing well.’ 
Because here I am, I'm the charge nurse. I'm supposed to not only be supervising 
staff but make sure that the milieu of the unit is safe, and dealing with the police that are 
coming in, the ambulances that are coming in, all the stuff that's going on. And I can't 
even fax a simple document. Something was really wrong. And that's the last shift I ever 
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worked. I didn't know it at the time, but I never went back. The supervisor came and 
relieved me so that I could leave. And I went to the doctor the next day and that was the 
beginning of all the nightmare." 
These women were involved in high-intensity jobs. When the symptoms of ME 
first started appearing, those jobs became unfeasible, no matter how much they fought it. 
Two participants used the same phrasing to emphasize the toll that their jobs took as they 
continued to work through their increasingly debilitating symptoms: “I broke.” They 
worked until they physically couldn’t anymore.  
Transitions62 
Lena: All the ripple effects … obviously it was incredibly difficult emotionally, 
psychologically, mentally, financially, socially, pretty much any way possible. It 
was very, very difficult. I just had to struggle to adapt.  
The onset of debilitating illness brings a host of changes and shifts that people 
with ME navigate as they adapt to unfamiliar conditions. They have to get used to a new 
kind of body that is frequently bedbound, quite different from the active one that traveled 
and cross-trained and worked. Tasks that were once easy, like showering or cooking, 
become difficult. It takes time to accept the realities of a paced, measured lifestyle; a 
lifestyle they did not choose but now have to navigate. 
The shift from independence to dependence on caregivers is a particularly 
difficult one. Losing the ability to be self-sufficient weighed heavily in many of the 
stories from the interviewees. 
                                                 
62
 tl;dr - Transitions - People with ME navigate many changes, such as the transition from an independent 
lifestyle to dependence on caretakers and reframing their beliefs about health and personal worth. 
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Ashanti: You know, this illness [took] away my independence which has been, for 
me, one of the biggest challenges. I've always been independent ... I've never 
asked for help … When you're chronically ill, that thought process goes out the 
window. I desperately need help. And I've gotten better at asking for help. I still 
really struggle, because for my whole life I didn't live like that. I would handle all 
of my business all on my own, being a single mom while going to nursing school, 
etc etc, I've always done it. So, to have my independence taken away has really, 
really, really been difficult. 
Adaline: I was a writer and editor. Well, guess what? Cognitive issues. Brain fog. 
I was an artist and photographer. My hands don't work anymore. I can't paint. I 
can't hold my camera because it hurts so bad. I did marketing. I did events. I can't 
do an event now, like, there's no way in hell. 
Their physical bodies react differently to exertion than they are used to. Ashanti 
compares her level of exhaustion as a nurse working twelve-hour shifts, sometimes being 
awake well over twenty-four hours at a time, to her exhaustion levels now with ME: 
I was tired then [working as a nurse] and it was exhausting but the level of 
exhaustion that comes with chronic illness makes that so-called exhaustion look 
like energy. There [were] nights where I wasn't even able to get a break because 
I'm chasing my tail the whole night trying to save a baby's life. So that level of 
exhaustion that I experienced [sometimes being awake well over 24-hours to meet 
the demands of nursing and motherhood], it really looks like energy compared to 
the level of exhaustion that comes with this illness. 
The shift away from being able to be physically independent not only brings 
material changes, such as being homebound or having a caretaker, it also impacts internal 
beliefs.  
Participants spoke with me about how living with ME has reframed their beliefs 
and changed the way they think about the world and themselves. 
Adaline: I really had to rewire my whole worldview because of getting sick … 
The whole thing is already stacked against sick people … People act like it's a 
moral failing that you're sick. And it's been really hard for me to divest myself of 
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that view. I'm not a bad person because I got sick. It's not my fault I got sick. I'm 
worth fighting [for] to get the care that I need. 
Up until her own illness onset, Cheryl believed that diet, exercise, and stress management 
would protect her health. 
Interviewer: And how would you describe your belief now? 
Cheryl: Shit happens [laughs]. I mean, I don't know, it's—did I choose this? Hell 
no. Would I wish it on my worst enemy? Hell no. But did I cause it? Hell no. 
Changes in physical ability can result in changes in personality and self-formation. These 
participants have had to reframe their thinking, create new ways of making decisions, and 
shift their worldview in order to incorporate what they’ve learned about living with 
chronic illness. 
“This disease obviously caused a lot of problems63”: Dealing with loss.64 With 
chronic illnesses, including ME, life after onset is drastically different than before. As a 
life event, it brings with it a period of grief. People with ME often lose their jobs, social 
contacts, and financial security after the onset of this disease (National Academy of 
Sciences, 2015). Time is needed to reconstruct their sense of self in the absence of 
previous activities that contributed to their identity formation. 
Cheryl: Grief is a huge part of the illness, right? You lose everything in a very 
short period of time. It's not like a death. It's like the death, you know what I 
mean? 
Interviewer: But you're still alive to watch yourself go through it.  
Cheryl: Yeah ... I was grieving hard and I went through all the stages of grief. 
                                                 
63
 Quoted from Lena’s interview. 
 
64
 tl;dr - Dealing with Loss - Participants share the losses that ME has caused and the period of grief that 
goes along with that. 
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On a similar note about going through the stages of grief, Kelli shared her experience of 
dealing with grief over a long period of time and not being prepared for this particular 
type of loss in her life. 
Kelli: It has been, definitely been, five years of grieving. It has. I think one of the 
things about this disease is that nobody, nobody, prepared me for this. Because it's 
not in the news. I knew that I could get a cancer diagnosis or MS or ALS or a 
stroke or—nobody told me there was a disease that's not going to kill you, but that 
will take so much away from you, and you will have to fight through illness, 
possibly every day of your life. Nobody ever said that. So ... it's been kind of a 
grieving process. 
These are just some of the losses that participants reported due to their illness: 
● loss of hobbies (hiking, baking, biking, writing, reading) 
● loss of professional skills (analysis, writing, photography, teaching) 
● loss of ability to walk their dog 
● loss of ability to drive a car 
● loss of time (having a limited number of active hours in a day) 
● loss of job and financial security 
● loss of home 
● loss of fitness 
● loss of relationships (divorce, isolation, missing out on social events) 
● loss of memory-function 
● loss of self-sufficiency 
Participants describe these losses in individual, personal ways.  
Kelli: I really miss baking. Just baking … If I do it, I do it in steps ... I look at the 
Great British Baking show and I think, I can't do that anymore. I couldn't do 
something like that. And then you get a little jealous because you're like, they 
could do that all day, and I can't do anything like that anymore. 
Cheryl: I learned the hard way. I kept pushing, I kept trying, I didn't want to lose 
my fitness. Oh my god, I was a fanatic and yeah, I've lost my fitness and that's 
okay. It's worth the gains. And I think I'll get it back at some point. I have that 
optimism.  
Lena: [The physician] saw me, diagnosed me with ME/CFS, and sent a letter to 
[profession] letting them know what was happening, and pronto (snaps fingers) 
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within hours they dismissed me from work. I was severed and let go … We lost 
our housing, my husband lost his job because he had a spousal job, it was 
dependent on mine, so now that I no longer had a job, he no longer had a job, so 
we lost both of our jobs, we lost our home, my kids got kicked out of their school. 
As Kelli put it simply, “it's a reduced life.” And the loss of employment has the 
compounding effect of financial insecurity. 
Ashanti: It's really a nightmare to say the least. It's really scary for me because I 
never envisioned not having financial security and stability for myself and for my 
family. And good health care. 
Elizabeth: Right now, even though I do have long-term disability coverage, like 
benefits, there's ... just the fear that at some point the insurance company will find 
some dumb excuse that, won't be legitimate, but will be hard to fight and then will 
kick me off. So, I just feel financially insecure in various ways and I have some 
personal long-term goals that make the most sense to be in a place with more 
support. 
These losses and the onset of ME also have an impact on family members of the person 
with ME, particularly their caregivers and their children. 
Lena: It was really hard for my kids too. I mean, obviously it's really hard for me, 
but it's also really hard for my kids because they lost their mom. I could not even 
speak or do anything at that point. They lost their dad. He was out of their life at 
that point … They lost their friends. They lost their community. They lost their 
school. 
The effects of illness radiate out into the lives of their family and community. 
 “Society is a huge barrier against sick people65”: Expectations Around Work 
and Worth.66 During the interviews, some participants acknowledged the idea that it is 
                                                 
65
 Quoted from Adaline’s interview. 
 
66
 tl;dr - Expectations Around Work and Worth - Social norms of productivity cause disruptions to self-
worth for people experiencing the physical limitations of chronic illness. 
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embarrassing to admit their limitations. Admitting the realities of what they can and 
cannot do is tough, and even saying the words could be a struggle. For example, 
admitting that all they could fix themselves for breakfast was a cup of yogurt carried 
substantial levels of embarrassment. There was an underlying fear of social judgement, 
based on past experiences. Cheryl shared a simple example of trying to check out at the 
grocery store when she was still relatively mobile. She was having memory issues as she 
tried to put in her pin number and was nervous about what the people behind her thought, 
knowing that she probably looked healthy to them. 
In a society where productivity and personal responsibility are highly valued, 
admitting personal limitations can chip away at a person’s sense of worth, particularly 
when that message is reinforced by medical professionals.67  
The internalized belief that worth is linked to work stands as a barrier for people 
with ME. In regard to her employment status, Elizabeth “wanted to be working and there 
was a lot of guilt and shame around my having been ill and still not really having any 
answer to why.” Adaline shared that before the onset of ME, she used her ambition and 
hard work to prove her worth. When she got sick, she felt like the universe was playing a 
cruel joke—she felt worthless before, when she could do so much more, and here was 
this illness saying, “Now you don't get to do any of it. I'm taking away everything that 
makes you, you. I'm taking away everything that you consider makes you worthwhile. 
                                                 
67
 For examples of dehumanizing language from clinicians, see Chapter 3 Navigating Healthcare.  
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Now how do you feel?" She emphasized that she would rather be working because so 
much of her life had centered on her ability to work. 
Adaline: I've been working since I was 10 years old, and paying my own way 
since I was 14, so having to quit a job because it crippled me was so 
embarrassing. It's been five or six years now, so I can talk about it without 
bursting into tears. But, you know, society is a huge barrier against sick people …  
Standards of productivity serve as social norms, and when illness becomes a part of 
everyday life, those norms are often weaponized against those with chronic illness. 
 Despite this social pressure to be productive, participants also shared ways that 
they shifted their perspective in order to identify ways in which they continued to have 
worth as a chronically ill person. 
Adaline: I can be kind. I can be on my support group and someone says, I'm 
having a really shitty day, and I could say, okay talk to me. I can listen. And I feel 
like what's missing a lot in our society is the feeling that bearing witness is 
worthwhile. So, when I'm talking to someone ... I'm bearing witness and I'm 
helping them carry that burden. And so that kind of helps me feel like I do have 
worth.  
Kelli: I know I'm a middle-aged woman with vague complaints but my life 
matters to me … my possibilities are worth looking at. 
Part of living long-term with any chronic illness is persisting in the knowledge of their 
own worth. See Chapter 3 Navigating Healthcare for more about self-advocacy. 
Relationships68 
As previously discussed, family relationships emerged in the data as core support 
systems; however, ME also puts a strain on those relationships. As Ashanti said, “Of 
course, you're unable to attend many things and people get upset.” Because of ME, she 
                                                 
68
 tl;dr - Relationships - Despite the difficulties of losing relationships, maintaining connections with 
family and online networks remains a key aspect of quality of life for people with ME. 
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was unable to attend her sister’s wedding in Mexico. International air travel was not 
feasible with her severe symptoms and the wedding venue was not wheelchair accessible. 
The risks associated with traveling out of the country, to an unfamiliar location with 
limited medical resources for her if an emergency were to arise, were too much to be 
expected, particularly in light of her multiple hospitalizations. Even though these 
circumstances were out of her control, Ashanti’s two sisters are no longer speaking to 
her. Missing family events due to symptoms and physical considerations can be 
interpreted as lack of care or effort, which impacts family relationships. 
Another theme that emerged was having family members (extended and 
immediate) who did not believe their ME diagnosis. Some family members came around 
eventually and some did not. Adaline received clear messages from her family when she 
first started trying to get medical treatment for her illness: “Even my husband didn't 
believe I was sick at first. He just kept saying, you need to find a job, you're just 
depressed, you need to try harder.” They pressured her to stop going to doctors, but she 
didn’t, “even with my mother and other people telling me: Just don't, you don't need to 
know what’s wrong with you, just give it up.” With Kelli’s extended family, they 
recognize her symptoms through a limited and psychological frame: “I know that the 
narrative out there is that Kelli's sick, but it's probably in her mind. There's something 
wrong with her.” Having just one or two family members shift their perspective made a 
positive impact on participants’ family relationships, such as Adaline’s husband growing 
into a supportive stance over time as he learned about ME. 
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Living with a chronic illness like ME affects intimate relationships, whether past, 
present, or potential. Looking back on her past relationships, Karen says, “I do think this 
illness has contributed to two divorces. I didn't understand it and my husbands at the time 
didn't understand the fatigue, the brain fog, the inability, my communication, my 
understanding of things.” In partnerships that do continue through the onset of ME, the 
physical symptoms impact everything. Cheryl describes the relational cost on her 
marriage: “I mean sex—nobody wants to have sex with this illness.” Even for potential 
future relationships, going out and dating is particularly problematic. 
Ashanti: Being chronically ill and primarily house-and-bed-bound and single, that 
makes it basically impossible—not impossible but near impossible—to date or try 
to have any sort of romantic [relationship]. I can't meet anyone … I'm not on any 
of the dating apps. I don’t do any of that because again with that comes, you need 
to be able to leave your home, to meet the stranger. I don't want strangers coming 
in my house … So, it makes it very difficult. And I'm a human, so I would like to 
have a life partner, especially to navigate chronic illness, but the fact that I didn't 
already have one at the time that I became ill, it makes it seem less likely that 
that's going to happen, unless, you know, I see somebody at a doctor’s 
appointment or something. [laughs]... these are things that when you're healthy 
you just, oh, meet someone, no big deal, but when you're sick … it's hard to get 
out. I'm not saying I'm never able to leave my house besides doctor appointments 
but it's very rare. It's hard to meet people. 
The continuous isolation emerged as a theme in the interviews, connected with the 
importance of creating new friendships via online support groups. 
Cheryl: … and then isolation. The online support thing was huge for me. And 
then advocacy work has given me a huge connection of friends, which helps, but 
I'm definitely isolated from my colleagues and my tennis friends and my gym 
friends and my yoga friends because I disappeared basically from all those 
activities and eventually people just stopped asking when you're still sick and it is 
isolating. So luckily, I like my own company and the wild animals [around her 
home]. 
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Kelli indicated that almost all her relationships are online now, with the exception of her 
husband, daughters, and granddaughters. Having access to an online network of people 
with ME has had a significant impact on her quality of life. 
Kelli: … one of the things that's helped me through this as much as anything else 
has been a social network of other patients. I do not know how people survived 
before social network. I just—hearing other people and knowing that they're 
going through the same thing or that they have gone through the same thing for 34 
years is lifesaving. It's eased the isolation quite a bit. 
Online groups and social media provide the platform, as a tool for connection and 
advocacy, which is accessible even for those who are homebound. Nepveux (2015) refers 
to this in her writing about the purposeful use of technology by health advocates: “social 
media has enabled geographically disparate disability groups to organize” and increase 
their “communicative and coalition-building capacities” (p.24). These online tools create 
opportunities for personal connections and a network of support. 
Despite outside messages to the contrary and periods of grief, these seven women 
have been able to stay clear on a key truth: people who live with ME matter. Their stories 
matter and their experiences are valid. Based on the impact of social expectations about 
ability and productivity on self-perception, those who live with ME are a valuable source 
of knowledge to view those expectations through a new lens. Within their community, 
they hold the knowledge that can re-pioneer social norms, with all the multi-faceted 
dynamics and various experiences they bring. They matter.  
 The elements of day-to-day life described in this chapter focused on the inner 
lives of people with ME, their experiences at home, and with loved ones. Another 
element remains which needs its own chapter: navigating healthcare. The cognitive and 
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physical labor required to get care is interwoven into the routines and balancing 
techniques of everyday life. Navigating healthcare emerged as a prioritized activity, not 
through choice, but by necessity.  
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CHAPTER 3 
NAVIGATING HEALTHCARE 
“All I wanted was to figure out what was wrong with me”69 70 
The energy it takes to navigate healthcare systems is one part of the lived 
experience of ME that needs further scrutiny. For people with ME, every day includes 
different elements of accessing healthcare that require exertion and planning. In her work, 
Riessman (1983) highlights the levels at which medicalization happens: conceptually, 
institutionally, and between doctors and patients (p. 48). Even though her work was 
published more than thirty years ago, the ideas she raised are still crucial to 
understanding disease in its social context. In this chapter, I will 1) address the 
conceptual formation of disease names and terminology related to ME, 2) examine the 
institutional barriers to care for people with ME, and 3) analyze the behavior of 
individual physicians toward study participants. 
During the onset of ME, each participant sought out medical care. Their searches 
include a great deal of trial, error, and iterative stories of both finding care and 
encountering harm. This period of searching for a diagnosis occurred for participants 
when their symptoms overtook their ability to work and function. When describing the 
period of time spent seeking healthcare after the onset of their symptoms, both Cheryl 
                                                 
69
 Quoted from Elizabeth’s interview. 
 
70
 tl;dr - This chapter focuses on the conceptual, institutional, and interpersonal barriers that participants 
encountered during their search for medical care. Some participants utilized their prior medical training to 
help them access care, with mixed results, and all participants expressed the desire to improve even in the 
face of stereotypes about malingering. 
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and Adaline characterize it as a “blur”. Others summarize this process as well, based on 
their personal experiences: 
Karen: Other than that, all those years I was just going to doctors trying to figure 
out what was going on. Everything was inconclusive. Or they would diagnose me 
with IBS or diagnose me with chronic bronchitis, asthma, just those standard type 
of things. 
Elizabeth: I was just so unwell, it was hard for me to keep up with what was 
going on. And then if I had a negative experience it just sort of got filed into ‘that-
was-BS-it's-not-going-to-help’. And then just trying to function again ... I 
remember [a doctor] telling me that … a lot of people have really bad reactions to 
amantadine. So she was making it sound like I might not want to take it. I think 
that was part of why didn't take it. Now I look back and I'm like, oh, I wonder 
what would have happened if I had taken it, but I was doing the best I could at 
the time. (emphasis added) 
Cheryl: I just wanted to see a general practitioner and find out what the hell is 
wrong with me. Why am I having these bizarre horrible symptoms that are 
unrelenting and that don't respond to normal treatments? 
Lena: It took me a while to come across a good doctor. And at first, I was too sick 
to even do research to find a good doctor. 
The process of seeking out medical care was fraught with complications for these 
interview participants due to the macro- and micro-level barriers discussed throughout 
this chapter.  
Of the seven participants, Ashanti and Cheryl have prior medical training as 
registered nurses. This training both helped and harmed them. 
Ashanti: I start[ed] requesting all kinds of specialists because I'm a nurse. I'm not 
working anymore. I'm disabled but I will always be a nurse. So I still refer to 
myself as a nurse. I'm a nurse, so I knew what specialists to ask for. I knew how 
to navigate the medical system. 
Because of her medical training, Ashanti knew what to ask for, and requested a referral to 
an allergist, and later to a rheumatologist who specializes in autoimmune diseases, as 
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well as referrals to a neurologist, gastoenterologist, and an infectious disease specialist. 
She also knew it would be beneficial to get her medical records, to see for herself what 
physicians had written71. Cheryl noticed that some clinicians continued to respect her 
medical training; for example, a neurologist who respected her standing as a recently 
working nurse, and believed her symptom reports right away. On the other hand, some 
clinicians were outright dismissive once they saw her diagnosis list. Cheryl’s training as a 
nurse is reflected in her use of the word ‘we’ when talking about medical professionals, 
grouping herself with her clinician colleagues. This training, however, resulted in her 
initially not believing CFS and CFIDS were ‘real’ when her doctor first diagnosed her. 
Overall, in discussing their search for care, participants emphasized that they want 
to get better. This stance is often challenged by medical professionals who characterize 
them as noncompliant (Dimmock & Lazell-Fairman, 2015). For Adaline, like many 
others with ME, her drive to find treatments was frequently derailed by clinicians: “I 
[had] to find out what I could do to get my energy back and deal with this fatigue. So I 
went to a doctor who basically said, there's nothing wrong with you.” Elizabeth 
emphasized that her main priority was to figure out what was wrong, even during the 
worst of her symptoms when she was unable to do much. Ashanti expressed this as well: 
“I'm grasping for straws at this point, because I want to figure it out, I want to get back to 
my life, working out, working, and being an active mom.” From hospitalization to 
hospitalization, doctor to doctor, and one diagnosis to another, she paved her own way 
and advocated strongly for herself. This was necessary because of the conceptual, 
                                                 
71
 As shown later in this chapter, this choice to pull her medical records allowed Ashanti to challenge 
inaccurate statements about her symptoms. 
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institutional, and interpersonal dynamics that create barriers to care for people with ME. 
These conceptual complexities are discussed in the following section.  
Concepts & Diagnostic Terms 
What’s in a Name72 
Myalgic encephalomyelitis does not exist in a vacuum. It is interrelated with a 
host of other diagnoses that have grown out of the medical model (see Appendix C for a 
constellation of other conditions that interrelate with ME).73 Language plays a role in 
how patients, physicians, and the public conceptualize illness. As previously discussed74, 
a multitude of different names fall in, around, and near the term myalgic 
encephalomyelitis. Each name carries its own connotations, usages, and history which 
intersect with the connotations, usages, and history of all the others. Each name is an 
attempt to capture a certain aspect of the illness. For example, CFS emphasizes the 
fatigue element, and ME emphasizes the neurological element.  
The terminology that each participant uses to describe their diagnosis reveals the 
ways in which language constructs illness conceptually: 
Ashanti: I hate the term chronic fatigue syndrome because it trivializes the illness 
and doesn't really convey all the multiple systems that this illness actually affects 
and impacts. It's not just about being fatigued. I wish it was that simple. 
                                                 
72
 tl;dr - The names and terms used to describe illness reflect and impact the conceptual formation of 
illness. People with ME use different medical terms, even amongst each other. 
 
73
 See the History of ME section of the Literature Review for a discussion of different names that have 
been used to describe ME. 
 
74
 See History of ME in the Literature Review. 
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The connotations around ‘fatigue’ have made life difficult for people with ME, when 
their fatigue symptoms differ significantly from the common usage of the word. 
Elizabeth describes her exhaustion as ever-present, “in a way that felt different from just 
normal tired, like everybody's tired and everybody's overworked, but this just felt like a 
whole ‘nother dimension of tired.” This type of fatigue is not improved by rest, in 
contrast to the experiences of people without chronic illness. Cheryl describes her 
approach to the concept of ‘fatigue’ in this way: 
An important thing that I want to make sure that I convey: for both of those two 
doctors that suspected the chronic fatigue syndrome, I never ever used the word 
fatigue. I never ever complained about being exhausted. I complained about sleep 
problems. But I did not recognize fatigue in myself. It was not a symptom that I 
identified with at all, which was part of why the diagnosis seemed so bizarre to 
me … But, yeah, for being fatigued or not having energy, that didn't click for me. 
All the other symptoms would happen because I was over extending my energy 
but I didn't understand they were consequences of that. I just—I felt like I should 
be able to do all the things that I normally did even with these weird symptoms. It 
didn't occur to me that I was pushing my body too hard. 
Each person with ME has their own relationship with their diagnosis and the terminology 
that accompanies it (see Table 2 for each participants’ preferred term).  
Terminology for individual symptoms is subject to these same issues. For 
example, the International Consensus Criteria (ICC) refers to post-exertional 
neuroimmune exhaustion (PENE) as the hallmark symptom of ME (Carruthers, et al., 
2011). This same symptom is also referred to as post-exertional malaise (PEM) or post-
exertional fatigue. All these terms refer to the same phenomenon, and they all have 
baggage. ‘Malaise’ possesses the negative connotations associated with ‘malingering’, 
and fatigue is a symptom routinely dismissed by clinicians, particularly for women, as 
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evidenced by medical practices in the context of hysteria (Dusenbery, 2018). Historically, 
PEM was used in diagnostic criteria up until 2011 (NAS, 2015), at which point the team 
that created the ICC replaced it with PENE. They view the word ‘malaise’ as “inaccurate 
and inadequate” (Carruthers, et al., 2011, p. 331) to describe these biophysical processes. 
However, the term ‘neuroimmune exhaustion’ can also be problematic. ‘Neuroimmune’ 
narrows the scope down to neurological and immunological processes which may 
preclude exploration into other causes for symptom flare ups. ‘Exhaustion’ has 
connotations in the general public as being a condition improved by rest, which 
neuroimmune exhaustion is not.75 This means that, along with the nuances of meaning 
and usage within medical literature, individual patients also differ in their choices of 
which term they personally use as they describe their symptoms to others. This array of 
words and meanings makes the diagnostic process complex for people with chronic 
illnesses such as ME.   
  
                                                 
75
 Paraphrased from discussions with Adaline. 
 
 96 
 
Table 2     
Diagnostic Terms within the Participant Interviews 
 Distractor Diagnoses1 Comorbid Diagnoses2 Diagnosis3 Term of Choice 
 
Adaline  
 
hormone imbalance 
endocrine disorder^ 
pain amplification 
syndrome^ 
thyroid dysfunction 
chronic lyme disease 
toxic mold syndrome  
 
 
hyper mobility (EDS) 
fibromyalgia 
insomnia 
Epstein-Barr virus 
radiculopathy nerve 
damage 
migraines  
TMJD  
depression 
osteoarthritis 
 
 
ME/CFS 
[2017] 
 
ME 
 
Ashanti  
 
none 
 
asthma*  
HAE*4 
autoimmune 
autonomic neuropathy 
 
 
ME [2017] 
 
ME 
 
Cheryl 
 
anxiety^ 
depression^ 
thyroid nodules 
tonsillar cysts 
arthritis  
asthma 
sleep apnea 
mild cognitive 
impairment 
 
 
POTS 
MCAS 
 
CFIDS & 
CFS [2015] 
 
ME5 
 
Elizabeth 
 
iron anemia 
stress (somaticized) 
 
uterine fibroids* 
insomnia* 
sleep apnea* 
 
 
SEID [2015] 
 
ME6 
 
Karen 
 
asthma 
 
 
scoliosis  
chronic bronchitis* 
Epstein-Barr virus 
MCAS 
fibromyalgia* 
IBSC* 
orthostatic intolerance 
 
CFS [1986] 
ME [2018] 
 
ME/CFS 
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Kelli 
 
stress 
deconditioning 
lupus7 
 
 
 
valley fever* 
MCAS 
POTS 
Epstein-Barr virus 
 
CFS [2015] 
 
ME8 
 
Lena 
 
none9 
 
mono10 
 
ME/CFS 
[2012] 
 
ME/CFS 
 
Note: acronyms 
CFIDS = chronic fatigue and immune dysfunction syndrome 
CFS = chronic fatigue syndrome 
MCAS = mast cell activation syndrome 
ME = myalgic encephalomyelitis 
SEID = systemic exertion intolerance disease 
 
* Indicates a comorbid diagnosis that participants currently (or formerly) receive treatments for, 
however, it was also used by clinicians as a distractor diagnosis, an inaccurate explanation for 
ME symptoms, which deterred them from finding answers about ME. 
 
1 Distractor diagnoses are guesses that clinicians made based on the participant’s 
symptomology; these turned out to be inaccurate explanations. These diagnoses were given 
when the participant started seeking medical care at the onset of ME symptoms. Participants do 
not have these conditions. Some distractor diagnoses were made in good faith but ultimately 
reflected a lack of knowledge. Distractor diagnoses that were made in bad faith, as evidenced by 
participant experiences, are marked with an ^ symbol. These are often due to physicians’ failure 
to engage best practice. 
 
2 Comorbid diagnoses indicate accurate diagnoses that participants have in addition to ME or 
are conditions that link back to the symptomology of ME, like insomnia. 
 
3 Diagnosis refers to the variation of ME the participant was first diagnosed with (usually CFS, 
CFIDS, ME/CFS, or ME, depending on what year they were diagnosed and what information 
their doctor had been exposed to). This does not include previous illnesses or diagnoses that 
were treated before onset. 
 
4 HAE = hereditary angioedema. This diagnosis is still inconclusive. 
 
5 Cheryl notes: “I prefer ME but will often use ME/CFS because that is what most agencies are 
using now. Depends on who I am talking to. Among friends or family, it is ME. When 
communicating to educate others, it is ME/CFS.”  
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6 Elizabeth notes: “I prefer ME, but I think SEID is ok, too. Anything that more accurately 
reflects the nature of the illness and my experience than CFS (e.g., it's not just fatigue).” 
 
7 This diagnosis was seriously investigated as a possible explanation; however, after recent tests 
it has been ruled out. 
 
8 Kelli notes: “I tell people ME, and when they don't know what that is, I tell them ME/CFS, and 
when they don't know what that is, I blush and tell them I have Chronic Fatigue Syndrome.” 
 
9 Because Lena was able to get an ME diagnosis quickly, she did not have distractor diagnoses. 
 
10 Lena notes: “Mono was a preceding diagnosis. Mono is what triggered the MECFS, so they 
did not occur at the same time.” 
 
 
Diagnoses of Trial and Error76 
Many diagnostic terms that came up in the interviews represent a category of 
conditions that people with ME do experience but were not the explanation for their ME 
symptoms (see Table 2 for comorbid diagnoses). For example, doctors told Ashanti her 
symptoms were due to her continuing asthma, and Karen’s doctors kept treating her for 
chronic bronchitis. For Elizabeth, her “main doctor decided that my uterine fibroids, 
which I've had for over a decade, were suddenly the problem and that I should have them 
removed and then I would feel fine. So I went to [another city] to have them removed.” 
This was not effective, nor were the dietary supplements they previously offered. 
In other cases, participants were given new possible diagnoses. For example, 
doctors told Kelli her symptoms were due to a new onset of valley fever, or ‘stress’, or 
possibly lupus. A few months after fibroid surgery proved to be an insufficient answer for 
                                                 
76
 tl;dr - Before receiving an ME diagnosis, participants navigated a series of other diagnoses that were 
ultimately inaccurate, comorbid, or unclear.  
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Elizabeth’s symptoms, she was diagnosed with sleep apnea; the treatment for this 
resulted in just enough improvement for Elizabeth to return (briefly) to work; however, 
under that work load, her symptoms resurfaced in force. Similarly, Ashanti received a 
diagnosis that brought some measure of relief, but was only loosely linked to her 
symptoms, explaining some but not all of her symptoms:  
[The allergist] ran extensive blood work. What he did find was a possibility that I 
had something called hereditary angioedema (HAE). Now at that time I had not 
had any symptoms of it, that I knew of … But then right after that I ended up 
presenting with these digestive system symptoms, which are a symptom of HAE 
… They ran multiple tests. It was decided that it was the HAE. I was given fresh 
frozen plasma. And my symptoms actually seemed to improve.  
… if it is HAE, which is possible … it still didn't explain everything. HAE doesn't 
explain muscle weakness. HAE wouldn't explain the voice hoarseness that I have. 
HAE wouldn't explain the profound fatigue that I have. 
These diagnoses were painstaking stepping stones on the way to understanding what was 
happening to them.  
Other diagnostic terms that came up in the interviews represent a category of 
conditions that participants experience simultaneously with ME. These comorbid 
conditions (see Table 2) may be linked to ME, as with insomnia or pain conditions, or 
they may exist independently from it. For example, Adaline considers ME her primary, 
overarching diagnosis, with other diagnoses underneath it which describe different 
aspects of ME: “Nutritional deficiencies point back to ME, with the mitochondrial 
dysfunction and causing malabsorption … Adrenal fatigue? ME. Insomnia? Goes back to 
adrenal fatigue, goes back to ME.” One diagnosis that comes up frequently in discussions 
of ME is the Epstein-Barr virus (EVB). Adaline notes that she “always tested positive for 
Epstein-Barr as if I have [an] active infection.” The CDC reports that 90% of adults test 
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positive for EVB, but this statistic does not differentiate between those who currently 
have the viral infection and those who have previously had the infection; in either case, 
antibodies are present, which is what clinicians look for in a blood test before making an 
EVB diagnosis (Centers for Disease Control and Prevention 2018C). Because this virus is 
so prevalent among the general population, its specific role in the onset of ME has been 
difficult for researchers to determine.  
 Some diagnoses do not describe the ME symptoms that participants experience. 
These are conditions that people have in addition to ME. Often, lifelong mental health 
issues that are under successful treatment are conflated with chronic illness symptoms. 
Adaline: Now the [diagnoses] that don't go back to ME—which it makes me 
really mad—when people say, oh you're just depressed. My mental illnesses, 
those I believe are separate from ME. I've had them all my life because of my 
childhood and they also run in my family. So those are the only ones I say don't 
go back to ME, but everything else I think [does]. 
Participants reported that even when they were actively treating their mental health issues 
with a professional clinician, doctors in other specialties would still place the blame on 
anxiety or depression. This messiness with negative stigma about mental health 
conditions made it important to participants to highlight the need for therapy and 
emotional support to get through the life-altering impact of chronic illness, since others in 
their patient support networks exhibit trepidation about bringing up mental health care: 
Lena: I have a therapist who I see once a week or every couple of weeks and so 
that's been really helpful … This is just a very difficult life … I think that it’s 
really important for people with these kinds of diseases, that are so tough 
emotionally and have so much stigma, to have therapy or some kind of emotional 
support structure. 
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Kelli: I have been seeing a counselor since long before I got ill. I was seeing her 
for childhood issues … we'd made some serious progress and I was getting ready 
to quit when I got ill and then I thought, I better keep it going. So I still see her 
every six weeks or so and it's been really helpful. I find actually that most of the 
doctors I've seen, when I mention that I'm seeing a counselor, have been 
respectful of that. They've said, good, you probably need to, it's probably 
important to do that. So most of them have been pretty good.  
Not every diagnosis from clinicians falls cleanly into the categories of comorbid 
conditions or misdiagnoses. There is a grey area of unconfirmed diagnoses that may or 
may not be answers for participant symptoms. Some diagnoses remain inconclusive, such 
as HAE for Ashanti, meaning that their doctors take it heavily into consideration when 
pursuing treatment options or adding diagnoses to their list, but opinions between doctors 
may differ on whether it is the best explanation of the symptoms. Additionally, 
participants mentioned specific diagnoses that they were not diagnosed with, but were 
tested for, in order to rule out other options before arriving at the ME diagnosis. 
Experiences with Institutions 
On a macro-level, medical institutions play an important role in the experiences of 
individual patients as they are seeking care. The term ‘medical institutions’ as used here 
refers to conceptual centers of medical knowledge (medical journals, research facilities, 
government health organizations, and professional organizations for clinicians) as well as 
medical locations (hospitals, clinics, and doctor’s offices). These are sites where 
institutional betrayal occurs. This is the landscape people with ME have to navigate. In 
the following sections, I will address the institutional-level hurdles that participants face, 
including, 1) harmful narratives of disbelief, psychogenesis, and recovery, and 2) the 
ways medical systems and procedures produce systemic barriers for people with ME. 
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Harmful Narratives77 
Disbelief as a medical narrative. The lack of credibility given to patients starts 
at the institutional level, and subsequently seeps down into clinician attitudes and 
behaviors. According to dominant medical norms, physicians hold the knowledge and 
dispense it to the patient (Conrad & Schneider, 1980). This social narrative about 
credibility dictates whose report is valid, valued, and listened to. It dictates whose 
knowledge is perpetuated and acted on. Having socially sanctioned legitimacy in addition 
to knowledge (whether experiential or academic) is power; currently that power is 
imbalanced in patient-physician interactions (Dusenbery, 2018). 
When asked what barriers she encountered during her search for treatment, 
Adaline pointed immediately to the norm of physicians not believing their patients: 
“Obviously a lot of barriers are disbelief. Doctors not believing you.” Other participants 
spoke about the harms of disbelief as well: 
Elizabeth: [My doctor] told me that she couldn't find anything wrong with me and 
therefore there was nothing wrong with me. And she wouldn't support me 
continuing to have medical leave even though I was no better than when I first 
started seeing her, and in fact may be a little bit worse … at that point even just 
having people who believe that there was something wrong with me was 
important, I think. 
Kelli: I feel like I have to convince them. I don't know how to convince them. 
They don't understand that even sitting in their office is a difficult thing for me. 
                                                 
77
 tl;dr - For people with ME, access to care is obstructed by assumptions that permeate the medical field: 
disbelief (the patient is not treated as a credible source of knowledge), psychosomatic cause (unexplainable 
symptoms are dismissed as psychological and not given treatment), and recovery (assumption that chronic 
illness will eventually go away). 
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Disbelief also falls into patterns of gender bias, which plays a significant role in 
patients’ experiences when they enter a doctor’s office, particularly in relation to having 
their symptom reports believed (Dusenbery, 2018; Newton, Southall, Raphael, Ashford, 
& Lemarchand, 2013). A study of medical interns showed that they responded to two 
identical cases of neck pain with different treatment recommendations. When given the 
case labeled with a male name, the interns suggested lab testing. When given the case 
labeled with a female name, the interns recommended psychoactive drugs or referred the 
case to a different doctor (Leresche, 2011). O’Leary (2018) claims that, due to the history 
of hysteria, “psychogenic diagnosis is entangled with an assumed lack of autonomy in 
women” (p. 9). Ashanti experienced this with her pulmonologist: “[He] didn't listen early 
on, he just kept saying that it was a severe asthma exacerbation. And maybe if I had been 
a male patient, maybe it would have been different, because doctors tend to not believe 
women.” Kelli said that sometimes she would resort to taking her husband with her to 
appointments, for the express purpose of creating a situation where her physician would 
pay more attention: 
I know a lot of this [harmful medical treatment] was because I'm a woman. I 
know that I was getting less attention than I was when my husband was there. 
There were doctors who would literally turn and talk to him. I know I'm a middle-
aged woman with vague complaints, you know, but my life matters to me just as 
much as their professional, highly-paid lives matter to them. 
This environment of disbelief is a barrier for patients with ME as they seek medical care. 
As Adaline put it, “A lot of doctors don't believe that their patient is a subject matter 
expert in their own illness.” 
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This narrative is powerful enough that some people with ME struggled to believe 
it was a real thing when they were first diagnosed. After a considerable search, Cheryl 
met with an infectious disease doctor who told her she had chronic fatigue syndrome: 
Cheryl: I'm like, I don't believe in that. That was my response. I don't believe in 
that. And that kind of took her [the infectious disease doctor] back for a minute 
and she said, "Well, I hate to be the one to tell you, but everything—all these 
symptoms you're describing—fit into that diagnostic category perfectly.” 
And I said, they do? And she said, “Absolutely.” 
And I thought, there is no way I have what I perceive as a psychosomatic illness 
because I'm a medical professional and I work in psychiatry and we have those 
kinds of patients. We refer to them as somatic and histrionic and we believe that 
their physical illnesses are not real … And in my brain I said, I'm going to figure 
out what this is and then I'm going to make sure I let this woman know she was 
wrong. She misdiagnosed me. That was literally my decision.  
But my husband and I walked out of there and we talked about it. He was a med-
surg nurse, so his experience was much like mine, where nobody really believes 
people who say that they have these sorts of illnesses, but he said, "Let's look at 
the paperwork."  
 … and we went down the list. And I had like twenty-one out of the twenty-three 
[symptoms]. And so my husband and I looked at each other and it was like, holy 
shit, she's right. This well-respected, from a world-class institution, doctor is 
saying this is not in your head. This is a real thing. This is physical, even though 
we don't know exactly why … My husband's like, “Look, there's treatments, 
maybe this is something.” So, I was like, okay. I still don't buy it. I still think I'm 
going to figure it out. But it's pretty hard to be in denial at this point. 
Cheryl indicated her medical training as the source of her initial disbelief and indicated 
that her husband had to overcome the same ideas due to his training as well. But this 
belief is not limited to medical personnel. The narrative of disbelief radiates out into 
public consciousness, as evidenced by the responses of people with ME who are not 
former nurses or clinicians. 
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Kelli: In the spring the Institute of Medicine's 2015 report on chronic fatigue 
syndrome came out. My daughter heard about it on NPR and she called me, and 
she said, “I think that's what you have.” And I said, I think that's in people's 
heads. I'm so embarrassed that I said that now, but I just—to tell you where my 
head was with it—I don't think that really exists.  
She said, “But it sounds right.”  
I went home and I looked at the thing and I was like, wow, I have all of this.  
Even in the absence of direct disbelief, participants knew that this diagnosis was 
undesirable. They responded to this diagnosis, at first, from a place of denial: 
Elizabeth: So [the Institute of Medicine] came out with the SEID term and the 
new standards for diagnostic criteria, and I fit this criteria to a T. 
Interviewer: And your primary care knew about it? 
Elizabeth: Yeah. And she told me, “This is what I think you have.” And I was just 
like, no, I don't want to have this. 
 At one point, Elizabeth thought sleep apnea was the full answer. However, the treatment 
for sleep apnea did not fully restore her health; it could not be the whole story. It was 
only after she delved into the medical literature that she realized ME “isn't a wastebasket 
diagnosis, it's just been treated like one.”  
Participants in this study reported their experiences encountering disbelief from 
clinicians. This trend is supported by Smith’s (2017) findings, where patients reported 
that healthcare professionals did not respond to their concerns and denied the accuracy of 
their negative reports. Smith’s work creates a robust discourse surrounding institutional 
betrayal, which she defines as the trauma experienced by an individual when an 
institution they trust or depend on becomes a source of harm (Smith & Freyd, 2014). 
Medical institutions fit this description. Smith (2017) found that 66% of participants 
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reported institutional betrayal in their healthcare experiences. The widespread nature of 
these findings underscores the need for change at the macro-level, not just at the micro-
level between patients and providers. As previously discussed78, patient trust can be 
categorized as fiduciary trust (“They will help me”), confidence (“They are able to and 
qualified to help me”), or satisfaction (“They helped me”); fostering an environment of 
trust is beneficial for healthcare organizations, as it is linked to higher rates of 
recuperation and lower cost (Smith, 2017). However, the medical narrative of disbelief 
persists, supporting harmful macro-level norms that result in harmful micro-level 
relationships between physicians and patients. 
It should be noted that medical curriculum is moving closer to patient-centered 
practices, as evidenced by the recent rise of medical humanities programs within schools 
of medicine as well as the increasing presence of patient advisory boards (Graham, et al. 
2016; Chu & Price, 2018). However, it remains widely documented that patients are 
routinely treated as non-credible, non-authoritative sources of information about their 
own bodies (Spandler, 2009; Edwards, 2008). Because of this persistent dynamic, the 
knowledge offered by this study’s participants exists as documentation of patient 
autonomy, authority, and credibility. 
Psychosomatic cause as a medical narrative. Medical institutions have nurtured 
the prevalent belief that medically unexplainable symptoms originate from the mind, 
while simultaneously failing to build robust mental health care protocols (Spandler, 
2018). This belief protects the institution at the cost of the patient (O’Leary, 2018). 
                                                 
78
 See Literature Review. 
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Clinical conceptions of ME and other chronic illnesses that depend on harmful 
psychosomatic narratives were previously discussed in the Literature Review. Specific 
participant experiences with individual physicians who used the psychosomatic narrative 
are included later in this chapter. According to O’Leary (2018), the medical norm of 
frequent assumptions of psychological causes for patient symptoms raises two issues 
about informed consent: 1) “When a patient consents to medical care from her doctor for 
specific bodily symptoms, does that include consent to evaluations and recommendations 
for psychosocial cause if the patient has never imagined such causes might be possible?” 
and 2) “How could a physician successfully explain, and support, [the] conceptual leap 
[from MUS to psychogenic diagnosis]?” (p. 8). For question one, many physicians 
operate as if the answer is automatically yes. Question two calls for physician 
accountability, in the form of justifying their direct leap from uncertainty to psychogenic 
explanations without the sort of deliberative steps that are generally expected to support a 
diagnostic conclusion. 
This psychosomatic narrative exists alongside a coinciding lack of mental 
healthcare resources, as referenced in Cheryl’s interview in the context of suicide 
interventions:  
Interviewer: What do you imagine that avenue being, if there was a robust 
medical response to suicidal ideation in chronic illness communities? 
Cheryl: Well, I think, you know, it's unfortunate because there just isn't adequate 
resources in mental health training to manage schizophrenia, the chronically 
mentally ill, and the people with chronic physical illnesses, but if specialty 
providers for ME/CFS … could provide some kind of psychological intervention 
that would be useful. Part of it is just getting people to reframe their perception of 
the illness, for example, and then part of it is actually providing help with things 
like insomnia, which is definitely a suicide risk. 
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People with chronic illness and people without chronic illness may need mental health 
services at some point in their lives. As it stands now, the psychosomatic narrative 
reinforces stigma without addressing large-scale improvements for mental health 
treatment (Spandler, 2018). 
 ‘Recovery’ as a medical narrative. Since the medical model is limited by 
protocols that only have the bandwidth to deal with acute illnesses, many clinicians and 
community members assume that people with chronic illnesses like ME will eventually 
‘get better’ or be ‘cured’79 by treatments. Interview participants in this study do not 
identify with the word recovery; it does not mesh with their illness experiences. 
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 Problematizing the concept of a ‘cure’. Conceptualizing physical difference in terms of a ‘cure’ is one 
aspect of the medical model that is detrimental for communities who value their identities of disability (the 
deaf community, as well as cerebral palsy, autism, and others). The continued refrain is that mental, 
emotional, or physical difference is not disease. The medical model, along with the concept of a normative 
body, is widely rejected among scholars and advocates in disability studies (Adams, Reiss, & Serlin, 2015), 
which uncovers the violence done in the name of ‘treatment’ and ‘rehabilitation’. They reject hegemonic 
claims that health is the result of a ‘normal’ body. As a field, disability studies interrogates normative 
standards of ability. At the same time, the idea of cure is essential for communities who grapple with ME 
and other chronic illnesses, particularly if the chronic illness is debilitating and painful. Advocacy groups 
such as MEAction and Dysautonomia International focus their efforts on funding and medical research in 
order to work toward better treatments, medical care, and if possible, a cure. Health equality movements 
led by ME patients align with the disability studies goal to promote the message that marginalized voices 
matter in policy, government, and community. Both groups seek to disrupt systems of biopolitics that 
create disability in the first place. Oliver (2012) argues that modern society, built on a capitalist ideology of 
individualism, places value on a narrow range of abilities (work and production) and does not provide 
space for communal considerations or people who cannot produce. In his view, medicalization 
continuously replaces social action and doctors are in charge of the disability experience instead of an 
interactive coalition of community members. Applying Siebers’ (2008) work to this conversation creates 
nuance, as he writes that disability identity must address and embrace both the negative and the positive in 
order to be a critical, effective category that crosses the boundaries of all other human categories, while 
also stating that his field is not interested in treatment, and instead frames human experience within social 
structures, both physical and otherwise. Critical disability studies is focused on this process of 
deconstructing both the social and medical models. 
In practical terms, communities that eschew the ideology of cure and those that seek cure would benefit 
from joining forces against ableist policies. Dysautonomia International and other advocacy groups 
primarily use medical terminology to spread awareness about dysautonomic conditions; however, they do 
so in a patient-centric manner (Dysautonomia International, n.d). This complicates the narrative by relying 
on diagnostic measures (empirical, medical knowledge) to describe patient experiences (qualitative, local 
knowledge). Within the literature of disability studies, chronic illness patients play a role, as Nepveux notes 
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Ashanti: With a chronic illness, even if you reach a point where your symptoms 
are very minimal, it's a chronic illness. So, it's lifelong. The illness is always 
lurking. And so, I think ‘recovery’ is misleading … I've read [about] a lot of ME 
warriors who have been sick for many years, have experienced periods where 
they feel pretty good, almost but not quite back to normal, and then that went 
away … So, I think recovery is a little misleading and not really accurate and it's 
more, I would say, like remission, relapse; those type of words, I think are more 
accurate.  
Karen: I never use [the word recovery]. That's why I'm laughing, because 
honestly, all these years the word recovery has never been in my vocabulary. I 
don't use that word. And when you say recovery to me, I laugh because there's no 
recovery. I've been ill since I was sixteen … so I've never been well. I can't relate 
to the word recovery at all.  
Adaline: I don't know that any of my doctors have used recovery as a—well, 
maybe the first primary who actually started to take me seriously, they might have 
thought that they could give me the right hormones, and I'd recover. But I don't 
really blame [them] so much, since it was at the beginning of my process of 
figuring out what was wrong with me, and I wish it had been it. 
… Society in general doesn't understand the idea of not recovering from an 
illness. 
… It's not really a term that's been used by a lot of doctors, I don't think, in my 
case. But it's been more—it's not necessarily that term specifically, but the idea of 
“Are you better?”, and “Are you well?” That has come up a lot. 
… no, I'm sick, I'm still sick, I'm not going to get better ... it just doesn't compute. 
Because all the illnesses that are given attention, like cancer, there's a path, there's 
a treatment regimen, and then you either recover or you don't. You don't ever see 
anybody who's in between. 
                                                 
in her scholarship about patient-driven advocacy: “Activists with chronic fatigue and immune dysfunction 
syndrome . . . for whom in-person activism is largely inaccessible, engage from home via the Internet” 
(2015, p. 24). Consider the example of Jennifer Brea’s #MillionsMissing campaign, which gained traction 
via online collaboration. The goals of this campaign are centered on the needs of people with ME: “1) 
Research commensurate to the disease burden; 2) clinical trials to secure medical treatments for ME; 3) 
accurate medical education and improved clinical care; 4) commitment by our governments that is serious 
and urgent” (MEAction, 2016A). The influence of the medical model runs strong in these demands; 
however, they do so by drawing on the most beneficial aspects of the medical model—solid research, 
innovative treatments, and improvement of quality of life. 
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People with chronic illnesses who have improved over time live in that middle space 
where their condition isn’t fatal, but recovery is out of the question. In conversations with 
their friends, family, and community members, recovery isn’t a useful concept. Social 
expectations constructed around recovery place undue pressure on people with ME. In 
our current system, the entire responsibility for getting better falls on patient, and cultural 
beliefs reinforce the idea that a sick person is a bad person (Conrad and Schneider, 1980). 
These social beliefs make the concept of recovery difficult for people with chronic 
illnesses. 
When asked about their own definitions for the term ‘recovery’, participants 
emphasized the ability to return to ‘normal’ life: 
Cheryl: Fully recovered, to me, means able to work full time, able to travel, able 
to engage in your previous level of activities, which includes sports and fitness 
type activities, with maybe a little decline due to the natural aging process... 
I'm still okay, but okay is different than recovered … Okay means that my quality 
of life is sufficient that I choose to live. Recovered is—my quality of life 
exceeds—if I ever was fully recovered, I imagine just being this happy grateful 
person after the suffering that led me there and how I see my peers suffer. 
 … [recovery] includes my ability to work and make money again.  
Lena: Recovery is different than remission. Right? Recovery would mean I don't 
have the disease anymore and I don't have any symptoms. That would be a full 
recovery. I don't know anyone who's had that situation.  
In terms of remission, I think remission is basically the same, except your 
symptoms have gone away but you still have the disease in your body and you 
still know that and so you still take preventive steps to keep it from coming back. 
Like they say with cancer, you never recover from cancer, you always have 
remission, because it can always come back. And so, I think that's probably at this 
point where we are with the science, more realistically. 
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These definitions sometimes clash with how clinicians conceptualize recovery in abstract 
ways. For example, Elizabeth met with a physician whose definition of recovery had no 
bearing on her lived reality:  
Elizabeth: His experience is like, if you rest enough, you'll get a little bit better.  
And I was like, okay, but would I ever be able to work?  
And he's like, well probably not, but you can recover.  
And I was like, but can I work?  
Probably not.  
So, I mean, his idea of recovery is different. 
Living with the day-to-day realities of ME changes these conceptual terms into concrete 
terms. For some participants, this results in a combination of optimism and realism about 
recovery: 
Ashanti: We don't even have any treatments, so we're so far from a cure it's not 
even funny. I don't even think in terms of those. Of course, I'm hopeful, I hope for 
a miracle. But realistically—I mean, there's illnesses that have actually been 
adequately studied for a number of years and there are still no cures for those, so 
it would be naive to believe that my illness, which is very poorly studied and 
poorly understood, is going to be the one that suddenly, miraculously has a cure in 
a short period of time. Science just doesn't work like that. 
Kelli: I think I used to swing more wildly from crashes so even though I rarely 
felt good, sometimes I would have a half a day or a day and a half and I would 
start planning for my recovery … I would have a little bit of a break and I would 
start planning. 
Cheryl: I have fantasies about what I'd like to do. I have difficulty really believing 
that my brain function will come back and that I'll have enough energy to be able 
to have a career again or play sports again. It's hard to imagine being that much 
better, but I've gotten this much better. So, I'd like to keep those fantasies going 
… I think it’s super important to believe in the possibility of recovery …  
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Asking the interview participants about recovery proved to be a highly emotional and 
difficult topic. During Cheryl’s interview, her narrative about recovery was marked by 
starts and stops, as it was hard to construct thoughts around the idea: “You know, it's hard 
to plan anything with an illness like this.” For Elizabeth, the word recovery is painful, 
and she shared her struggle to even think in those terms:  
Interviewer: What does the word recovery mean for you? And do you even use it? 
Elizabeth: No. It feels impossible. [pause] Wow, that brings up a lot of emotions. 
I don't know. I know that people have gone into remission and been able to live 
fully active lives, but they're pretty few and far between. And I think even then, if 
they're fairly knowledgeable about the disease, which having been completely 
ignorant about my own disease for so long, I recognize that many people are 
aware of the possibility of both relapse and also that maybe they aren't quite back 
to what they had been before.  
… it's a funny thing because there are people who say they've recovered. They 
tend to do a lot of weird stuff, right? Like they don't live fully normal lives. They 
eat weird diets, they take tons of pills, they sleep and eat at weird times of day, 
whatever it is. To me, I guess, recovery means that you would be totally back to 
the way you had been before. And maybe that's not ever really true because you 
never go back to the way things were before anything. But just in terms of that 
you would have all of the capacity that you had before. I guess if you still had to 
be on medications for that recovery to persist—that seems reasonable—that still 
seems like recovery, I guess … I don't allow myself to think that much about, or 
dwell that much on, remission or recovery. I do things and I make plans to do 
things that I hope will help me get into at least some kind of temporary remission, 
… I think because of the Fukuda definition and so many questions around, well, if 
they recovered do they even have my disease? You know, that's such a big 
question in the field, among the patient community. And then I think there are a 
lot of questions about it in the medical community. And it's just hard because I 
don't feel like we have enough information to know what recovery can look like, 
how often it really does happen, or doesn't.  
I have a lot of fear around recovery too, because I know I don't want to go back to 
the job that felt like it caused my—I mean, I know that it didn't cause it—but I 
don't plan to go back into teaching science or doing research.  
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Interviewer: It's a really high pace of life.  
Elizabeth: Yeah… I think even if I recovered to a considerable degree, I have 
trouble imagining—I think I just—I can't even wrap my head around it. I have 
trouble imagining a time where I would have energy enough to live a normal life 
and do that job, and still feel like I wasn't dying.  
And then there's a lot of fear around, well, what if I get just enough better that I 
can work some—what kind of job could I do? And, I don't know, maybe I have 
less confidence than I used to. I used to just be like, well, I'll figure it out, I'm 
smart, I have a PhD, I can make this work, but it feels like everything is difficult 
and maybe that's partly just because of my illness but it's just so hard to point at 
… the whole idea of what I would do for work and what I'd be capable of 
physically—it is just such a big question. Yeah, makes it hard to think about. 
Those are my musings on recovery … I won't pretend that there aren’t a lot more 
complex emotions going on underneath it all but … I want to speak cogently 
rather than break down in tears. 
Elizabeth’s narrative shows how abstract medical terms are very real to people with ME, 
who live the everyday experiences that these terms are supposed to describe, but often 
fall short as meanings are separated from their context. 
Systemic Barriers80 
 In addition to, and intertwined with, the harmful conceptual narratives in the 
medical model, people with ME also face systemic and procedural barriers as they 
navigate healthcare systems. 
The system is not designed for chronic illness. At an institutional level, the 
medical systems that dictate physician training, medical record keeping, insurance 
coverage, cost of healthcare, and disability benefits create sizable barriers for people with 
ME.  
                                                 
80
 tl;dr - Large-scale issues such as inadequate physician training, the cost of healthcare, lack of 
information about ME, and lack of ME specialists create barriers to care. 
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Elizabeth: If we're just thinking about what the medical community does with respect 
to chronic illness, I think that there's just a general problem with the medical 
community not being set up to engage with people who have higher medical needs, 
right, and that starts with a general dismissal of anybody who has multiple 
complaints…  
I don't think anybody has illusions that this system works well. You know? It doesn't 
work well for preventive care, it doesn't work well for complex patients. 
Certain procedures in our current healthcare system, discussed below, stood as 
roadblocks to the people with ME that I interviewed. 
Physician training. The communication methods and norms of behavior that 
physicians leave medical school with have a direct impact on patient experiences.  
Interviewer: In those times, in those moments in clinics when the physician is 
dismissing whatever it is you're reporting, what changes do you think could 
happen in those patient-physician relationships?  
 
Lena: Well, I mean, not much I can do from my end because I'm so sick, I can't 
even speak … I'm not the one who has the problem in this interaction, right? It's 
them being rude, dismissive, uncompassionate. They're really not trying to 
connect and support their patient and relate to their patient, they're reacting from a 
place of ego and closed-mindedness. So, I think you just have to do a better job 
training physicians. 
In addition to explicit training, Adaline points out the cyclical nature of discrimination in 
medical schools: 
Adaline: Logically, it seems probable that medical students are also being poorly 
treated if they have a disability, which likely has the two-fold result of disabled 
people not pursuing a medical career, and those people who do stay in medical 
programs are taught that it’s okay to treat those with disabilities as less than/other. 
They likely aren’t even taught explicitly how to work with people who have 
illnesses that aren’t easily solved and/or cause disability. Those lessons then stay 
with them as they go into their medical practices, which leads to a lot of the abuse 
[of] patients in general– and those with ME/CFS, a difficult to diagnose illness– 
experience from doctors. 
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Not only does current training leave clinicians unprepared to address chronic 
illness, the pressures placed on them to run a lucrative practice place them in a tough 
spot. The financial incentive structure of medical practice causes direct harm to patients 
with chronic illnesses. 
Elizabeth: A fifteen-minute exam is just never going to be enough. And the 
system doesn't reward the deep kind of work that certainly ME and probably a lot 
of other more complex multi system diseases need…  
My impression is that at least an MS doctor knows how much time they need to 
spend with a [patient], and I would say our very expert clinicians do, but the rest 
of the clinical world isn't set up for that. If you go in complaining of chronic 
fatigue syndrome, they may or may not even write it in your chart, and they may 
or may not even know that it leaves you at risk for certain other diseases or issues. 
As expressed by Elizabeth in her interview, clinicians often do not have the training to 
know approximately how long they should be sitting with a chronic illness patient during 
an appointment. On top of that, physicians are under pressure to streamline appointments 
to maximize profit. Studies have shown that physicians will prioritize the things they are 
paid for, even at the expense of accurate treatment. In one medical network in St. Louis, 
the number of cataract surgeries dropped by 45% when physician reimbursement 
changed from per-surgery to salary (Shrank, Ettner, Slavin, & Kaplan, 2005). This shows 
that when other influencing factors are controlled for, the method of physician 
reimbursement dictates the number of surgeries performed in that medical network. This 
kind of decision-making is incentivized by the medical system and is dangerous to 
patients. 
Insurance coverage. Insurance is a topic that came up frequently in the 
interviews as an example of a systemic barrier to care. 
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Adaline: Insurance obviously needs a huge overhaul. They'll send you these 
educational leaflets on things to help with pain and those things will include 
acupuncture, but they won't pay for acupuncture … insomnia is a huge issue and 
[I have] horrible sleep, just horrible sleep, and [my insurance] refuses to cover a 
sleep study. My psychiatrist sent a letter, my primary sent a letter, I sent them data 
off of my watch showing that in the previous twelve months before that date, I 
had not slept at all 51 days, and they still denied it. 
For people with ME, their unique symptoms make navigating insurance plans even more 
fraught, due to the effects of cognitive limitations and brain fog. 
Ashanti: That's very frustrating for me because you often have to read. You have 
to know what you're signing up for. So, I find myself doing phone calls instead of 
trying to read the stuff online. And I try to let the people tell me and then I try to 
take notes that are abbreviated so that I can actually understand them, instead of 
[in] paragraph form, because there's no way that's going to stick. So, it's hard. And 
my ability to focus, concentrate—I become very frustrated when I try to read stuff 
and I can't figure out what I'm supposed to do. Especially if it's something I need 
to fill out … that is so stressful. And I was never like that before. I was always an 
excellent writer … so to be unable to formulate my thoughts onto paper for short 
answers is extremely frustrating and I often end up with things that were past due 
... but I can't meet the deadline because every time I sit down to look at them, my 
brain is like, no, we can't do this, no. 
These issues with navigating health insurance, while common across various illness 
categories, are particularly difficult for people with ME due to the effects of post-
exertional neuroimmune exhaustion. 
 Notably, one participant reported that insurance does not pose a barrier to her: "I 
have insurance and insurance has done okay. So that, for me, has not been a huge 
barrier.” Another participant couched their description of insurance coverage with the 
caveat that they feel fortunate to even have insurance and others have it far worse. 
Cost of healthcare. Participants reported the burden of medical care costs on 
themselves and their families. Lena characterized the cost of treatments and medical 
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devices like heart rate monitors as “incredibly expensive.” Elizabeth faces the decision 
between buying supplements that are cheaper or buying ones that work well for her but 
are “very expensive.” Cheryl reported that she “spent $8,000 getting these injections in 
my hip and my neck and my arms. And it did not make me well … we have depleted our 
savings, believe me, through all of this, all of these treatments paying out of pocket for 
specialists $500 an hour.” The cost of insurance without employment takes a toll as well. 
After she was unable to continue working as a nurse, Ashanti “had to go on COBRA 
which costs a fortune.” These costs for treatments, traveling to specialists, and paying for 
insurance plans create financial instability for these participants.81 
Disability benefits. The system in place to provide financial help for those who 
are unable to work for medical reasons ends up creating more barriers for many people 
with ME: 
Kelli: I finally was able to apply for disability benefits … I have a hearing in 
February and so I was finally able to apply for that because without a diagnosis I 
couldn't even get started, and again I'd been out of work for nearly two years by 
that time … the disability system is terrible for things like that. To make you wait 
so long is to make you stay sick so long. It's so counteractive. They want you to 
get better, you want to get better, but they put you in limbo for all this time … 
something needs to be done with it because it's such a ridiculous, compassionless 
system.  
Adaline: Applying for disability has been a complete nightmare. I've been denied 
three times. The judge didn't believe me; my primary didn't submit the 
prescription for my rollator, the judge acted like I was making up needing it … 
disability says I should be able to work, and I tried until I broke myself. 
Elizabeth: I moved from [city] because my initial application for long-term 
disability was denied and I was running out of money. So, I moved to my mom's 
                                                 
81
 For more about the financial impacts of this illness, see Chapter 2, “This disease obviously caused a lot 
of problems”: Dealing with loss. 
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house … But right now, even though I now have long-term disability coverage, 
there's just the fear that at some point the insurance company will find some dumb 
excuse, that won't be legitimate but will be hard to fight, and then will kick me 
off. So, I just feel financially insecure in various ways …  
Between the cost of medical care and the precariousness of disability benefit eligibility, 
financial security goes by the wayside. 
Lack of options. Harmful narratives and a system that was not designed to handle 
chronic illness contribute to a continuing lack of options for people with ME. This topic 
emerged in the interviews, as participants returned frequently to the theme of not having 
options available to move their medical care forward. Their experiences fell into three 
broad categories: lack of general clinical knowledge, lack of specialists, and lack of 
research. 
General clinical knowledge. When participants met with both specialists and 
primary care providers, they encountered a general lack of information about ME. Many 
clinicians had not received medical training about ME or other neuroimmune diseases, 
and therefore were not able to identify it. A study of medical curriculum found that CFS 
represented only .09% of medical textbook content, a lower percentage than other 
conditions that are less prevalent (Jason, Paavola, Porter, & Morello, 2010). This results 
in clinicians moving in inaccurate directions with their subsequent diagnoses and 
treatment plans.82 Adaline commented that it “took a while to find—obviously—to find 
out what I actually had.” This can prove dangerous when patients cannot rely on medical 
providers to be proficient in possible complicating factors, as Elizabeth indicates: 
                                                 
82
 Refer to the earlier section in this chapter, Diagnoses of Trial and Error. 
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Because I know myself and I know what things I think I'm at risk for, I can go 
into surgery and not worry that anesthesia will be a problem. But many other 
people with ME shouldn't be that cavalier about it. But I know that if I told an 
anesthesiologist, I have chronic ME, they won't know what it means. And if I say, 
chronic fatigue syndrome, they won't think it's something that they need to 
consider. 
She later notes, “That's why I work hard to try to get us into more medical school 
curriculum.” 
Specialists. Gaining access to ME specialists is particularly difficult when 
medical institutions are failing to educate clinicians in this area. A recent study with ME 
and CFS patients found that 52.2% of participants had never seen a specialist, with 
geographic distance being the number one barrier, followed by cost and insurance 
coverage (Sunnquist, Nicholson, Jason, and Friedman, 2017; see Figure 1 in this article 
which maps the percentage of patients who see a specialist by region, ranging from 0% in 
middle America to 17% in Middle Atlantic states). Adaline notes the significant burden 
of finding a doctor who knows about ME in her own experience searching for care: “I 
started trying to figure out what is wrong with me. Initially, they just said, oh it's 
hormones, you're out of hormones. Nope. Oh, well, maybe it's your thyroid. Nope. So, I 
went to all kinds of specialists and I did not get my ME diagnosis until November of last 
year.” She saw 41 doctors over the course of three years. 
I saw an endocrinologist. I saw a rheumatologist. I saw a general practitioner. I 
went to physical therapy, orthopedic, pain specialist, neurologist, another 
orthopedic, and other pain specialist—he refused to treat me—mental therapists, 
physical therapy, endocrinologist, psychologist, rheumatologist, 
gastroenterologist, acupuncturist, chiropractor, allergy, dental, eye. 
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Seeking out care from these specialists makes sense when looking at individual ME 
symptoms; however, none of these clinicians were looking at the whole picture and none 
possessed specialized training in ME specifically.  
 Due to the lack of specialists, the wait lists for existing specialists are 
prohibitively long, with no guarantees that the appointment will offer any substantive 
treatments. 
Adaline: The rheumatologist I saw … I waited months for an appointment. I was 
supposed to have one in August, but then he canceled it and I had to wait another 
month. So, it ended up being like four or five months’ wait to see this 
rheumatologist, who then said, “Eh, you have terrible fibromyalgia, try this 
antidepressant, I can't help you.” 
These wait times for specialists are a significant barrier for people with ME. 
Research. Decades of institutional neglect have resulted in sparse treatment 
options, even for people who do manage to find a doctor who knows about ME 
(Dimmock, & Lazell-Fairman, 2015). There are currently no FDA-approved treatment 
options for ME. This presents a problem to patients who are trying to find answers, often 
on their own. 
Elizabeth: I feel like between the fact that there were so many just conflicting 
pieces of information around it, like doctors telling me like SEID is real, and this 
new report says you have this, but still not having any treatment protocol and 
therefore not really being—to me—a useful diagnosis. 
… I started seeing [doctor] who was—is still—one of the thirteen or so doctors 
who know anything about ME. So, she was very helpful in many different ways. 
She also has a pretty narrow arsenal of medical approaches—like medications 
and treatments—that she uses regularly. So, I still wasn't getting treatments. 
(emphasis added) 
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Karen was initially diagnosed with CFS in 1986. In the more than thirty years since then, 
relatively little progress has been made in the clinical understanding of the disease, 
particularly compared with other diseases over the same time period (NAS, 2015). 
Karen: I did not even look at the internet regarding my health until 2017 really. 
And I was shocked to find out that really there had been no research really until 
like 2010 on chronic fatigue syndrome that really made any difference. And I 
thought, oh my gosh, I wasn't missing out on anything. Here I thought it was 
going to jump in and find all these cures and medicines and then I looked at it and 
I thought, wow. That was an absolute shock ... just unbelievable that there hadn't 
been any additional research.  
She assumed that since CFS impacts so many people, there would be some sort of 
progress. These assumptions were based on what she knew about other diseases such as 
cancer or diabetes. 
 Even with this litany of systemic problems and barriers to care, patients still bear 
the burden of responsibility when things go wrong. 
Adaline: The pharmacy would say, oh we didn't get the script ... then I'd have to 
call the doctor and say that they didn't get the script. They say, we sent it. I'm like, 
can you send it again, and then call [the pharmacy again] ... [this is a] bullshit 
process around just getting the care that you need. Nobody wanted to take 
responsibility for who was supposed to be doing what. They all act like it was 
your fault if something didn't happen. Even if you had done everything that had 
been requested of you. 
This responsibility to keep all the plates spinning is placed on patients in addition to their 
cognitive and physical symptoms. These barriers at the institutional level persistently get 
in the way of medical care. They also influence the ways in which individual physicians 
approach their medical practice. 
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Experiences with Individual Physicians 
 Interview participants shared their in-office experiences with individual 
physicians, which revealed patterns of physician behavior. Behaviors that support 
effective medical care will be discussed in Chapter 4; these behaviors resulted in 
participants receiving accurate diagnoses and working out treatments collaboratively with 
their medical team. Physician behaviors that create barriers to care for the participants are 
detailed in the following sections. 
Barriers83 
Half of participant responses regarding barriers to care fall under the category of 
physician behavior. When directly asked, “What barriers to care did you encounter?”, 
five of the interviewees brought up physicians’ responses as the very first thing, 
indicating its importance in their process of gaining care. In one interview, the participant 
first gave the caveat that others have it worse than her, and then immediately talked about 
physician response and sexism. And the last participant talked about insurance coverage 
being the primary barrier, followed by how much energy it takes to navigate the system, 
and then she talked about physicians’ responses. These responses are characterized by 
disbelief, dismissal, psychosomatic assumptions, and expectations about patient behavior 
and appearance. Disbelief can be summarized as “I don’t believe you”—an issue of 
credibility. Dismissal can be summarized as “I don’t care”—an issue of physician 
empathy. The narratives in each section illustrate the specific one-on-one experiences that 
                                                 
83
 tl;dr - On an interpersonal level, between physicians and patients, physician behaviors can create barriers 
to receiving effective care. These behaviors include approaching patients with disbelief, telling patients 
‘you’re fine’, using dismissive and dehumanizing language, assuming psychogenic cause, and giving bad 
faith diagnoses. 
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participants had with physicians, influenced by macro-level beliefs and norms reproduced 
in medical institutions. 
Disbelief from physicians. Narratives of disbelief can occur in the form of 
physicians telling patients “you’re fine” even when they clearly are not. This scenario 
repeated across the interviews, and carried this theme: in clinical encounters, the 
physician assumed that their own opinion was valid, and the patient’s experience 
received little to no validation. For example, doctors told Cheryl, "No, your brain scan 
was fine. You don't need any other testing.” Another physician told her that her case of 
foot drop means nothing, that she was fine, and that it would resolve itself in six weeks. It 
did not. Adaline got blood work back from a physician who said everything looked fine 
on the labs, so she must be okay. Lena had one experience with physician disbelief that 
flipped the usual narrative but still had the same negative results: 
Lena: The doctor was like, “There’s no way you have chronic fatigue syndrome; 
you walked in here. Chronic fatigue syndrome is a really serious disease.” 
Nobody ever thinks that, right? He’s like, “There’s no way you have chronic 
fatigue syndrome. I just did your check, you have all the antibodies to mono now, 
so it looks like what happened is you had a bad case of mono, and it's gone, and 
you should start getting better soon. So, don’t worry about this chronic fatigue 
syndrome.” 
On the one hand, he thought it was a serious disease, on the other hand he was 
completely uninformed, had no clue that it’s a spectrum illness and that I in fact 
had it. And by telling me I’m perfectly fine, he was really putting the nail in the 
coffin because he was basically saying, act normal and do your normal thing, 
you’re fine. So, the exact opposite of “it’s not a disease, you’re fine”, no, “it’s a 
serious disease, you’re fine.” 
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These physicians were comfortable telling patients that they are ‘fine’ in the same 
moment that patients experience extreme drop offs in physical and cognitive ability. 
Physician authority can be so inflated that it crosses over into gaslighting: 
Adaline: The ENT doctor didn't [say I think this is in your head] but he also didn't 
listen to me. He would say, “Oh, you have X symptom.” 
“No, I don't.” 
But he put it in my chart anyway. 
This physician assumed complete authority over his patient’s symptoms. He was not 
influenced or informed by the direct words and testimony of the patient in front of him. If 
he said a symptom was real, it was real, and he made it real by writing in her medical 
record, meaning that she would have to deal with the real effects of that recorded 
symptom over and over, even though that specific symptom was in no way part of her 
physical experience. 
Dismissal by physicians. In contrast to disbelief, which engages physicians’ 
internal belief systems and training about credibility, dismissal operates in terms of 
concern. How attentive is the physician to patient needs? How does the physician treat 
the patient? Does the physician use the cognitive skills needed for empathy?84 Different 
kinds of dismissive behaviors emerged in the interviews: 1) overt dismissal, including 
dehumanizing language, and 2) subtle dismissal, including delay and inaction. Both result 
in harm to the patient because they obstruct access to medical care. 
                                                 
84
 Chapter 4 contains more information on empathetic behavior, which is centered on three cognitive 
strategies: 
1) understanding the patients’ point of view, 2) successful communication of that understanding, and 3) 
taking action to help (Frankel, Hojat, DeSantis, & Gonnella, 2017). 
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Overt dismissal occurs when physicians communicate outright disdain toward 
their patients. They laugh at the patient, or repeatedly fail to listen to the patient, or refuse 
to incorporate new knowledge provided by the patient. In participant examples, it often 
reads as being brushed aside. 
Lena: They laughed. They literally laughed when I asked for a lyme test. They 
rolled their eyes and started laughing like it was the most ridiculous funny thing 
they’d ever heard. 
Kelli: So, they finally said, "Well, we've done as much as we can for you there." 
The pulmonologist said, "You know what, come back, if you're not feeling better 
in a year come back." He was kind of laughing as he said it. So, after that I was on 
my own. 
Cheryl: These people are treating me like I'm crazy and all I'm trying to do is get 
a diagnosis … [The doctor responded with a loud noise] “Ppuuhh!” [the sound of 
a dismissive burst of air]. Literally, he's like, “Ppuuhh!” And I'm like, sorry?  
And he's like, “People get foot drop all the time, drunks get it when they pass out 
in bad positions. You're fine, that foot drop’s going to resolve in six weeks.”  
That's how he talks to me. So, I'm like, okay. I said, well, why would I have 
gotten it, and isn't it strange that it kind of coincides with all these other 
symptoms that I've been having? 
And he's like, “Pfft. Listen. It'll resolve in six weeks.” 
Elizabeth: I feel like there are different levels of engagement and all of them are 
appropriate and the only one that's inappropriate is dismissal, for whatever reason. 
Either because you don't believe it's a disease, because you haven't thought about 
it, or read about it, or learned about it, since you were in medical school and back 
then they didn't know anything, or were actively trying not to know anything, or 
for whatever reason you're not interested. 
This is an iterative experience. Participants reported encountering this behavior from 
multiple physicians as a matter of course, not just from one or two bad actors. When 
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asked, Adaline recounted three physicians who exhibited dismissive behavior, off the top 
of her head: 
The last rheumatologist I saw diagnosed me in the top one percent of most severe 
fibro cases ever, but suggested an antidepressant. He also denied some of my 
other diagnosis that I have, and said they weren't real. 
You know, the first doctor I saw, to try to get better, basically looked at the blood 
work and said, “you're fine.”  
The pain doctor, she just refused to treat me at all. 
People with ME also experience overt dismissal in the form of dehumanizing language 
from physicians. 
Lena: The doctor said basically, "She'd be better off dead, because she’s a drain. 
Not only is she so sick and can't do anything and there's no cure no treatment, but 
she's a drain on her family as well. And so she'd be better off dead.” And I was 
lying there, not particularly thrilled. 
This physician told a mother with three children that they would be better off without her. 
Basic standards of professionalism were not present at that appointment for Lena and her 
family. Kelli also shared an experience with outright dismissal that was a flashpoint for 
her as she sought medical care. The way the physician treated her is an example of this 
pattern of dehumanizing dismissal. 
Kelli: When there was a question about lupus and I thought that the 
rheumatologist was the one to go to, for ME, for CFS, I had my GP at the time 
recommend someone. So, I went to this rheumatologist. I liked the office staff, 
they were real nice and things. I went in there and told him what I had, told him 
that I was there with a question about lupus. And he took blood tests and things 
and I came back for the results and I didn't have lupus, it was a negative test. And 
I thought he was going to be watching my CFS. I just thought he was—and he 
wasn't. I don't know if he just wasn't good with patients or what. He started 
basically kicking me out of his office, he told me, "Rheumatologist have enough 
patients with rheumatoid arthritis, we don't need other people with other things, 
we don't want patients that have those." 
 127 
 
And I was shocked. It was so not what I expected, that he was like, "I don't want 
to see you anymore." 
… I didn't understand that he was just looking into the lupus and if I didn't have 
lupus I was out … the other rheumatologist had offered to see me like once a year 
and watch me, so I just didn't know. And I finally was trying again to be proactive 
and I said, tell me you do believe in chronic fatigue syndrome. And he said, "Oh, 
I believe chronic fatigue syndrome exists. I just have no idea if you have it." And 
there was something about that in that moment—and I'd had the disease three and 
a half years—just knocked me off my center …That was the worst that ever got 
for me. That was the moment when I was like, I just can't do this anymore. I don't 
know what it was about the dismissal, but it was just … it was a stinger. 
This experience is more than a bad day at the doctor’s office. This is a potentially life-
altering, meaningful event. Kelli shared the desperate feeling that forms after several of 
these dismissive interactions with professionals who are tasked with providing medical 
care: 
Kelli: How do I get you to care? Because I need someone to care. It's a very 
orphan feeling to go home almost bedbound, almost homebound, and have 
nobody, no physician, no medical provider, even care. They're not asking about 
you. They're not thinking about you. They're not concerned about you. You're not 
dying. All your tests look good. That's the way it is. So, you just really feel like a 
medical problem with the ME. You really do. 
In addition to the examples above, physicians may also exhibit subtle dismissive 
behaviors. In these instances, physicians are polite on the surface but ultimately 
disinterested. There is no patient-blaming or confrontation, but there is a lack of 
engagement, no effort to research possibilities, and no feeling of responsibility from the 
physician. It comes from a simple foundation of “I can't/won't help you.” This less overt 
form of dismissal often emerges as delay or inaction, meaning that physicians fail to 
follow up on tests, labs, treatment, and appointments. These behaviors are less abrupt 
than dehumanizing language, but they also pose significant barriers to accessing medical 
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care. It was dismissal from a physician that caused Lena to stop seeking treatment for a 
time: 
Lena: The problem was that Dr. ___ told me that this disease is basically 
hopeless; I will be totally and permanently disabled for life. I was still at the point 
where I could barely talk, I couldn’t sit up, and he said this is how my life would 
be for the rest of my life, and in five, ten years I might get a little bit better but 
there’s nothing I can do. People are doing all kinds of research but they don’t 
know what they’re doing, and so what I would suggest is don’t even waste your 
time trying different treatments because there’s nothing that works and there’s no 
hope, and this is the kind of disease that just—it’s not solvable. 
Interviewer: And how did you respond to that? 
Lena: Well, I wasn’t happy about it, but I kind of believed him that he knew what 
he was talking about, and so for several years I never sought out treatment or 
doctors or anything because he was a very respected doctor … so I kind of 
believed him that he knew what he was talking about. 
Dismissal from physicians is also expressed through non-verbal communication: 
Kelli: When I say chronic fatigue syndrome—I try to say ME, but nobody knows 
what ME is—but if I say chronic fatigue syndrome, I have seen their eyes just 
glaze over. 
Following these interactions, participants experience delay and inaction from these 
medical providers, further obstructing their access to medical care. 
When physicians tell patients, “it's probably stress”, they are enacting a form of 
dismissal, because this response from a medical professional is often followed by no 
action; no further testing and no investigation into causes or treatments. It serves as a 
polite stand-in for “I can't/won't help you.” 
From an ethical standpoint (O’Leary, 2018), institutions that are responsible for 
medical training must ask themselves why a person’s diagnosis is an acceptable reason 
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for medical professionals to treat them with disdain. And they must then ask what they 
are doing to reconstruct their own norms in order to address this existing problem. 
Psychosomatic assumptions by physicians. The way physicians think about ME 
is formed over time by exposure to medical curriculum that routinely advantages visible 
illness and protects clinician authority. Assuming psychogenic cause leads down a 
treatment path that ignores biological treatments and leaves patients at dead ends, as 
Adaline experienced: 
The pain doctor who refused to treat me never said specifically, didn't spell out, I 
think this is in your head, but kind of acted like it. Same thing with the 
endocrinologist … Now one of the psychiatrists I saw did tell me that I should be 
able to imagine my pain away. So, that was great.  
The rheumatologist suggested an antidepressant. The orthopedic doctor just sent 
me to the neurologist who sent me to another orthopedic doctor. So, I wouldn't 
say—it wasn't as overt as some of the stories I've heard. But I would say that it 
was there and sometimes it was implied. 
When physicians spend limited time with patients, without doing any examinations, they 
tend to fill in the gaps with assumptions. For example, Ashanti met with an infectious 
disease specialist who spoke with her briefly, ordered a cursory blood test, and sent her 
on her way. He did not communicate what he wrote in her medical records. 
Ashanti: I ended up requesting my consultation note from him … and he had the 
audacity to put on there that I might be ill from a psychological illness … I sent 
him a very not-so-nice email—it was very professional, but it was not so nice—
and he apologized profusely.  
[He] didn't even examine me physically. [He] talked to me for five minutes and 
had the audacity to put in my consult note that I might be sick due to something 
psychological ... I told him off, in a professional way, and he did change what he 
wrote on the note. He apologized profusely, he agreed that I was correct, and 
changed it. So that was nice, but not everyone knows that they can do that and not 
everyone gets that kind of response. But what I wrote in the email was right and I 
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called him on it and I used my medical knowledge to be able to convey to him 
how wrong that was … I was glad that I had requested the records and actually 
read and saw that and was like, oh no, excuse me sir, you're not going to have this 
on my record, because it's not accurate. And you can't draw those conclusions on 
a patient that you spend five minutes with, that's just asinine. You're not a 
psychiatrist. You're not a psychologist. You're an infectious disease specialist. So 
please stay in your lane. 
These psychosomatic assumptions impact the level of trust that patients have with 
clinicians; they can’t be sure if the clinician will act in their best interest. 
Interviewer: Have you found that people with CFS themselves are hesitant to 
embrace their own anxiety and depression symptoms or even recognize or talk 
about it because there's a fear of being dismissed? And that their whole treatment 
process is at risk? Like, if I admit that I am depressed, will I suddenly not be able 
to get treatment for my POTS? 
Cheryl: Right. Or will they say you don't really have POTS85, you just have 
depression and you somaticize the POTS. It’s hard to somaticize a heart rate that 
increases. I mean, that's pretty objective. 
Chronic illness patients who repeatedly experience these types of reactions from 
physicians are less trusting of practitioners in general (Smith, 2017) and it takes longer to 
find adequate care (Dusenbery, 2018). 
Care and Harm from the Same Hand86 
Not surprisingly, the interactions with physicians did not cleanly divide into 
binaries of good/bad, effective/harmful. What did arise from my data was a pattern of 
three-steps-forward, two-steps-back. For example, when talking about specific physicians 
sometimes participants had infrequent negative experiences in the context of an office 
                                                 
85 Postural Orthostatic Tachycardia Syndrome (POTS). See footnote in the hygiene section of Chapter 2. 
 
86
 tl;dr - Interactions with individual physicians often contain positive and negative elements, and do not 
sort cleanly into a binary of effective/ineffective. 
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environment that is supportive overall. This is feasible to maintain, as progress happens 
iteratively over many appointments and trying different tactics. However, they also 
reported instances of gaining one positive piece of information from a physician despite 
the wider context of a degrading and inept office environment. 
The physician that finally provided answers for Adaline by diagnosing her with 
ME/CFS was an example of this sort of mixed-bag experience. She did get a diagnosis 
there, which moved her in a productive direction, but there were also problems with 
delay, disbelief, lack of insurance coverage, and unprofessional organization of medical 
records. 
Elizabeth described one appointment she had with a “scatterbrained” doctor who 
had wildly disorganized records, lost Elizabeth’s payments, and was two hours late for 
the appointment while Elizabeth struggled to sit upright in the waiting room. She 
recalled, “The whole experience was too physically taxing to be sustainable.” The 
positive take away? This physician did know about ME/CFS. On another occasion, 
Elizabeth had a mixed positive/negative experience with a clinician with good bedside 
behavior, but nothing real to offer: 
Elizabeth: [My primary care doctor] sent me to this mind/body clinic… and that 
doctor there had a resident with him that day when I saw him, and he was asking 
me all these questions. And every time I'd answer, he'd turn to the resident and 
say, that's so typical of this disease, and it was really nice to have, like this is 
something people see and it's normal, I'm normal, within the same group of 
people.  
But also, the only real things that he offered me were yoga and meditation, which 
I already did and was pretty deeply trained in for a long time. So, it just didn't 
make sense—I was like, I know these things aren't going to help me.  
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Elizabeth’s experience at this clinic illustrates the nuanced ways in which care comes 
about. This clinic provided the validation of a medical professional recognizing the 
disease, while also falling into the trope of offering yoga as treatment, when Elizabeth 
was already extensively trained in it. 
It can be tempting to categorize clinical encounters as either effective care or 
ineffective care, but for the most part doctor’s appointments contain both. Successful care 
and negative experiences can co-occur. Physician engagement exists on a spectrum, 
ranging from full dismissal to cooperative care. Somewhere in the messy middle of that 
spectrum are the physicians who acknowledge that they are unable to help with ME (they 
may even hold questionable underlying beliefs about recovery or the nature of illness); 
however, they do step up for specific needs, such as letters to insurance companies or 
getting assistive devices. These physicians are problematic and helpful. 
Conclusion 
These responses from participants echo the broader global problems that women 
with ME experience, as quantified by Hansen and Lian (2016), which reports that quality 
of care was rated as ‘poor’ by women with ME and CFS 60.6% of the time for primary 
care, 47.7% of the time for specialist care, and 71.2% of the time for coordination of care. 
The limitations in current medical policies and practices need to be changed. Despite the 
difficulties that they have faced while seeking medical care, the participants in this study 
made a point of saying that others with ME have it worse. For example, Ashanti’s illness 
narrative covers multiple years, hospitalizations, unclear diagnoses, disbelief, confronting 
inaccurate records, and still she frames her experiences as far smoother than average. 
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With this in mind, participants offer collaborative solutions to many of the systemic 
barriers, which are discussed in the following chapter.  
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CHAPTER 4  
RECOMMENDATIONS87 
Everybody in our community knows, but few people outside of our community know,  
that there needs to be a sea change in terms of education, increased clinical care, 
destigmatization, and increased urgency for the research and drug trials.  
There's so much that needs to be done on this disease. - Lena 
The lived experiences of people with ME reveal key domains within medical 
practice, structure, and belief systems that need to be reconstructed so that medical care is 
accessible to those with chronic illnesses such as ME. Participant experiences provide 
insight into these medical norms at both the institutional and interpersonal levels. 
                                                 
87
 tl;dr - see Table 3. 
Table 3. 
Recommendations for Overcoming Barriers to Effective Care 
 
Level 
  
Recommendations 
 
Institutions  1. Include ME in the U.S. Medical Licensing Examination. 
2. Implement feedback systems for medical students and patient 
groups. 
3. Strengthen the role of communication skills in medical curriculum.  
4. Incentivize the use of telemedicine. 
5. Coordinate professional medical care through a case manager. 
 
 
Individual 
Physicians 
 1. Believe the patient. 
2. Express statements of willingness. 
3. Engage meaningfully in collaborative care. 
 
 
Patients  1. Find and stick with physicians who advocate for you. 
2. Self- advocate by asking questions and requesting medical records. 
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Recommendations for Institutions 
Throughout the interviews, participants in this study suggest institution-level 
solutions to address the barriers discussed in the previous chapter. Their comments focus 
primarily on medical training and telemedicine. 
In order to receive effective care, people with ME need clinicians to be better 
trained in two key areas: 1) content knowledge about ME and 2) communication skills. In 
the interviews, Lena mentions that we “have to do a better job training physicians”, in 
reference to the harmful behavior physicians exhibit with no accountability. Cheryl 
indicates that while training alone “won’t entirely solve the problems in this field” it 
remains a key component of systemic change, because “educating physicians is essential 
and will make a difference.” People with ME frequently encounter a knowledge gap 
(Dusenbery, 2018) with their physicians because these medical practitioners were not 
exposed to the diagnostic criteria for ME or CFS in medical school (Jason, Paavola, 
Porter, & Morello, 2010). In one health advocate’s investigation of this lack of coverage 
in medical curriculum, she reached out to the directors of a few top ranked medical 
schools in the United States. They each displayed a lack of knowledge about ME. When 
asked why their medical curriculum did not include ME/CFS, the director for the Office 
of Medical Education at The University of Nebraska Medical Center responded that 
medical students will be exposed to ME while they are in rotations. ME advocates 
noticed a striking oversight by the director: “This presumes, however, that the students in 
clinic will have a chance encounter with a patient who has ME/CFS – likely – but that the 
individual will have the diagnosis of ME/CFS – far less likely” (MEAction, 2016). It also 
assumes that the attending physician in the rotation would know how to work with people 
 138 
 
with ME or what to teach medical students about the illness88. This circular fallacy 
highlights a persistent problem: for many patients, getting a diagnosis takes years because 
their physician received no training, and those in charge of training are relying on chance 
encounters with diagnosed patients in rotations. This knowledge gap can begin to be 
addressed by adding the diagnostic criteria for ME, as well as key considerations for 
differential diagnosis, to the U.S. Medical Licensing Examination. This would incentivize 
medical schools to include it in their curriculum. Additionally, this gap can be addressed 
through the development and wide dissemination of continuing medical education 
courses specifically about ME for physicians already in the field. 
Another knowledge gap that needs to be addressed at an institutional level is the 
incorporation of student feedback and patient collaboration in subject areas that have 
historically been marginalized; namely, chronic illness and women’s health. In their 
work, Henrich, Viscoli, and Abraham (2010) document the perceptions of medical 
students about the level of preparedness their medical training offered in the area of 
women’s health. They found that students were engaged in only ‘brief to moderate’ 
coverage of sex and gender information pertaining to mental health disorders, 
reproductive function, preventative health, interpersonal violence, and common medical 
conditions. The ratings were lower among female medical students, indicating a possible 
difference in expectations. Henrich, et al. suggest further study to implement student 
feedback into teaching protocols. Using this suggestion to integrate feedback from 
medical students—and adding to it the need to incorporate consistent, integral feedback 
                                                 
88 From a discussion with Elizabeth. 
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from patient committees into medical teaching—would act as one possible tool to resolve 
barriers to care for the women with ME. 
Another element of medical training that emerged from the interviews is the issue 
of physician communication: 
Kelli: A barrier was lack of communication from the doctors. [The primary care 
and the rheumatologist] were not sharing information with me. So I can't help 
them because they're acting like it's a secret and I don't get to be in on the secret. 
That's how it feels, like this is a secret language— “we need to know, but you 
don't need to know.” 
Including more robust communication skills and professional expectations in medical 
training would help to address this issue, especially in regard to preparing physicians to 
conference with patients about complex medical conditions. As noted by a key scholar in 
bioethics, “in medical education there exist few guidelines for communicating with 
patients about diagnostic uncertainty—and given the incredible prevalence of MUS 
[medically unexplained symptoms], this seems both surprising and worrisome” (O’Leary, 
2018, p. 8). Training physicians with better communication skills should not be employed 
solely for the purpose of increasing patient compliance, as this runs the risk of reinforcing 
hierarchical and paternalistic models of communication. It also fails to account for patient 
credibility and agency. Rather, physicians should be equipped with the skills necessary to 
engage meaningfully with patients with the goal of mutual understanding and effective 
care. The way forward for improving physician training can be found in patients’ 
experiences and descriptions of collaborative solutions. Participants in this study 
reinforce the need for change, to create expectations of collaborative clinical encounters 
where the knowledge of both the patient and the physician is valued.  
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A recent study on clinician behaviors tracks the importance of empathy in a 
clinical setting (Frankel, Hojat, DeSantis, & Gonnella, 2017). The researchers define 
empathy in this setting as a cognitive characteristic founded on three main behaviors:  
● understanding the patients’ point of view 
● successful communication of that understanding 
● taking action to help 
Patients’ perceptions of empathy are more highly correlated to clinical outcomes than the 
perceptions of third-party observers, and both of those are better indicators of correlation 
than the doctors’ self-reported perceptions (Frankel, et al., 2017, p. 79). Barriers to care 
arise when clinicians lack any of these three behaviors. Frankel, et al. suggest 
implementing better training for doctors to verbalize and communicate their 
understanding of patient experiences and needs. Their recommendation is supported by 
the experiences documented by participants in this thesis research. 
In addition to medical training, medical institutions can implement the practice of 
telemedicine. This includes following up with patients via email, telephone, or video 
conferencing. The need for telemedicine and the reasons it is necessary are expressed by 
participants in the context of their own geographic location and physical needs: 
Karen: [My most recent doctor] is the first one that's ever suggested 
[telemedicine] and been able to do that as an option. And if she had not, I 
wouldn't be getting the care I am right now … I don't know where I would be 
right now without having those ongoing virtual appointments.  
And especially having [a traumatic setback], because when that happened I was 
able to contact her immediately and she recognized the set back and she 
understood what was going on with that. 
Interviewer: And in the middle of that set back with heighted symptoms, you 
didn't have to drive to [city]. 
 141 
 
Karen: Yeah, and there's no way I could have. There's just no way I could have. I 
barely made it up there for the first appointment because I knew how critical it 
was. I even spent the night up there. So even spending the night and making the 
drive back … I barely made it. She saw how ill I was when I was up there. It's 
dangerous… I explained how unsafe and unacceptable it is for a single woman 
who is very ill, driving across the barren desert, to get to quality healthcare, and 
how thankful I am that she would meet with me subsequently via virtual. 
Similarly, when Elizabeth was too unwell to travel three to four hours away to see her 
doctor, she attempted to coordinate her care via email and phone conversations, with little 
success. Clinicians currently have little motivation to engage remotely because it is not 
part of their billing system and payment method; incentivizing the practice of 
telemedicine would open the door to patients for whom distance is an obstacle. 
 These main themes of physician training and telemedicine are accompanied in the 
participant interviews by two smaller themes: perception and coordination of care. Public 
perceptions about ME create barriers, as Cheryl indicates, “part of it is just getting people 
to reframe their perception of the illness.” Kelli has personally seen how increased news 
coverage, new research papers, and the conversations about new research affect 
individual people in positive ways. Her path to diagnosis depended on hearing about ME 
through news coverage and then learning more through conversations about new 
emerging research. 
Participants also report that the responsibility to coordinate care falls on them, 
which is unfeasible during the worst of their symptoms when they need effective care the 
most. They were responsible for coordinating communication between specialists, 
primary care physicians, pharmacists, and insurance representatives. Having a team of 
professionals working in collaboration, with an assigned case manager, would help to 
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address this barrier. Currently, this type of collaboration does not happen for participants 
unless they coordinate it themselves.  
As it is set up currently, the healthcare system has implicit prerequisites for care 
that are unacceptable moving forward. These prerequisites are never explicitly stated, nor 
do they appear in policy. They are created by the material implications of current and past 
priorities and biases in medical institutions, such as the second-class role of women’s 
health89 and the lack of specialists for chronic illnesses that primarily impact women. 
These prerequisites, as described throughout patient narratives, include the ability to fly 
to another state to see a specialist (including the exertion required to do this and the 
financial burden of travel), the necessity of convincing clinicians to do their job (based on 
gendered norms of credibility), and the frequent requirement to be more educated on ME 
than their clinicians (due to knowledge gaps in medical curriculum). Elizabeth’s narrative 
of seeking medical care includes many different but interrelated barriers along these 
lines: doctors believing she was fine; having difficulty sorting through theories online; 
not finding helpful information about ME from the Mayo Clinic or the CDC; and 
cognitive limits making researching it all on her own unfeasible. This experiential 
knowledge from participants is key to guiding changes within medical systems at an 
institutional level, which will create systems and contexts in which individual physicians 
will be equipped to provide effective care. 
                                                 
89 See Literature Review, ‘The changing position of women’s health within medical institutions.’ 
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Recommendations for Physicians 
Across the interviews in this research project, participants describe the 
characteristics of effective physicians. This topic is heavily represented in the interview 
data; when asked about barriers to care, more than half of participant responses related to 
physician behavior. The characteristics of effective physicians come from three vital 
traits that emerge from the data:  
1. Belief: Effective physicians believe their patients. 
2. Willingness: Effective physicians make statements of willingness. 
3. Engagement: Effective physicians actively work with patients as 
collaborators. 
These three traits differentiated effective experiences from harmful and obstructive 
experiences for the participants in this study. 
As a counter-action to the harmful narratives of disbelief, effective physicians are 
characterized by the way they believe their patients. They take patient reports seriously 
and respect the patient’s knowledge about their own body. Effective physicians believe 
that ME is a physical disease, not caused psychologically. The way they treat patients 
reflects these beliefs. 
Participants reported that effective physicians also made statements of 
willingness, such as: 
● I will treat you. 
● I will refer you to a specialist. 
● I will read up on ME research. 
● We can follow-up over phone or email. 
These statements indicate that the physician is, at a minimum, willing to meet with the 
person with ME and consider different treatment options. A physician may not know 
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about ME, but expresses willingness to pursue the available options, such as identifying a 
specialist to refer the patient to, or providing documentation for mobility devices, 
insurance, and/or disability hearings. Whether or not this willingness translates into 
effective care is revealed over time by the level of follow-through exhibited by the 
physician and their staff. 
Last of all, participants reported that effective physicians actually do the things 
they said they were willing to do. They actively listen to patients, ask questions, perform 
examinations, and follow through with a well-communicated plan of action. This sounds 
like a basic job description of what physicians should be expected to do. But participants 
interacted with numerous physicians who do not exhibit these traits, on the way to 
painstakingly finding physicians who do. Engagement is distinct from willingness in the 
interviews, as shown in this example from Adaline: 
My former primary was actually kind of a big barrier because anytime I needed 
something I would have to fight for it. I'd have to call and email, or they'd only 
send me part of what I requested. They were supposed to be on my side, and when 
I was in the office in front of them they acted like they were on my side, but then 
they wouldn't do what they said they were going to do. 
Expressing willingness while a patient is in the office is not enough. In order to provide 
effective care, physicians need to follow through in a collaborative manner with patients. 
When it comes to physicians lending a listening ear, participants have a lot of 
non-examples at hand, of what not to do: 
Adaline: Again, my biggest gripes are the doctors not listening. And they also 
have blinders on. If you don't fit in what they think you should fit in, they either 
ignore what you say, or they don't want to help you at all. 
Kelli: He really just was a horrible doctor. He was always an hour and a half late 
to appointments. And the last time I saw him, I was his first appointment of the 
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day and he was an hour and a half late into the office. So, there [was] a whole 
office full of people waiting for him. So of course, he was in kind of a hurry. So, 
he walks in and … he didn't even ask, he said, “You're feeling better.” 
And I said, no, no, I'm not. I'm not feeling any better.  
He said, “But that's because there's a lot of viruses going around right now” and 
he left within a couple of minutes. And he said, “So I'm glad to hear you're feeling 
better. Well, you will be once you get rid of that virus.” 
And at least I was like, I’ve got to get rid of this guy. This guy's just not listening 
at all.  
Through careful listening, effective physicians know their patients well enough to know 
what is helpful for them on an individual basis:  
Elizabeth: Having a doctor who gave me scientific papers, for me that was 
helpful. I think for most patients it wouldn't be. But I think that's part of treating a 
patient, based on who they are, not just what disease they have.  
Physicians can get to know patients during face-to-face interactions and also by engaging 
meaningfully with the documentation that patients provide: 
Interviewer: If you could imagine better clinical care, what would those 
interactions look like for you in your doctor's appointments? What kind of tone or 
behaviors would you expect in those clinical meetings? 
Adaline: First of all, it would be nice if they actually read my eff'ing medical 
information document. I think I have had two doctors, in all of [the forty-one], 
actually read them. One was my allergist. And the second one was the geneticist I 
saw on Monday. Nobody else reads it.  
Adaline took the initiative and spent energy to track her heart rate, pain symptoms, and 
activity levels in an app, as well as documenting her medical history (a list of her 
allergies, prescriptions, diagnoses, doctors she has seen, and medications she has 
previously tried or is currently taking), which her doctors refused to look at, with the 
notable except of her allergist and geneticist. Patients are taking the time and attention to 
 146 
 
gather data and there is not a reciprocated level of time and attention given by their 
physician. Patients have more incentive to return to clinicians that respect their work and 
input. 
In addition, physicians who initially received medical training that is ineffective 
for their patients can personally implement the institutional recommendations listed at the 
beginning of this chapter. For example, instead of waiting for systemic changes to be 
enacted from the top down, Karen’s doctor implemented telemedicine protocols into her 
own practice because it meets the needs of her patients. These recommendations can 
prepare physicians to meet the needs of people with ME and improve patient outcomes. 
Recommendations for Patients 
 Health advocates are working to address systemic issues that make healthcare 
inaccessible to people with ME. However, systemic changes take time. In the meantime, 
people with ME need practical actions to implement when they face barriers to care. In 
the interviews, participants commented on the necessity of holding out for effective 
physicians and of advocating for themselves. 
Participants in this study were persistent in trying again and again to find doctors 
who are willing and able to help them, despite the difficulty of receiving dismissive and 
dehumanizing feedback from many of their clinicians. Descriptions in medical articles, 
and physician attitudes, sometimes rely on caricatures of ME patients as lazy. The data in 
this study indicates that these women with ME are active, involved participants in their 
own well-being. Ashanti summed up the reasoning for this persistence in the face of 
barriers: 
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For me, when you're dealing with an illness like this that is so poorly understood 
and difficult to navigate, you need to stick with the doctors that are familiar, the 
doctors that believe you, the doctors that advocate for you, the doctors that are in 
your corner. 
Weeding out ineffective physicians from one’s team of medical providers is a labor-
intensive process, but one that participants engaged in with ultimately positive outcomes. 
In the absence of adequate physician training, for example, Lena takes her own 
precautions before meeting with a new physician: 
I have this really good technique now for finding doctors ... I first go on Yelp and 
check all the reviews. And then I go on Google and check all the reviews. And if I 
can find anybody who's in my vicinity who has all great reviews, then I see if they 
take my insurance and then I call them up. And pretty much I've done that for all 
my doctors and it's been great. And then once I find somebody good, I ask them 
for recommendations. That works really well, and I have a great doctor. My kids’ 
doctor is great. Our dentist is great. My therapist is great. I have wonderful, 
wonderful people helping me. … I've been pretty well informed enough to be able 
to research and seek out good doctors. And so that's been really wonderful. 
Implementing this system helps Lena find effective care and avoid repeats of the 
dismissive experiences she had previously. 
Self-advocacy also plays a major role. People with ME are often in situations 
where they have to develop a clear knowledge of what is in their own best interest and 
what is not, even in the face of medical uncertainties. During appointments, the 
participants take on a proactive role, asking questions, requesting referrals, requesting to 
see their own medical records, and calling out reckless or biased actions by clinicians. 
Both before and after appointments, these participants search online for scientific articles 
and reports about treatment options. They learn what they can and use that knowledge to 
move their medical care forward. Researching on their own is not easy given the 
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symptoms of ME, but participants share their experiences of doing what they can, 
whenever they can. 
Adaline: I don't know where I got the wherewithal to keep fighting, but obviously 
I did. And a lot of it was me researching and me going, okay, I have these 
symptoms, what causes these symptoms?  
Interviewer: Where did you go to do your research?  
Adaline: Google. Scientific journals. A little bit WebMD, but I don't really trust 
them so much. I try to go to the source ... I go back to the primary source. 
Cheryl sometimes uses a combination of asking for insight from her online patient groups 
and using her professional knowledge as a nurse. This is how she arrived at her POTS 
diagnosis; she navigated the information with her community, not through doctors. 
Ashanti indicates the benefits and limitations of entering an appointment with prior 
preparation: “I think me being a nurse and knowing what to ask for and how to ask for it 
definitely helps tremendously. But even still I encountered the infectious disease 
specialist who writes in my medical record that this was in my head.” Patients who are 
not medically trained often seek out friends or family members who are trained, to 
support them and teach them. Some people with ME use apps to track biophysical 
feedback like heart rate and sleep patterns. Each strategy may not work in all instances; 
however, the combination of a variety of actions, including these strategies, help 
participants access a greater degree of medical care.  
Throughout all of this, participants held on to the underlying truth of their own 
worth as people. Kelli repeated this theme throughout her interview: My life matters. 
Over the course of her search for medical care, she had to continuously assert the value of 
her own life in the face of procedures and people who do not value it. 
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Recommendations for Future Research 
As a chronic illness community, people with ME require research that is 
commensurate with the disease burden. This means a twenty-seven-fold increase in 
funding from the NIH, according to the NIH’s own algorithms for calculating the burden 
of a disease (Dimmock, Mirin, & Jason, 2016). This funding would support biomedical 
research to isolate biomarkers and treatments for ME, and studies to clearly capture the 
current prevalence of ME90. 
In addition to biomedical and prevalence studies, researchers can build on the 
original data from this study to continue to expand our understanding of the lived 
experience of ME. This expansion is particularly needed across categories of gender 
identity and race. Additional interviews with women of color need to be prioritized to 
reveal the particular nuances of navigating healthcare that result from the intersectional 
domains of race, health, and gender. Previous ME research has been unable to address 
these specific issues because of the consistent focus on primarily white populations in 
research samples, compounded with under-representation in patient advocacy leadership 
positions. 
To conclude, the lives of the seven women with ME in this study reveal that 
medical policies and definitions do not exist solely in the clinical realm; they show up in 
the lived experiences of patients. As health inequality continues to be a pressing issue in 
U.S. healthcare, creating responsive medical protocols for chronic illness communities is 
increasingly important. Research that centers patient narratives can help disrupt the cycle 
                                                 
90 Elizabeth notes that “prevalence studies are currently being proposed under the auspices of the CDC but 
require additional funding to that agency.” 
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of underfunding, stigma, and dismissal from medical institutions and physicians that 
people with ME have experienced for decades.  
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This thesis includes summaries of each section to make this piece as accessible as 
possible to all communities impacted by chronic illness. Each heading, or group of sub-
headings, has a footnote containing “tl;dr” and a brief sum-up the main ideas of that 
section.  
The acronym tl;dr stands for “too long; didn’t read”. It is used on social media 
platforms to sum up a long post. Providing my own version of this within an academic 
paper supports my commitment to plain language (see Theoretical Framework & 
Methodology) and facilitates communication with key communities outside academia. 
Including the tl;dr footnotes will also allow interview participants from this study to 
more readily scan, analyze, and provide feedback on this thesis. Their feedback is vital to 
the formation of this work.  
Below is a collection of all the tl;dr footnotes, which condenses each chapter 
down to a page or two. 
 
Chapter I 
 INTRODUCTION 
 
Overview 
Beliefs and ideas about illness are created socially. This makes advocacy and patient 
narratives necessary in order to challenge harmful beliefs about illness held by dominant 
medical institutions. Disability studies offers analytical tools to reconstruct medical 
norms. 
 
Literature Review 
Myalgic Encephalomyelitis: ME has gone by various names over the years. These 
names reflect social attitudes of the time period toward the disease, by their emphasis on 
fatigue/burnout OR on specific biological processes. 
 
ME in Context 
Funding: In the United States, the NIH does not fund ME research at a level 
appropriate to the disease burden. 
Medical model: The medical model claims that all life events are under the 
jurisdiction of medical institutions. Under this model, symptoms and illnesses are 
counted as ‘real’ when they are visible and thereby granted medical legitimacy by 
the institution. 
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The relationship between women and chronic illness: Women are more likely 
to have chronic conditions. Men are more likely to have fatal conditions. An 
estimated 75% of people with ME are women. 
The changing position of women’s health within medical institutions: Limited 
gains have been made in integrating women’s health concerns into medical 
curriculum and clinical practice. The FDA banned women from participating in 
drug trials from 1977 to 1993. Despite attempts to reverse this practice, drug 
companies still test drugs primarily on male subjects, resulting in consumer risk 
for the broader public. 
Naming chronic conditions: Conditions that fall in the neuroimmune and 
autoimmune category have similarities in patient experiences of stigma, dismissal, 
and lack of specialists. 
The role of institutional betrayal: When people are harmed by institutions they 
depend on for their well-being, this is called institutional betrayal. In healthcare, 
this occurs when patients’ reports of their conditions are dismissed and their 
reports of negative experiences are not believed. 
 
Feminisms and Disability Theories 
Multiple feminisms: Feminist theory encompasses the lived knowledge of 
multiple groups (queer theory, disability theory, Latinx theory, womanist theory) 
and makes ample room for the contradictions within and between these groups. 
Feminist research acknowledges that the scientific method and ‘objective’ 
research are impacted by human biases. It seeks to reveal hidden power 
imbalances. 
Disability Theories 
Feminist Disability Theory: Feminist disability theory uses the tools 
within feminism and critical race theory in order to address the social 
inequalities experienced by people disabled by that society’s norms. 
Critical Disability Theory: Critical Disability Theory (CDT) examines 
medical and social systems that create disabling circumstances. 
Multiple strategies: Solutions to health inequality require simultaneous 
work in both medical and social systems. 
 
Theoretical Framework & Methods 
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Qualitative feminist inquiry: A method of study that critiques bias and power 
imbalances. 
Feminist Disability Theory: Used here to center the stories and perspectives of people 
with ME, in keeping with the disability rights motto ‘Nothing About Us Without Us’. 
Epistemic injustice: Certain types of knowledge (empirical) are privileged over others 
(experiential). 
Plain language movement: Language and documents should be accessible to the people 
they are made for. 
Interpretivist processes: This method of research uses ethnography (close up study of 
communities) and awareness of positionality (intersections of social privileges and 
oppressions). 
Methods: In conducting this study, I used semi-structured interviews with seven 
participants with ME. 
 
 
Chapter 2 
THE LIVED EXPERIENCE OF ME 
“It was a lifesaver just to have somebody understand”: Direct quotes from each 
interview participant give an overview of life with ME. 
Exertion, Payback, & Rest: The Balancing Act: People with ME are careful about 
overexertion in order to minimize crashes. Rest serves the purpose of counterbalancing 
physical or cognitive activity, to the degree it is possible. Restorative, scheduled, and pre-
emptive rest are some of the types of rest that participants utilize. 
 
Day-to-Day-Life 
Routines: While day-to-day routines differ between each person with ME, 
common concerns include managing energy output and symptoms. Large portions 
of the day are dedicated to rest. 
“The most benign activity is taxing to your energy”: Boundaries Around 
Exertion: Living with post-exertional neuroimmune exhaustion (PENE) means 
that physical and cognitive activities (such as hygiene, online tasks, advocacy, 
emotional labor, and sensory input) take a serious toll and must be accounted for. 
 
Changes 
Onset: Participants share their personal stories about when their symptoms 
started. 
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Transitions: People with ME navigate many changes, such as the transition from 
an independent lifestyle to dependence on caretakers and reframing their beliefs 
about health and personal worth. 
“This disease obviously caused a lot of problems”: Dealing with Loss: 
Participants share the losses that ME has caused and the period of grief that goes 
along with that. 
“Society is a huge barrier against sick people”: Expectations Around Work 
and Worth: Social norms of productivity cause disruptions to self-worth for 
people experiencing the physical limitations of chronic illness. 
 
Relationships: Despite the difficulties of losing relationships, maintaining connections 
with family and online networks remains a key aspect of quality of life for people with 
ME. 
 
 
Chapter 3  
NAVIGATING HEALTHCARE 
“All I wanted was to figure out what was wrong with me”: This chapter focuses on 
the conceptual, institutional, and interpersonal barriers that participants encountered 
during their search for medical care. Some participants utilized their prior medical 
training to help them access care, with mixed results, and all participants expressed the 
desire to improve even in the face of stereotypes about malingering. 
 
Specific Diagnostic Terms 
What’s in a Name: The names and terms used to describe illness reflect and 
impact the conceptual formation of illness. People with ME use different medical 
terms, even amongst each other. 
Diagnoses of Trial and Error: Before receiving an ME diagnosis, participants 
navigated a series of other diagnoses that were ultimately inaccurate, comorbid, or 
unclear.  
 
Experiences with Institutions 
Harmful Narratives: For people with ME, access to care is obstructed by 
assumptions that permeate the medical field: disbelief (the patient is not treated as 
a credible source of knowledge), psychosomatic cause (unexplainable symptoms 
are dismissed as psychological and not given treatment), and recovery 
(assumption that chronic illness will eventually go away). 
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Systemic Barriers: Large-scale issues such as inadequate physician training, the 
cost of healthcare, lack of information about ME, and lack of ME specialists 
create barriers to care. 
 
Experiences with Individual Physicians 
Barriers: On an interpersonal level, between physicians and patients, physician 
behaviors can create barriers to receiving effective care. These behaviors include 
approaching patients with disbelief, telling patients ‘you’re fine’, using dismissive 
and dehumanizing language, assuming psychogenic cause, and giving bad faith 
diagnoses. 
Care and Harm from the Same Hand: Interactions with individual physicians 
often contain positive and negative elements, and do not sort cleanly into a binary 
of effective/ineffective. 
 
 
Chapter 4 
RECOMMENDATIONS 
Refer to Table 4 for a summary of institutional, interpersonal, and patient 
recommendations. 
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APPENDIX B 
INTERNATIONAL CONSENSUS CRITERIA (ICC) 
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As found in Table 1 in: Carruthers, B., van de Sande, M., De Meirleir, K., et al. (2011). 
Myalgic encephalomyelitis: International Consensus Criteria. Journal of Internal 
Medicine, 270(4):327-338. 
Also referred to as the ICC for myalgic encephalomyelitis. 
The following four categories constitute the criteria for ME according to the ICC: 
 
Category 1: Postexertional neuroimmune exhaustion (PENE) 
Patient must exhibit this symptom. 
 
Marked, rapid physical and/or cognitive fatigability in response to exertion, 
which may be minimal such as activities of daily living or simple mental tasks, can be 
debilitating and cause a relapse. Postexertional symptom exacerbation: e.g. acute flu‐like 
symptoms, pain and worsening of other symptoms. Postexertional exhaustion may occur 
immediately after activity or be delayed by hours or days. Recovery period is prolonged, 
usually taking 24h or longer. A relapse can last days, weeks or longer. Low threshold of 
physical and mental fatigability (lack of stamina) results in a substantial reduction in pre‐
illness activity level. 
  
  
Category 2: Neurological Impairments 
Patient must exhibit at least three of the four symptom categories. 
  
1. Neurocognitive impairments 
For example, difficulty processing information: slowed thought, impaired 
concentration e.g. confusion, disorientation, cognitive overload, difficulty with 
making decisions, slowed speech, acquired or exertional dyslexia 
OR 
Short‐term memory loss: e.g. difficulty remembering what one wanted to say, 
what one was saying, retrieving words, recalling information, poor working 
memory 
 
2. Pain  
For example, headaches: e.g. chronic, generalized headaches often involve aching 
of the eyes, behind the eyes or back of the head that may be associated with 
cervical muscle tension; migraine; tension headaches  
OR  
Significant pain can be experienced in muscles, muscle‐tendon junctions, joints, 
abdomen or chest. It is noninflammatory in nature and often migrates. e.g. 
generalized hyperalgesia, widespread pain (may meet fibromyalgia criteria), 
myofascial or radiating pain 
 
3. Sleep disturbance  
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For example, disturbed sleep patterns: e.g. insomnia, prolonged sleep including 
naps, sleeping most of the day and being awake most of the night, frequent 
awakenings, awaking much earlier than before illness onset, vivid 
dreams/nightmares  
OR  
Unrefreshed sleep: e.g. awaken feeling exhausted regardless of duration of sleep, 
day‐time sleepiness 
 
4. Neurosensory, perceptual, and motor disturbances  
For example, neurosensory and perceptual: e.g. inability to focus vision, 
sensitivity to light, noise, vibration, odor, taste and touch; impaired depth 
perception  
OR  
Motor: e.g. muscle weakness, twitching, poor coordination, feeling unsteady on 
feet, ataxia 
  
 
Category 3: Immune, Gastro‐intestinal, and Genitourinary Impairments 
Patient must exhibit at least three of the five symptom categories. 
 
1. Flu‐like symptoms may be recurrent or chronic and typically activate or worsen with 
exertion. e.g. sore throat, sinusitis, cervical and/or axillary lymph nodes may enlarge 
or be tender on palpitation 
 
2. Susceptibility to viral infections with prolonged recovery periods 
 
3. Gastro‐intestinal tract: e.g. nausea, abdominal pain, bloating, irritable bowel 
syndrome 
 
4. Genitourinary: e.g. urinary urgency or frequency, waking in the night to urinate 
 
5. Sensitivities to food, medications, odors, or chemicals 
  
 
Category 4: Energy Production/Transportation Impairments 
Patient must exhibit at least one of the four symptom categories. 
 
1. Cardiovascular: e.g. inability to tolerate an upright position ‐ orthostatic intolerance, 
neurally mediated hypotension, postural orthostatic tachycardia syndrome, 
palpitations with or without cardiac arrhythmias, light‐headedness/dizziness 
 
2. Respiratory: e.g. air hunger, labored breathing, fatigue of chest wall muscles 
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3. Loss of thermostatic stability: e.g. subnormal body temperature, marked diurnal 
fluctuations; sweating episodes, recurrent feelings of feverishness with or without low 
grade fever, cold extremities 
 
4. Intolerance of extremes of temperature 
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NAMING MULTI-SYSTEM CONDITIONS 
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Medical Terms  
& Definitions 
 
 
Diagnostic 
Examples 
 
 
 
 
 
 
 
 
 
 
 
 
Immune 
System
Immunodeficiency
an under response; the body 
is unable to defend against 
viral or bacterial infection 
primary immunodeficiency
HIV
Autoimmunity
an over response; the body 
attacks its own tissues
lupus
allerigies
celiac disease
mast cell activation
autoimmune encephalitis 
Autonomic 
Nervous 
System 
(ANS)
Failure of the ANS to properly 
regulate involuntary functions 
(blood pressure, heart rate, 
temperature, breathing, 
digestion)
Also called:
dysautonomia
autonomic nerve disorders
autonomic disorders
autonomic disease
autonomic neuropathy
postural orthostatic 
tachycardia syndrome 
(POTS)
orthostatic hypotention
cluster headaches
multiple symptom atrophy
pure autonomic failure
familial dysautonomia
syncope (fainting)
Undiagnosed 
Symptoms
Patients may remain 
undiagnosed due to a 
combination of possible 
factors: dismissal from their 
physicians, their constellation 
of symptoms does not match an 
existing diagnostic criteria, lab 
results remain in the 'normal' 
range. 
medically unexplained 
symptoms (MUS)
persistent physical 
symptoms
chronic multisymptom 
illness
Gulf War Syndrome
body distress disorder (a 
psychiatric somatoform 
disorder)
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Note: ME is classified as a neurological disease by the World Health Organization. It is 
related to the above classifications due to the neurological elements of the autonomic 
nervous system, as well as symptoms of ME that involve the immune system. 
 
 
References for Appendix C 
(alphabetized by diagnosis) 
 
Autoimmune encephalitis: 
Graus, Titulaer, Balu, Benseler, Bien, Cellucci, . . . Dalmau. (2016). A clinical approach 
to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391-404. 
 
Bodily distress disorder: 
Gureje, O., & Reed, G. M. (2016). Bodily distress disorder in ICD-11: problems and 
prospects. World psychiatry: official journal of the World Psychiatric Association 
(WPA), 15(3), 291-292. 
 
Dysautonomia: 
Dysautonomia International. (n.d). What is Dysautonomia? Retrieved from 
www.dysautonomiainternational.org. 
 
Gulf War Syndrome: 
U.S. Department of Veteran Affairs. (2017). Public Health: Gulf War veterans’ medically 
unexplained illnesses. Retrieved from 
www.publichealth.va.gov/exposures/gulfwar/medically-unexplained-illness.asp 
Note: The VA avoids the term Gulf War Syndrome. 
 
Medically unexplained symptoms (MUS): 
Marks, E. M., & Hunter, M. S. (2015). Medically Unexplained Symptoms: An acceptable 
term? British Journal of Pain, 9(2), 109-114. 
 
Smith, R. C., & Dwamena, F. C. (2007). Classification and Diagnosis of Patients with 
Medically Unexplained Symptoms. Journal of General Internal Medicine, 22(5), 685–
691. 
 
 
Myalgic encephalomyelitis: 
ICD-10-CM - International Classification of Diseases, Tenth Revision, Clinical 
Modification, July 26, 2018. Retrieved from 
 173 
 
https://www.cdc.gov/nchs/icd/icd10cm.htm#FY%202019%20release%20of%20ICD-10-
CM. 
 
The ICD-10 categorizes ME under the name benign myalgic encephalomyelitis, as 
follows: 
| Diseases of the nervous system 
| Other disorders of the nervous system 
 | Other disorders of brain 
  | Postviral fatigue syndrome 
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SUICIDE IN CHRONIC ILLNESS COMMUNITIES 
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Participant commentary on the topic of suicide, from various interviews, presented in six 
segments (bold emphasis added). 
 
I. 
Participant: I get why suicide is one of the top three causes of death with this illness. 
And it's not necessarily just to end suffering but to avoid being a burden to people who 
give up everything for you, which my husband thank god is that kind of supportive 
partner …  
Interviewer: Is there anything you want to add about the suicide rates? 
Participant: Just that first of all, they don't even track the disease, much less the suicide, 
so it's really tricky. But I see it on social media all over the place, people from all over the 
world killing themselves with this illness at all ages because of the just devastation of it. 
And I really believe it should be researched, studied, and we should be looking for 
specific interventions that we can provide to people with chronic invisible illness to 
help them cope. 
Which is— I thought that maybe I could do something. I doubt that I can— I can't. I just 
can't. You know, I'm not a researcher. That's not my thing. But I have definitely— I've 
got my sort of hypothesis and ideas about research that could be done using some 
interventional stuff that might help— not medication but other types of interventions. 
But it's a really taboo subject. What I found in reaching out to other advocates 
nationally is that people don't want to really address it. 
Interviewer: Specifically with ME/CFS? 
Participant: Yeah. Well, part of it is they worked so hard at destigmatizing and 
clarifying that it's not psychological or psychosomatic or a psychiatric problem that they 
don't want to be seen as depressed, anxious, or suicidal people. But they are, because 
they're killing themselves. You know what I mean? And so it's tricky and if you bring it 
up— I brought it up to, as I said, some top advocates and nobody wanted to form a 
committee or work on it. I've asked a couple researchers. I've asked even my specialist if 
she would reach out to some people. And just people aren't— people are afraid to touch 
it. I don't blame them. 
But I just know psychiatric emergency rooms. I know how people deal with crises. And I 
know what happens when people call suicide hotlines and things like that. And I've had 
plenty of patients brought in handcuffs and having their— losing their civil rights and 
being treated—taking— we take their clothing. We take their cell phones. We isolate 
them. We put them in areas that might have violent people, or loud agitated people, 
people high on meth, they're all thrown in a room, no matter what their stuff is, in 
psychiatric emergency rooms. And sometimes they're held for days and days, sometimes 
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even weeks in [location]. It happens for weeks. I've worked in there and it's horrifying to 
me and anybody with a chronic illness that's triggered by stimulation like that; lights, not 
being able to have control over temperatures, and scents, and things that trigger them. It's 
just not a good option. 
 
II. 
Participant: I have actually a friend in [location] who has been suicidal recently, who 
reaches out when she feels that way, and she actually asked me at one point: What's the 
best psych hospital in [location] and I told her go to [hospital name] because they'll at 
least treat you and they’ll try to keep you with depressed people instead of violent people 
… it's a nicer facility and there's activities and art therapy and there's things to do. It's not 
just a holding tank. But I said, it's still— they still take your cell phone away, they're 
going to take your belts and your shoelaces and anything that you could use to harm 
yourself. And it's still not—you're not going to have internet access and you're not going 
to have any— She was like, I'm gonna choose to stay home and just ask my husband to 
come home from work and sit with me. And I feel bad for her. I wish there was better 
resources for her, but there aren't. 
 
III. 
Interviewer: Have you found that people with CFS themselves are hesitant to embrace 
their own anxiety and depression symptoms or even recognize or talk about it because 
there's a fear of being dismissed? And that their whole— if I admit that I am depressed, 
will I suddenly not be able to get treatment for my POTS? 
Participant: Right. Or will they say, you don't really have POTS, you just have 
depression and you somaticize the POTS— it’s hard to somaticize a heart rate that 
increases, I mean that's pretty objective. 
But yeah, I do believe that people avoid it. 
Some do and then others just— I can't tell you how many Facebook posts that I see or is 
like, oh I can't take it anymore. You know, and I just think this is so inappropriate, like 
this should not be the only avenue for these people to ask for help. It's frightening to 
me and as somebody who was a psychiatric nurse who could involuntarily commit people 
to mandatory evaluation or treatment, I don't feel comfortable really because I'm still 
licensed and just in case, and I just, I don't feel comfortable with advising people or 
intervening and neither should anybody be doing that on social media, but they do so I 
just— I try not to look at a lot of that. But it is it is really tragic to me how many people 
have died by suicide. 
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Interviewer: What do you imagine that avenue being, if there was a robust medical 
response to suicidal ideation in chronic illness communities? 
Participant: Well, I think it's unfortunate because there just isn't adequate resources in 
Mental Health Training to manage the schizophrenia, the chronically mentally ill, and the 
people with chronic physical illnesses. But if specialty providers for ME/CFS, like 
Bateman Horne has done now, could provide some kind of psychological intervention 
that would be useful. Part of it is just getting people to reframe their sort of perception of 
the illness … and then part of it is actually providing help with things like insomnia, 
which is definitely a suicide risk. 
… there's three I's … of suicide, and the three I's were perceiving your situation as 
interminable, intolerable, and inescapable. Which anybody who gets the diagnosis, 
once they start researching it, starts to see that oh my god, that's so characteristic. You 
don't know when it's going to end. You don't know if you can ever get better. The 
symptoms can be so severe that you don't know if you can suffer that pain one more day 
or that insomnia one more night or whatever it is. 
 
  
IV. 
Participant: But the worst [physician interaction] that hit me hardest was two years ago. I 
went to another rheumatologist, the first one that diagnosed me … he took blood tests and 
things and I came back for the results and I didn't have lupus. It was a negative test. And I 
thought I was going—I thought he was going to be watching my CFS. I just thought he 
was … and he wasn't. I don't know if he just wasn't good with patients or what. He started 
basically kicking me out of his office saying … "Rheumatologist have enough patients 
with rheumatoid arthritis, we don't need other people with other things, we don't want 
patients that have those." And I was shocked. It was so not what I expected … he was 
like, "I don't want to see you anymore." 
Interviewer: How many appointments had you made with him? 
Participant: This was a second. So, this was the blood test. I didn't understand that he 
was just looking into the lupus and if I didn't have lupus I was out. I thought he was 
maybe going to— because the other rheumatologist had offered to see me like once a 
year and watch me, so I just didn't know. 
And I finally was trying again to be proactive and I said, tell me you do believe in 
chronic fatigue syndrome. And he said, "Oh, I believe chronic fatigue syndrome exists. I 
just have no idea if you have it." And there was something about that in that moment— 
and I'd had the disease three and a half years— just knocked me off my center. 
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If I had had the means at that moment, I think I would have ended it. It hurt that bad 
and it was that shocking … And I walked out, almost in a daze, and I remember the 
receptionist saying, "When are we going to see you again?" And I said, he doesn't want to 
see me. She's like, "What?" and she confirmed it with him … And I kind of just reeled 
out into the light and then after about five minutes, because I am 56-years-old and have 
been through a certain amount in my life, I remembered that he hadn't given me the 
disease and he had no answers for me and I'd be okay. Yeah, I didn't need him … I just 
laughed it off and things. But it stung. That was the worst that ever got for me. That was 
the moment when I was like, I just can't do this anymore. And I, like I said, I don't 
know what it was about the dismissal … I think I don't even know his name. I would 
have to really do some research to even remember his name. But it was it was a stinger. 
So. 
Interviewer: Yeah, those stand out. 
Participant: Yeah. And I think to myself, had I not had the support system—what 
happens to people? [pause] It actually still upsets me. 
Interviewer: It's upsetting. 
Participant: … I've had worse, but that was the most upsetting one. 
 
  
V. 
Interviewer: Is there anything I haven't touched on that you would like to include? 
Participant: Let me think real quick. 
Interviewer: Take your time. 
Participant: Probably one last thing, and that was probably one of the things that's helped 
me through this as much as anything else, has been a social network of other patients. I 
do not know how people survived before social network. I just— hearing other people 
and knowing that they're going through the same thing or that they have gone through the 
same thing for 34 years or what— is lifesaving. It's eased the isolation quite a bit. So 
that's just one—you know, that's just been really important. Even if I get no information 
on the disease, it's not— it's aside from that. It's just knowing, recognizing, that when 
someone's talking about their life it sounds a lot like mine. That's been good because 
otherwise I would literally not know one other person who's experiencing what I have. 
We all in our bedrooms. 
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VI. 
Participant: But you know if it wasn't— to be completely honest, if it wasn't for my 
husband taking care of me, I would probably have killed myself. Because it's just— I 
have no one else. And I— I’m in— disability says I should be able to work and I tried 
until I broke myself. 
So, instead of— I really believe that when I had first gotten sick, to the extent that I got 
sick that I felt like I needed help for it, if someone had said, "This is what you have. 
Learn how to pace, you know, do these things," I would be a hundred times better. 
Because I wouldn't have run myself ragged. But there was nobody to say those things. 
There was— you know back to society saying your worth is based on you working and 
what you contribute. So, sorry I just got a little soap box there. 
 Interviewer: That was very articulate and such a beautiful way to put it. Yeah, all of the 
ways that medical systems are working or not working for people who can't work. 
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EXEMPTION GRANTED 
 
Annika Mann 
Humanities, Arts and Cultural Studies, School of (SHARCS) 
- 
Annika.Mann@asu.edu 
Dear Annika Mann: 
On 10/26/2018 the ASU IRB reviewed the following protocol: 
Type of Review: Initial Study 
Title: Patient Narratives of Myalgic Encephalomyelitis: 
Context-rich descriptions of access, diagnosis, and 
recovery 
Investigator: Annika Mann 
IRB ID: STUDY00008992 
Funding: None 
Grant Title: None 
Grant ID: None 
Documents Reviewed: • IRB Application Protocol for Patient Narratives of 
ME, Category: IRB Protocol; 
• Recruitment Scripts for Patient Narratives of ME, 
Category: Recruitment Materials; 
• CITI Completion Report for Annamaria Oliverio 
Lauderdale, Category: Other (to reflect anything not 
captured above); 
• CITI Completion Report for Annika Mann, 
Category: Other (to reflect anything not captured 
above); 
• ICC Checklist, Category: Screening forms; 
• Consent Form for Patient Narratives of ME, 
Category: Consent Form; 
• Contribution Matrix and Selection Process, 
Category: Screening forms; 
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The IRB determined that the protocol is considered exempt pursuant to Federal 
Regulations 45CFR46 (2) Tests, surveys, interviews, or observation on 10/26/2018.  
In conducting this protocol you are required to follow the requirements listed in the 
INVESTIGATOR MANUAL (HRP-103). 
Sincerely, 
IRB Administrator 
cc: Carmen Cutler 
Annika Mann 
Carmen Cutler 
Annamaria Oliverio Lauderdale 
 
 
 
  
• Interview Instrument, Category: Measures (Survey 
questions/Interview questions /interview guides/focus 
group questions); 
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